This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Combinations of oral blood glucose lowering drugs
COMB_ORAL_GLUCLOW
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
1 out of 7 registries used, show all original rules. |
12344 |
4. Check minimum number of events
Min. number of events
3
|
12344 |
5. Include endpointsNone |
12344 |
6. Filter based on genotype QC (FinnGen only) |
12344 |
Control definitions (FinnGen only)
- Control exclude
- DIAB_MED_OTHER
Extra metadata
- First used in FinnGen datafreeze
- DF2
Similar endpoints
↥List of similar endpoints to
Combinations of oral blood glucose lowering drugs
based on the number of shared cases.
Similar with more cases:
- Other (not insulin) diabetes medications
- Diabetes medication
- Type 2 diabetes
- Diabetes mellitus
- Endocrine, nutritional and metabolic diseases
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 12344 | 4702 | 7642 |
| Unadjusted period prevalence (%) | 2.70 | 1.60 | 3.37 |
| Median age at first event (years) | 61.39 | 61.11 | 61.55 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 10741
- Matched controls
- 107411
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
A10BX01
ATC
guar gum; systemic
10.8
323.3
648
633
103
Kela drug reimbursment
Diabetes, insulin-treated
1553.5
323.0
10502
2907
346
Kela drug reimbursment
Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)
2516.5
323.0
2507
12
A10BX02
ATC
repaglinide; oral
651.9
323.0
499
8
SPAT1262
SPAT
Handing over of treatment supplies
16.0
323.0
5288
6145
A10BD08
ATC
metformin and vildagliptin; systemic
11056.4
323.0
1014
*
162
Kela drug reimbursment
liraglutide
5745.1
323.0
556
*
A10BK01
ATC
dapagliflozin; oral
91.3
323.0
2171
297
T90
ICPC
Diabetes non-insulin dependent
105.0
323.0
8434
3610
215
Kela drug reimbursment
Diabetes, non-insulin-treated
750.4
323.0
10178
2527
SPAT1306
SPAT
Counselling and guidance related to nutrition and weight management
4.0
323.0
2008
5879
A10BG02
ATC
rosiglitazone; oral
1541.9
323.0
711
5
A10BJ01
ATC
exenatide; parenteral
+∞
323.0
417
*
A10BX09
ATC
[U] dapagliflozin; oral
1994.0
323.0
538
*
A10BD05
ATC
metformin and pioglitazone; systemic
+∞
323.0
564
*
205
Kela drug reimbursment
Chronic hypertension
4.5
323.0
4939
17151
A10AC01
ATC
insulin (human); parenteral (insulins and analog. for injection, intermediate-acting)
7.6
323.0
1216
1770
A10BD20
ATC
metformin and empagliflozin; systemic
1668.0
323.0
1172
8
C10AA05
ATC
atorvastatin; oral
2.8
323.0
5585
29755
A10BB12
ATC
glimepiride; oral
524.2
323.0
3279
91
177
Kela drug reimbursment
Insulin glargine 300 U / ml
17.4
323.0
550
332
A10BG03
ATC
pioglitazone; oral
1566.9
323.0
1368
10
E11.7
ICD-10 Finland
Type 2 diabetes mellitus, with multiple complications
40.0
323.0
1487
429
A10AB05
ATC
insulin aspart; parenteral (insulins and analog. for injection, fast-acting)
15.3
323.0
1985
1571
A10BD03
ATC
metformin and rosiglitazone; systemic
7361.1
323.0
1869
*
A10BA02
ATC
metformin; oral
2368.7
323.0
10415
1436
I10
ICD-10 Finland
Essential (primary) hypertension
3.9
323.0
8148
47783
XCK10
NOMESCO Finland
Photography of fundus of eye
4.9
323.0
1727
4035
A10BD15
ATC
metformin and dapagliflozin; systemic
1975.0
323.0
777
*
A10AE06
ATC
insulin degludec; parenteral
12.9
323.0
699
574
A10BD07
ATC
metformin and sitagliptin; systemic
16384.0
323.0
7048
7
A10BH02
ATC
vildagliptin; oral
429.9
323.0
651
16
A10BJ02
ATC
liraglutide; parenteral
583.9
323.0
1153
22
E11.9
ICD-10 Finland
Type 2 diabetes mellitus, without complications
120.7
323.0
8343
3018
160
Kela drug reimbursment
exenatide
11691.2
323.0
1066
*
E11.6
ICD-10 Finland
Type 2 diabetes mellitus, with other specified complications
59.6
323.0
506
89
A10BK03
ATC
empagliflozin; oral
198.6
323.0
3353
245
A10BD11
ATC
metformin and linagliptin; systemic
+∞
323.0
355
*
C10AA01
ATC
simvastatin; oral
4.2
323.0
7035
33226
A10BH01
ATC
sitagliptin; oral
816.8
323.0
4229
84
A10BB01
ATC
glibenclamide; oral
183.5
323.0
877
52
E11.3
ICD-10 Finland
Type 2 diabetes mellitus, with ophthalmic complications
45.4
323.0
899
216
A10AE04
ATC
insulin glargine; parenteral
37.3
323.0
3800
1552
SPAT1008
SPAT
Photography of fundus of the eye or interpretation of photograph
31.5
323.0
1055
370
E11.2
ICD-10 Finland
Type 2 diabetes mellitus, with renal complications
61.7
323.0
957
170
A10BX07
ATC
[U] liraglutide; parenteral
+∞
323.0
654
*
E66.00
ICD-10 Finland
Metabolic syndrome
10.8
323.0
1259
1299
E66.01
ICD-10 Finland
Obesity due to excess calories
5.8
323.0
1144
2158
A10BH05
ATC
linagliptin; oral
279.1
323.0
1214
49
A10AE05
ATC
insulin detemir; parenteral
22.1
323.0
1705
908
E11.4
ICD-10 Finland
Type 2 diabetes mellitus, with neurological complications
57.3
323.0
637
118
C08CA01
ATC
amlodipine; oral
2.3
323.0
4617
26513
A10BJ05
ATC
dulaglutide; parenteral
+∞
323.0
383
*
285
Kela drug reimbursment
Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)
2959.1
323.0
2826
12
A10BX04
ATC
[U] exenatide; parenteral
+∞
323.0
509
*
SPAT1250
SPAT
Comprehensive monitoring of chronic illness
8.4
323.0
6040
14302
E11.00
ICD-10 Finland
Non-insulin dependent diabetes diabetic hypoglycaemic coma
31.0
323.0
805
280
E11
ICD-10 Finland
Type 2 diabetes mellitus
68.2
323.0
5512
1635
E11.8
ICD-10 Finland
Type 2 diabetes mellitus, with unspecified complications
68.8
323.0
3242
672
A10BJ06
ATC
semaglutide; parenteral
16384.0
323.0
1746
*
C10AA07
ATC
rosuvastatin; oral
2.5
322.2
3379
16831
E66.8
ICD-10 Finland
Other obesity
6.8
295.5
793
1247
SPAT1253
SPAT
Initiation, adjustment, discontinuation or repetition of medication
2.3
285.1
3600
19427
C09AA02
ATC
enalapril; systemic
2.5
280.0
2658
12381
SPAT1054
SPAT
Examination of peripheral nervous system
27.5
279.3
390
147
E11.5
ICD-10 Finland
Type 2 diabetes mellitus, with peripheral circulatory complications
21.6
254.7
382
183
358
Kela drug reimbursment
liraglutide
+∞
249.9
239
*
E78.01
ICD-10 Finland
Pure hypercholesterolaemia
2.3
243.5
2688
13386
G47.3
ICD-10 Finland
Sleep apnoea
2.3
230.9
2799
14520
SPAT1225
SPAT
Implementation of podiatry rehabilitation plan
9.4
229.2
495
551
C03CA01
ATC
furosemide; systemic
2.1
228.1
3192
17656
C07AB07
ATC
bisoprolol; oral
1.9
225.5
5483
37706
E14.9
ICD-10 Finland
Unspecified diabetes mellitus, without complications
14.4
222.9
388
278
SPAT1263
SPAT
Sampling
2.0
220.9
4588
29670
SPAT1249
SPAT
Treatment-related counselling outside office
2.0
215.1
4303
27352
C09AA05
ATC
ramipril; oral
2.1
214.6
3121
17457
C09BA02
ATC
enalapril and diuretics; systemic
3.2
212.2
1253
4270
H3601, E113
ICD-10 Finland
NA
20.1
212.0
325
166
G63.2*E11.4
ICD-10 Finland
Non-insulin-dependent diabetes mellitus - Diabetic polyneuropathy
41.6
205.9
260
64
A10AB06
ATC
insulin glulisine; parenteral
30.9
192.5
260
86
SPAT1299
SPAT
Other function in accordance with podiatry nomenclature
13.0
190.1
346
274
H3600, E113
ICD-10 Finland
NA
23.0
188.1
276
123
SPAT1310
SPAT
Counselling related to known health issue
1.9
179.0
3437
21124
A10BB07
ATC
glipizide; oral
85.9
172.8
194
23
Z13.5
ICD-10 Finland
Special screening examination for eye and ear disorders
24.9
171.8
246
101
A10AD05
ATC
insulin aspart; parenteral (insulins and analog. for injection, intermediate- or long-acting comb. with fast-acting)
16.5
164.8
271
168
M04AA01
ATC
allopurinol; systemic
2.4
164.5
1614
7397
Z01.0
ICD-10 Finland
Examination of eyes and vision
2.2
161.7
1830
8984
CL2S4
NOMESCO Finland
Ocular fundus photography for diabetic retinopathy screening
13.5
157.4
281
213
E66.9
ICD-10 Finland
Obesity, unspecified
6.1
153.7
439
740
C09DA01
ATC
losartan and diuretics; oral
2.5
152.9
1359
5896
C10AX09
ATC
ezetimibe; oral
2.4
152.7
1472
6664
N08.39*E11.2
ICD-10 Finland
Non-insulin-dependent diabetes mellitus - Diabetic nephropathy
17.6
149.8
240
139
OAB50
SPAT
NA
10.4
146.3
296
291
310
Kela drug reimbursment
Orlistat, sibutramine and other major and expensive medicines used to treat obesity
13.2
146.3
264
205
C03AA03
ATC
hydrochlorothiazide; oral
2.6
144.2
1168
4803
E78.5
ICD-10 Finland
Hyperlipidaemia, unspecified
2.5
144.0
1284
5567
Z13.1
ICD-10 Finland
Special screening examination for diabetes mellitus
16.5
142.4
234
145
SPAT1305
SPAT
Counselling and guidance related to physical exercise
2.7
142.3
1092
4348
E66
ICD-10 Finland
Obesity
4.7
137.4
499
1109
SPAT1148
SPAT
Treatment of chronic ulcer or burn
2.2
136.7
1606
7960
T82
ICPC
Obesity
5.2
128.8
423
843
I25.1
ICD-10 Finland
Atherosclerotic heart disease
1.9
127.6
2503
15137
C03DA01
ATC
spironolactone; oral
2.4
127.2
1208
5392
C02AC05
ATC
moxonidine; oral
3.6
125.9
611
1768
C10AB05
ATC
fenofibrate; oral
6.6
125.6
338
526
206
Kela drug reimbursment
Chronic coronary artery disease and dyslipidaemia associated with chronic coronary artery disease
1.9
125.4
2077
11812
B03BA03
ATC
hydroxocobalamin; parenteral
3.1
124.2
737
2479
T31
ICPC
Metabolic, Medical examin/health eval partial
17.4
122.6
197
115
A10BK02
ATC
canagliflozin; oral
210.7
120.9
125
6
C09CA03
ATC
valsartan; oral
2.4
120.7
1119
4927
C03EA01
ATC
hydrochlorothiazide and potassium-sparing agents; oral
2.1
120.4
1597
8306
C09CA01
ATC
losartan; oral
1.8
120.3
2700
17021
C01DA14
ATC
isosorbide mononitrate; oral
2.1
118.2
1634
8637
E78.0
ICD-10 Finland
Pure hypercholesterolaemia
1.9
116.5
2073
12061
C07AB02
ATC
metoprolol; systemic
1.9
116.3
2184
12945
D50.9
ICD-10 Finland
Iron deficiency anaemia, unspecified
2.8
116.2
808
3014
C08CA13
ATC
lercanidipine; oral
2.1
114.6
1465
7488
C01DA08
ATC
isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal
1.8
112.2
2528
15892
B01AC04
ATC
clopidogrel; oral
1.9
106.3
1841
10567
H36.01
ICD-10 Finland
Diabetic maculopathy
12.1
105.5
197
165
T89
ICPC
Diabetes insulin dependent
4.0
103.6
439
1129
A10BD19
ATC
linagliptin and empagliflozin; oral
+∞
101.2
97
*
SPAT1256
SPAT
Intramuscular and subcutaneous injection
1.6
99.9
4391
32918
C09DA03
ATC
valsartan and diuretics; oral
2.9
98.7
637
2260
SPAT1325
SPAT
Vaccination
1.6
97.9
3513
25002
I50.9
ICD-10 Finland
Heart failure, unspecified
2.1
97.6
1296
6693
C01DA02
ATC
glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal
1.8
97.6
1977
11932
T45
ICPC
Metabolic, Observ/health educat/advice/diet
7.4
97.5
240
329
N02BE01
ATC
paracetamol; systemic, rectal
1.7
97.1
8891
79318
SPAT1252
SPAT
Overall medication plan or its review
2.5
96.5
806
3338
FN1AC
NOMESCO Finland
Angiography of heart and/or coronary arteries
1.7
95.6
2497
16283
J01DB01
ATC
cefalexin; oral
1.6
95.1
8280
72547
SPAT1254
SPAT
Administration of medicine
2.0
94.1
1442
7876
K76.0
ICD-10 Finland
Fatty (change of) liver, not elsewhere classified
4.9
94.1
324
679
I70.2
ICD-10 Finland
Atherosclerosis of arteries of extremities
2.3
92.6
946
4341
S97
ICPC
Chronic ulcer skin
2.8
92.1
647
2419
C08CA02
ATC
felodipine; oral
2.2
92.1
1031
4939
R5140
NOMESCO Finland
Monitoring the use of the aid
2.1
91.1
1212
6255
H36.00
ICD-10 Finland
Diabetic background retinopathy
9.0
90.7
198
224
A08AB01
ATC
orlistat; oral
13.5
88.9
158
119
CK2S4
SPAT
NA
25.0
88.6
126
51
F43
ICPC
Eye, Other diagnostic procedure
5.8
88.4
262
462
EBA00
NOMESCO Finland
Extraction of tooth
1.6
86.3
3148
22327
N47
ICD-10 Finland
Redundant prepuce, phimosis and paraphimosis
3.6
86.0
419
1212
CL2S4
SPAT
NA
34.3
85.5
112
33
AN1
HP
Coronary angiography
1.9
84.8
1381
7690
C09DX01
ATC
valsartan, amlodipine and hydrochlorothiazide; oral
4.4
84.6
320
739
C09DA06
ATC
candesartan and diuretics; oral
2.3
84.4
856
3909
L97
ICD-10 Finland
Ulcer of lower limb, not elsewhere classified
3.4
83.4
427
1284
213
Kela drug reimbursment
Fat metabolism disorder associated with chronic coronary artery disease
2.4
83.1
795
3528
T90
ICD-10 Finland
Sequelae of injuries of head
78.3
82.2
93
12
SPAT1099
SPAT
Measurement of blood pressure with Doppler ultrasound device
3.4
81.6
413
1231
6488A
ICD-9 Finland
Other current conditions in the mother classifiable elsewhere but complicating pregnancy, childbirth and the puerperium, Abnormal glucose tolerance
7.2
81.2
203
285
E66.0
ICD-10 Finland
Obesity due to excess calories
9.0
80.2
175
198
A46
ICD-10 Finland
Erysipelas
1.8
80.2
1472
8537
E10.9
ICD-10 Finland
Type 1 diabetes mellitus, Without complications
3.3
80.0
432
1353
SPAT1301
SPAT
No procedures
1.6
79.8
3099
22222
T69
ICPC
Metabolic, Other reason for encounter NEC
27.1
79.2
110
41
C09AA03
ATC
lisinopril; oral
2.7
79.0
577
2207
H36.09*E11.3
ICD-10 Finland
Non-insulin-dependent diabetes mellitus - Diabetic retinopathy
17.2
78.5
126
74
2500A
ICD-9 Finland
Diabetes mellitus without mention of complication[DIABETES MELLITUS SINE COMPLICATIONE,TYYPPI II]
7.7
78.4
188
248
D64.9
ICD-10 Finland
Anaemia, unspecified
2.0
77.1
1035
5339
KGH10
NOMESCO Finland
Operation for phimosis
3.7
76.9
355
982
T30
ICPC
Metabolic, Medical examin/health eval complete
27.4
76.6
106
39
I20.81
ICD-10 Finland
Other angina pectoris stenosed coronary artery
2.1
75.9
913
4499
B81
ICPC
Anaemia vit B12/folate deficiency
3.0
75.9
466
1597
S20
ICPC
Corn/callosity
4.8
75.4
263
559
C10AA04
ATC
fluvastatin; oral
2.1
74.9
939
4706
SPAT1222
SPAT
Counselling/guidance promoting independent living
1.8
74.5
1448
8543
A10AB04
ATC
insulin lispro; parenteral (insulins and analog. for injection, fast-acting)
3.7
74.3
346
965
E11.1
ICD-10 Finland
Type 2 diabetes mellitus, with ketoacidosis
16.5
73.0
119
73
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
1.7
72.0
1634
10110
SPAT1156
SPAT
Guidance concerning treatment of rash and skin
1.8
71.1
1361
7978
J01FF01
ATC
clindamycin; systemic
1.5
69.7
2618
18504
T62
ICPC
Metabolic, Administrative procedure
32.0
69.3
92
29
SPAT1281
SPAT
Other administrative function
2.2
68.8
781
3746
JDF11
NOMESCO Finland
Laparoscopic gastric bypass
7.1
68.8
174
249
O24.4
ICD-10 Finland
Diabetes mellitus arising in pregnancy
4.0
68.6
290
744
L17
ICPC
Foot/toe symptom/complaint
1.6
67.0
2314
16004
M10.9
ICD-10 Finland
Gout, unspecified
2.2
66.8
721
3380
T66
ICPC
Metabolic, Referral to non-MD provider
28.3
65.8
90
32
K05.31
ICD-10 Finland
Periodontitis pronounced
1.9
65.0
1064
5901
A10BX12
ATC
[U] empagliflozin; oral
138.8
64.9
69
5
SPAT1260
SPAT
Consultation of another employee
1.6
63.1
1698
10989
K40.9
ICD-10 Finland
Unilateral or unspecified inguinal hernia, without obstruction or gangrene
0.5
62.9
616
11302
L28
ICPC
Limited function/disability (L)
1.7
62.8
1457
9039
C02EA02
ATC
NA
2.7
62.5
459
1758
E78.9
ICD-10 Finland
Disorder of lipoprotein metabolism, unspecified
2.8
62.5
425
1556
C10AA03
ATC
pravastatin; oral
2.1
62.4
755
3718
C09DB01
ATC
valsartan and amlodipine; oral
2.8
61.3
420
1543
WZB00
NOMESCO Finland
Telephone receipt or other advice
1.5
59.9
2464
17671
A10BH03
ATC
saxagliptin; oral
591.3
59.8
59
*
C09DA07
ATC
telmisartan and diuretics; oral
2.5
59.7
497
2044
112
Kela drug reimbursment
Severe psychotic and other severe mental disorders
2.2
58.5
665
3185
J01CE02
ATC
phenoxymethylpenicillin; oral
1.4
58.3
6485
56069
-45
ICPC
Observ/health educat/advice/diet
3.1
57.1
337
1124
E66.2
ICD-10 Finland
Extreme obesity with alveolar hypoventilation
7.1
56.3
142
203
T60
ICPC
Metabolic, Result test/procedure
7.0
55.9
142
205
C09CA07
ATC
telmisartan; oral
2.0
55.1
771
4020
K74.6
ICD-10 Finland
Other and unspecified cirrhosis of liver
5.4
54.6
169
316
C03BA11
ATC
indapamide; oral
3.0
54.3
330
1122
N02AJ06
ATC
codeine and paracetamol; systemic
1.4
54.2
3488
27259
E78.29
ICD-10 Finland
Other mixed hyperlipidaemia
6.2
53.7
149
243
N48.1
ICD-10 Finland
Balanoposthitis
3.2
53.6
296
942
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
2.5
53.5
459
1919
C07AG02
ATC
carvedilol; oral
2.1
52.8
618
2995
JAB30
NOMESCO Finland
Repair of inguinal hernia using prosthetic material
0.5
52.7
462
8794
SPAT1312
SPAT
General health counselling
1.4
52.7
2844
21471
SPAT1097
SPAT
Recording of ECG
1.6
52.3
1510
9912
I50.0
ICD-10 Finland
Congestive heart failure
2.1
51.9
613
2983
WX722
NOMESCO Finland
PEEP
2.3
51.6
516
2329
SPAT1251
SPAT
Organisation of medication
2.7
51.5
366
1375
G63.2
ICD-10 Finland
Diabetic polyneuropathy
14.0
51.4
89
64
I11.9
ICD-10 Finland
Hypertensive heart disease without (congestive) heart failure
2.4
51.4
447
1881
WX110
NOMESCO Finland
Local anesthesy
1.4
50.7
6449
56316
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
1.7
49.9
1086
6584
FN1YT
NOMESCO Finland
Percutaneous insertion of coronary artery stent
2.1
48.9
607
3016
O24.1
ICD-10 Finland
Diabetes mellitus in pregnancy: Pre-existing diabetes mellitus, non-insulin-dependent
28.8
48.7
66
23
QDB10
NOMESCO Finland
Major dressing of wound of skin of lower limb
2.3
48.5
485
2190
XPX99
NOMESCO Finland
Other diagnostic examination of periferal vessel
2.0
48.0
648
3327
O24.0
ICD-10 Finland
Diabetes mellitus in pregnancy: Pre-existing diabetes mellitus, insulin-dependent
10.5
48.0
95
91
FNA01
NOMESCO Finland
Anastomosis to coronary artery from internal mammary artery, one distal anastamosis
2.2
47.8
520
2438
I25.9
ICD-10 Finland
Chronic ischaemic heart disease, unspecified
1.8
47.3
894
5180
C09BA03
ATC
lisinopril and diuretics; oral
3.0
47.0
278
930
A10BD10
ATC
metformin and saxagliptin; systemic
+∞
46.9
45
*
SPAT1149
SPAT
Suture or treatment of traumatic wound
1.6
46.8
1273
8203
SPAT1100
SPAT
Long-term monitoring of blood pressure
2.0
46.6
660
3451
C10AB02
ATC
bezafibrate; oral
5.0
46.5
155
316
N05AX12
ATC
aripiprazole; systemic
3.1
46.4
266
870
H3603, E113
ICD-10 Finland
NA
7.1
46.0
115
163
WX290
NOMESCO Finland
Other blockade of nerve
1.4
45.5
3612
29037
I21.41
ICD-10 Finland
Acute subendocardial infarction stenosed coronary artery
2.2
45.3
505
2395
N02AX02
ATC
tramadol; systemic, rectal
1.4
45.0
4112
33800
E78.00
ICD-10 Finland
Familial hypercholesterolaemia
2.3
45.0
434
1924
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
1.7
44.7
1074
6688
C07FB02
ATC
metoprolol and felodipine; systemic
2.7
44.5
324
1236
G56.0
ICD-10 Finland
Carpal tunnel syndrome
1.6
44.2
1142
7252
C07BB07
ATC
bisoprolol and thiazides; systemic
2.4
44.1
407
1766
I21.49
ICD-10 Finland
Acute subendocardial infarction unspecified coronary artery status
2.1
43.9
554
2769
SPAT1010
SPAT
Ophthalmoscopy
11.1
43.8
84
76
FN1BC
NOMESCO Finland
Extensive angiography of hear and/or coronary arteries
2.0
43.5
561
2829
SPAT1229
SPAT
Assessment of need for aid
1.9
43.2
717
3974
SPAT1217
SPAT
Assessment of need for services (elderly/care support)
1.9
43.1
635
3372
A28
ICPC
Limited function/disability NOS
1.6
42.9
1317
8742
C07AB05
ATC
betaxolol; oral
2.8
42.6
288
1051
81
HP
Angiography of the heart and coronary arteries
1.9
42.2
615
3249
I20.99
ICD-10 Finland
Angina pectoris, unspecified
1.9
42.1
646
3479
CJE20
NOMESCO Finland
Phakoemulsification with implantation of artificial lens in posterior chamber
1.4
42.1
2681
20699
C08CA10
ATC
nilvadipine; oral
3.2
42.1
229
723
SPAT1070
SPAT
Doppler ultrasound examination of blood flow in arteries of lower extremity
3.3
41.9
218
666
J01AA02
ATC
doxycycline; systemic
1.3
41.4
7660
69629
K08.3
ICD-10 Finland
Retained dental root
1.9
41.3
685
3794
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
1.3
41.1
4330
36213
Z95.1
ICD-10 Finland
Presence of aortocoronary bypass graft
2.2
40.7
436
2032
EB1AA
NOMESCO Finland
Tooth X-ray examination
1.3
40.5
5054
43287
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.4
40.5
2656
20581
S22
ICPC
Nail symptom/complaint
2.0
40.3
531
2699
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.3
40.1
4307
36083
AN4
HP
Balloon angioplasty and drug eluding stent
2.3
39.7
390
1745
N03AX16
ATC
pregabalin; oral
1.4
39.6
2118
15810
SPAT1144
SPAT
Treatment of reopened or infected surgical wound
1.8
39.5
704
3993
H3602, E113
ICD-10 Finland
NA
20.8
39.1
58
28
4019X
ICD-9 Finland
Essential hypertension, Unspecified
2.9
39.1
243
841
N18.9
ICD-10 Finland
Chronic kidney disease, unspecified
2.0
38.4
500
2530
I25.2
ICD-10 Finland
Old myocardial infarction
1.9
38.3
628
3464
I20.09
ICD-10 Finland
Unstable angina
1.9
38.2
553
2918
J01DA01
ATC
[U] cefalexin; systemic
1.3
38.1
5693
49826
R4180
SPAT
NA
18.8
37.8
58
31
H25.8
ICD-10 Finland
Other senile cataract
1.7
37.7
936
5869
R03AC02
ATC
salbutamol; inhalant
1.3
37.6
4493
38094
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
1.8
37.6
717
4159
SPAT1139
SPAT
Nutrition survey
2.5
37.1
291
1160
E13.9
ICD-10 Finland
Other specified diabetes mellitus, without complications
4.7
37.0
129
277
J01MA02
ATC
ciprofloxacin; systemic
1.3
37.0
3677
30343
C10BA02
ATC
simvastatin and ezetimibe; oral, topical
3.6
36.9
170
473
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
1.5
36.7
1482
10448
N17.9
ICD-10 Finland
Acute renal failure, unspecified
2.3
36.5
352
1558
OAB42
SPAT
NA
2.2
36.2
375
1721
SPAT1216
SPAT
Assessment of functional ability
1.5
36.0
1347
9338
M17.0
ICD-10 Finland
Primary gonarthrosis, bilateral
1.5
35.9
1210
8186
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
1.6
35.8
1103
7305
Z95.5
ICD-10 Finland
Presence of coronary angioplasty implant and graft
2.2
35.8
392
1845
L60.0
ICD-10 Finland
Ingrowing nail
2.2
35.0
363
1665
EBA30
NOMESCO Finland
Excision of root of tooth
1.9
34.2
522
2805
N05AA02
ATC
levomepromazine; systemic
2.2
34.1
369
1726
SPAT1137
SPAT
Taking care of patient’s/customer’s hygiene
2.0
34.1
458
2346
A12BA01
ATC
potassium chloride; oral
2.3
34.1
341
1539
I25.0
ICD-10 Finland
Atherosclerotic cardiovascular disease, so described
1.9
33.7
530
2879
E11.09
ICD-10 Finland
Non-insulin-dependent diabetes mellitus - With coma
36.0
33.6
43
12
K02.1
ICD-10 Finland
Caries of dentine
1.3
33.6
4893
42363
M17.1
ICD-10 Finland
Other primary gonarthrosis
1.4
33.6
1941
14641
L02.2
ICD-10 Finland
Cutaneous abscess, furuncle and carbuncle of trunk
2.2
33.5
347
1591
CKC12
NOMESCO Finland
Photocoagulation of retina
2.0
33.4
423
2117
SFC01
NOMESCO Finland
Adjuvant procedure of filling therapy
1.4
33.2
2336
18215
N05AH04
ATC
quetiapine; oral
1.5
32.8
1191
8186
P72
ICPC
Schizophrenia
3.3
32.8
168
509
H03AA01
ATC
levothyroxine sodium; systemic
1.4
32.7
1791
13371
A08AA10
ATC
sibutramine; oral
10.5
32.7
64
61
F20.9
ICD-10 Finland
Schizophrenia, unspecified
3.0
32.4
193
650
SPAT1324
SPAT
Screening procedure
1.6
32.2
908
5878
SPAT1240
SPAT
Therapeutic discussion
1.7
31.9
672
4013
J02AC01
ATC
fluconazole; systemic
1.3
31.9
2858
23102
C09BA04
ATC
perindopril and diuretics; systemic
2.9
31.8
198
689
I25
ICD-10 Finland
Chronic ischaemic heart disease
1.9
31.7
460
2425
N06AX16
ATC
venlafaxine; oral
1.6
31.6
988
6559
FN2BA
NOMESCO Finland
Percutaneous transluminal coronary angioplasty with stent (includes balloon pre-dilation)
1.8
31.5
592
3413
T48
ICPC
Metabolic, Clarification/discussion RFE/demand
9.2
31.4
66
72
SPAT1304
SPAT
Counselling and guidance related to ageing
1.8
31.4
615
3592
EBA05
NOMESCO Finland
Complicated extraction of tooth
1.4
31.4
1687
12545
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
1.3
31.4
2562
20417
C09BA05
ATC
ramipril and diuretics; oral
2.8
31.3
207
746
A02BC02
ATC
pantoprazole; systemic
1.3
31.3
6179
55385
C03EB01
ATC
furosemide and potassium-sparing agents; systemic
2.3
31.0
304
1359
C09CA06
ATC
candesartan; oral
1.4
30.9
1876
14243
FN1AT
NOMESCO Finland
Endovascular dilatation of coronary arteries (PTCA)
1.9
30.9
480
2594
C07AB03
ATC
atenolol; systemic
1.8
30.9
511
2826
SPAT1255
SPAT
Intravenous administration of medicine
1.8
30.9
598
3480
S10
ICPC
Boil/carbuncle
1.9
30.7
454
2411
SPAT1285
SPAT
Provision of consultation response
1.9
30.6
475
2570
R05DA20
ATC
opium alkaloids and derivatives - combinations
1.4
30.5
2117
16431
207
Kela drug reimbursment
Chronic arrhythmias
1.5
30.5
1341
9591
SGB10
NOMESCO Finland
Fiiling of rooth of tooth with one root channel
1.5
30.4
1063
7243
K04.5
ICD-10 Finland
Chronic apical periodontitis
1.3
30.2
2271
17851
K28
ICPC
Limited function/disability (K)
2.7
30.1
211
790
290
Kela drug reimbursment
Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation
1.4
29.9
1374
9908
PE1AT
NOMESCO Finland
Femoral artery PTA
3.8
29.8
129
342
C08DB01
ATC
diltiazem; oral
1.9
29.6
421
2206
2780A
ICD-9 Finland
Obesity and other hyperalimentation, Obesity
7.2
29.5
72
100
N05AX08
ATC
risperidone; systemic
1.8
29.4
569
3308
N06AB04
ATC
citalopram; systemic
1.4
29.4
1703
12813
E16.0
ICD-10 Finland
Drug-induced hypoglycaemia without coma
10.6
29.3
57
54
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
1.5
29.3
1032
7039
A10BH04
ATC
alogliptin; oral
+∞
29.2
28
*
C07AB12
ATC
nebivolol; oral
2.2
29.1
291
1313
I35.0
ICD-10 Finland
Aortic (valve) stenosis
1.8
29.0
523
2976
PE1YT
NOMESCO Finland
Femoral or popliteal artery PTA with stent
4.4
28.8
107
247
A08AA02
ATC
fenfluramine; oral (centrally acting antiobesity products)
4.4
28.5
105
240
L03.0
ICD-10 Finland
Cellulitis of finger and toe
1.7
28.5
563
3298
M10
ICD-10 Finland
Gout
1.9
28.5
412
2171
I20.90
ICD-10 Finland
Angina pectoris, unspecified
2.1
28.5
327
1573
CKD05
NOMESCO Finland
Puncture of vitreous body with injection of medication
2.0
28.4
401
2092
R03AK06
ATC
salmeterol and fluticasone; inhalant
1.5
27.9
1124
7884
WZC30
SPAT
NA
2.7
27.8
193
720
M14.6*E11.6
ICD-10 Finland
Non-insulin-dependent diabetes mellitus - Diabetic neuropathic
19.2
27.7
42
22
I79.2*E11.5
ICD-10 Finland
Non-insulin-dependent diabetes mellitus - Diabetic peripheral angiopathy
11.3
27.7
52
46
TPH07
NOMESCO Finland
Cathetrisation of artery
1.5
27.6
941
6366
I20.01
ICD-10 Finland
Unstable angina
2.2
27.5
295
1375
ACC51
NOMESCO Finland
Release of median nerve
1.7
27.4
592
3563
FN1BT
NOMESCO Finland
Extensive endovascular dilatation of coronary (PTCA) arteries
2.4
27.4
235
986
E0000UV
ATC
NA
1.3
27.1
3213
26854
R03.0
ICD-10 Finland
Elevated blood-pressure reading, without diagnosis of hypertension
0.3
27.1
71
2131
R06.0
ICD-10 Finland
Dyspnoea
1.3
27.1
2072
16290
S18
ICPC
Laceration/cut
1.3
27.1
3967
34049
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
1.3
27.0
2033
15940
M10.0
ICD-10 Finland
Idiopathic gout
2.1
26.9
303
1444
SGA01
NOMESCO Finland
Tooth opening as first aid
1.4
26.8
1201
8607
C07AB08
ATC
celiprolol; oral
2.3
26.8
248
1081
D50.8
ICD-10 Finland
Other iron deficiency anaemias
3.5
26.4
126
363
N03AX12
ATC
gabapentin; oral
1.4
26.3
1292
9416
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.3
26.2
4362
37957
R05FB02
ATC
cough suppressants and expectorants
1.3
26.1
3284
27623
SPAT1211
SPAT
Application of soft bandage
1.6
26.1
742
4806
E87.5
ICD-10 Finland
Hyperkalaemia
3.2
26.0
142
453
3472A
ICD-9 Finland
Cataplexy and narcolepsy[OBSTRUKTIIVINEN UNIAPNEA]
3.2
26.0
142
453
D07AC01
ATC
betamethasone; topical
1.3
25.8
2985
24840
C01AA05
ATC
digoxin; systemic
1.7
25.7
579
3525
A10BX03
ATC
nateglinide; oral
261.2
25.7
26
*
SPAT1081
SPAT
Cardiorespiratory global assessment
1.7
25.7
522
3082
E87.2
ICD-10 Finland
Acidosis
7.6
25.6
60
79
E78
ICD-10 Finland
Disorders of lipoprotein metabolism and other lipidaemias
2.1
25.4
306
1503
R05FA02
ATC
opium derivatives and expectorants; systemic
1.3
25.3
3474
29517
N05AB03
ATC
perphenazine; systemic, rectal
2.1
25.2
282
1342
F41
ICPC
Eye, Diagnostic radiology/imaging
19.1
25.1
38
20
C09AA04
ATC
perindopril; oral
1.8
25.1
473
2731
SFA10
NOMESCO Finland
Fillning on one surface of tooth
1.2
25.0
4545
39869
M01AB01
ATC
indometacin; systemic, rectal
1.6
25.0
732
4777
SPAT1234
SPAT
Support of social functional capacity
1.9
25.0
399
2181
SAA01
NOMESCO Finland
Simple examination of mouth
1.2
24.8
6238
56700
SPAT1309
SPAT
Guidance related to psychoactive substances / risk behaviour
2.4
24.8
213
895
C02LM02
ATC
NA
3.3
24.8
128
393
I85.9
ICD-10 Finland
Oesophageal varices without bleeding
4.0
24.7
100
251
351
Kela drug reimbursment
Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation
1.4
24.7
1180
8551
NHQ40
NOMESCO Finland
Amputation of toe
3.0
24.7
148
502
82
HP
Single vessel balloon catheter extension
2.4
24.7
211
885
B80
ICPC
Iron deficiency anaemia
2.9
24.6
156
551
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
1.4
24.6
1303
9628
SPAT1245
SPAT
Provision of support and information to patient’s family members
1.9
24.5
351
1844
J01CA04
ATC
amoxicillin; systemic
1.3
24.5
7392
68538
SGA02
NOMESCO Finland
Opening and dilatation of root canal of tooth
1.5
24.4
1025
7242
N18.8
ICD-10 Finland
Other chronic renal failure
2.3
24.4
233
1033
UJF32
NOMESCO Finland
Coloscopy
1.3
24.4
2308
18672
E03.9
ICD-10 Finland
Hypothyroidism, unspecified
1.5
24.2
845
5742
CK2X4
NOMESCO Finland
Optical coherence tomography (OCT) of ocular fundus
1.5
24.0
753
4994
PD4DE
NOMESCO Finland
Lower extremity artery ultrasound examination with Doppler method
2.9
24.0
152
537
27799
ICD-8 Finland
Obesity not specified as of endocrine origin
5.4
24.0
73
137
Z02.7
ICD-10 Finland
Issue of medical certificate
1.7
23.8
463
2698
SFA30
NOMESCO Finland
Filling on tree or more surfaces of tooth
1.2
23.8
3634
31195
WYA05
NOMESCO Finland
Emergency visit or other similar visit involving procedures
1.2
23.8
4097
35655
SPAT1157
SPAT
Guidance concerning treatment of mouth and mucous membranes
3.3
23.6
120
364
J45.9
ICD-10 Finland
Asthma, unspecified
1.4
23.5
1376
10335
M79.6
ICD-10 Finland
Pain in limb
1.3
23.2
2954
24807
C10AB04
ATC
gemfibrozil; oral
4.3
23.1
87
205
E78.11
ICD-10 Finland
Other hypertriglyceridemia
5.5
23.1
69
127
N05AH03
ATC
olanzapine; systemic
1.8
22.9
404
2285
D01AC02
ATC
miconazole; topical
1.6
22.9
678
4433
I48
ICD-10 Finland
Atrial fibrillation and flutter
1.3
22.7
2019
16169
FNC20
NOMESCO Finland
Aorto-coronary venous bypass with two distal anastomoses
2.3
22.7
212
928
Z3231
NOMESCO Finland
Registered nurse
1.3
22.6
2347
19200
J18.9
ICD-10 Finland
Pneumonia, unspecified
1.3
22.6
1949
15548
F32.10
ICD-10 Finland
Moderate depressive episode without somatic syndrome
1.7
22.5
494
2985
M05BA04
ATC
alendronic acid; oral
0.6
22.4
257
4560
Z3229
NOMESCO Finland
Other healthcare associate professional
1.5
22.2
701
4655
61
HP
Catheterization and pressure measurement of the left side of the heart
2.6
22.2
161
618
B01AA03
ATC
warfarin; systemic
1.3
22.1
1735
13643
I20.89
ICD-10 Finland
Other angina pectoris unspecified coronary artery status
1.9
22.1
349
1901
N19
ICD-10 Finland
Unspecified kidney failure
2.1
22.0
263
1290
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
1.4
21.8
1370
10410
6480A
ICD-9 Finland
Other current conditions in the mother classifiable elsewhere but complicating pregnancy, childbirth and the puerperium, Diabetes mellitus
5.6
21.7
63
112
PEF23
NOMESCO Finland
Thrombendarterectomy of femoral artery
2.7
21.7
152
573
K04.4
ICD-10 Finland
Acute apical periodontitis of pulpal origin
1.6
21.6
655
4305
Z50.1
ICD-10 Finland
Other physical therapy
1.7
21.6
461
2764
I50.1
ICD-10 Finland
Left ventricular failure
1.8
21.6
361
2007
L82
ICD-10 Finland
Seborrhoeic keratosis
0.7
21.4
776
10766
I63.9
ICD-10 Finland
Cerebral infarction, unspecified
1.5
21.4
818
5668
P99
ICPC
Psychological disorders other
2.4
21.4
180
750
N06AB06
ATC
sertraline; oral
1.5
21.3
726
4903
N05AF03
ATC
chlorprothixene; systemic
2.2
21.2
216
988
C22.0
ICD-10 Finland
Malignant neoplasm: Liver cell carcinoma
4.3
21.2
79
185
D01AE15
ATC
terbinafine; topical
1.6
21.2
621
4052
N06AX21
ATC
duloxetine; oral
1.5
21.2
765
5238
J01MA12
ATC
levofloxacin; systemic
1.3
21.1
1604
12545
D07AC13
ATC
mometasone; topical
1.3
20.9
2422
20052
F20.00
ICD-10 Finland
Paranoid schizophrenia continuous
2.6
20.9
154
598
R73.9
ICD-10 Finland
Hyperglycaemia, unspecified
2.3
20.9
194
848
63703
ICD-8 Finland
Pre-eclampsia, eclampsia and toxaemia, unspecified, Prae-eclampsia levis
3.1
20.8
119
392
F32.2
ICD-10 Finland
Severe depressive episode without psychotic symptoms
1.7
20.8
428
2541
D50
ICD-10 Finland
Iron deficiency anaemia
2.9
20.8
131
462
J01FA06
ATC
roxithromycin; oral
1.2
20.8
3398
29282
D51.9
ICD-10 Finland
Vitamin B12deficiency anaemia, unspecified
3.2
20.7
112
357
I34.1
ICD-10 Finland
Mitral (valve) prolapse
0.3
20.7
49
1540
TFC10
NOMESCO Finland
Catheterisation of left atrium or ventricle
2.7
20.6
147
559
XG466
NOMESCO Finland
Sleep oxymetry
1.9
20.5
291
1527
PD4AC
NOMESCO Finland
Arterigography of lower extremity with X-ray
3.0
20.5
119
398
N05AC02
ATC
thioridazine; oral
2.5
20.5
168
690
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
1.4
20.2
857
6066
M17.9
ICD-10 Finland
Gonarthrosis, unspecified
1.4
20.1
905
6472
A98
ICPC
Health maint/preventive medicine
1.4
20.0
9830
95170
E14.8
ICD-10 Finland
Unspecified diabetes mellitus, with unspecified complications
9.3
20.0
41
44
SGC10
NOMESCO Finland
Covering pulpa of tooth
1.6
19.9
590
3856
SPAT1014
SPAT
Treatment of eyes
2.5
19.9
152
603
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
1.4
19.8
1122
8372
A10BD13
ATC
metformin and alogliptin; systemic
+∞
19.8
19
*
A10BD09
ATC
pioglitazone and alogliptin; oral
+∞
19.8
19
*
-64
ICPC
Encounter/prob initiated by provider
2.6
19.7
144
557
R60.0
ICD-10 Finland
Localized oedema
1.4
19.7
877
6262
SPAT1151
SPAT
Treatment of major wounds
2.8
19.7
125
444
SFA40
NOMESCO Finland
Replacement of krone of tooth
1.3
19.6
1887
15239
K42.9
ICD-10 Finland
Umbilical hernia without obstruction or gangrene
1.7
19.6
438
2660
N08.39
ICD-10 Finland
Glomerular disorders in diabetes mellitus microalbuminuria
5.1
19.5
61
119
K07
ICPC
Swollen ankles/oedema
1.8
19.5
335
1878
I50
ICD-10 Finland
Heart failure
2.1
19.5
230
1121
D50.0
ICD-10 Finland
Iron deficiency anaemia secondary to blood loss (chronic)
2.0
19.5
259
1326
N06AB03
ATC
fluoxetine; oral
1.4
19.4
915
6605
WX780
NOMESCO Finland
Remote monitoring CPAP
1.8
19.3
339
1917
C02EA03
ATC
NA
2.7
19.3
131
483
I11.0
ICD-10 Finland
Hypertensive heart disease with (congestive) heart failure
2.3
19.3
179
786
SPAT1307
SPAT
Psychosocial counselling and guidance
1.9
19.2
278
1468
D01AC20
ATC
imidazoles/triazoles in combination with corticosteroids; topical
1.3
19.2
1953
15883
SPAT1083
SPAT
Initiation and monitoring of IV fluid therapy
1.8
19.2
365
2115
SPAT1284
SPAT
Extensive health certificate
2.2
19.1
206
966
-50
ICPC
Medication/prescr/renewal
1.8
19.0
351
2016
A41.5
ICD-10 Finland
Sepsis due to other Gram-negative organisms
1.9
18.9
261
1355
C10AA02
ATC
lovastatin; oral
1.8
18.9
326
1831
EBA15
NOMESCO Finland
Extraction of large number of teeth
1.8
18.7
339
1938
H25.1
ICD-10 Finland
Senile nuclear cataract
1.3
18.6
2055
16882
A08AX01
ATC
rimonabant; oral
20.8
18.6
27
13
40199
ICD-8 Finland
Essential benign hypertension
2.6
18.4
138
541
F32.9
ICD-10 Finland
Depressive episode, unspecified
1.5
18.4
739
5169
B01AC30
ATC
platelet aggregation inhibitors excl. heparin - combinations
1.6
18.4
510
3282
H02AB06
ATC
prednisolone; systemic
1.2
18.4
4086
36209
JFA15
NOMESCO Finland
Endoscopic polypectomy in colon
1.6
18.3
442
2745
TPH04
NOMESCO Finland
Cathetrisation of vein
1.3
18.2
1767
14273
F25.20
ICD-10 Finland
Schizoaffective syndrome, mixed type with only concomitant bipolar and schizophrenic symptoms
4.8
18.2
60
125
K08.1
ICD-10 Finland
Loss of teeth due to accident, extraction or local periodontal disease
1.4
18.2
878
6365
T63
ICPC
Metabolic, Follow-up encounter unspecified
19.3
18.1
27
14
G51.0
ICD-10 Finland
Bell palsy
2.1
18.1
213
1038
C07AG01
ATC
labetalol; systemic
4.3
18.1
67
157
QDB05
NOMESCO Finland
Revision of wound of skin of lower limb
2.1
18.1
210
1018
SPAT1257
SPAT
Teaching of medicine inhalation technique
1.9
18.0
280
1520
BEF00
SPAT
NA
32.9
17.9
23
7
PD4BC
NOMESCO Finland
Extensive arterigography of lower extremity with X-ray
2.6
17.9
129
497
SPAT1033
SPAT
Irrigation or wax removal of outer auditory canal
1.3
17.9
1774
14366
N77.1*B37.3
ICD-10 Finland
Candidiasis of vulva and vagina
3.7
17.9
79
217
K73.80
ICD-10 Finland
Non-alcoholic fatty liver (NASH, Non Alcoholic Steatohepatitis)
7.4
17.8
42
57
TQW11
NOMESCO Finland
Vacuum treatment of wound
2.3
17.8
166
731
XCK10
SPAT
NA
16.5
17.8
28
17
SPAT1298
SPAT
Other function in accordance with nutritional therapy nomenclature
3.5
17.8
82
233
K04.0
ICD-10 Finland
Pulpitis
1.5
17.8
628
4277
N39.4
ICD-10 Finland
Other specified urinary incontinence
1.5
17.7
543
3581
A10BD21
ATC
saxagliptin and dapagliflozin; oral
+∞
17.7
17
*
E11.01
ICD-10 Finland
Non-insulin dependent diabetes diabetic coma with hyperglycaemia
13.7
17.7
30
22
R4180
NOMESCO Finland
Podiatric therapy
3.0
17.6
101
335
N05AH02
ATC
clozapine; systemic
2.6
17.6
131
514
M75.1
ICD-10 Finland
Rotator cuff syndrome
1.3
17.5
2088
17293
104
Kela drug reimbursment
Thyroid insufficiency
1.6
17.5
508
3309
G03FA01
ATC
norethisterone and estrogen; systemic (progestogens and estrogens, fixed comb.)
0.7
17.5
452
6666
A06AD11
ATC
lactulose; oral
1.4
17.4
1095
8300
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
1.5
17.4
674
4676
S09
ICPC
Infected finger/toe
2.0
17.4
236
1218
PF1AT
NOMESCO Finland
Intravascular dilatation of arteries of knee, lower leg and ankle (PTA)
3.7
17.4
76
207
I20.80
ICD-10 Finland
Other angina pectoris no detected stenosis of coronary artery
2.5
17.4
133
530
D05AX52
ATC
calcipotriol, combinations; topical
1.6
17.4
461
2934
R4135
NOMESCO Finland
Rehabilitation for hearing problems
2.3
17.4
157
681
NGB20
NOMESCO Finland
Primary total prosthetic replacement of knee joint without patellar part
1.4
17.4
845
6132
SPAT1053
SPAT
Memory test
1.3
17.3
1288
10017
L73.2
ICD-10 Finland
Hidradenitis suppurativa
3.9
17.3
71
183
D07AB02
ATC
hydrocortisone butyrate; topical
1.2
17.2
2225
18593
K80.2
ICD-10 Finland
Calculus of gallbladder without cholecystitis
1.4
17.1
821
5941
N06AX12
ATC
bupropion; oral
1.7
17.1
335
1961
C07BB02
ATC
metoprolol and thiazides; systemic
2.7
17.0
116
433
M01AE02
ATC
naproxen; oral, rectal
1.2
16.9
4846
43844
JKA21
NOMESCO Finland
Laparoscopic cholecystectomy
1.4
16.9
802
5791
PD4CG
NOMESCO Finland
Extensive MRI examination of abdominal aortta and vasculature of lower extremities with high intensity magnet
2.7
16.9
113
416
I65.2
ICD-10 Finland
Occlusion and stenosis of carotid artery
2.2
16.8
177
823
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.2
16.8
3405
29831
E16.2
ICD-10 Finland
Hypoglycaemia, unspecified
3.0
16.8
94
310
AA1
HP
Conventional CABG
2.1
16.7
182
861
U04
ICPC
Incontinence urine
1.7
16.7
317
1838
K02.2
ICD-10 Finland
Caries of cementum
1.7
16.7
374
2279
M75.0
ICD-10 Finland
Adhesive capsulitis of shoulder
1.6
16.6
448
2863
B01AB05
ATC
enoxaparin; parenteral
1.2
16.6
2651
22667
SPAT1352
SPAT
Inspection, maintenance and instruction for use of hearing aid
2.6
16.6
123
481
C09AA01
ATC
captopril; oral
2.5
16.5
133
544
D07BC01
ATC
betamethasone and antiseptics; topical
1.4
16.5
996
7503
S91.3
ICD-10 Finland
Open wound of other parts of foot
2.2
16.5
172
798
SGC00
NOMESCO Finland
Local medication of root channels of tooth
1.4
16.4
781
5648
D12.6
ICD-10 Finland
Benign neoplasm: Colon, unspecified
1.6
16.4
428
2714
K04.08
ICD-10 Finland
Other specified pulpit
1.6
16.3
413
2602
A02BC01
ATC
omeprazole; systemic
1.2
16.2
2296
19378
L02.3
ICD-10 Finland
Cutaneous abscess, furuncle and carbuncle of buttock
2.2
16.1
160
727
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
1.3
16.1
1527
12278
J01CF05
ATC
flucloxacillin; systemic
1.8
16.1
288
1638
B01AC24
ATC
ticagrelor; oral
1.7
16.1
317
1861
I20.00
ICD-10 Finland
Unstable angina
1.8
16.0
255
1395
F33.10
ICD-10 Finland
Recurrent depression, moderate episode without somatic syndrome
1.8
16.0
298
1719
M01AE03
ATC
ketoprofen; systemic, rectal
1.2
16.0
3329
29203
A06AC01
ATC
ispaghula (psylla seeds); oral
1.3
15.9
1922
15917
212
Kela drug reimbursment
Gout
2.2
15.9
166
773
11
HP
Coronary artery bypass surgery
2.2
15.9
166
773
L84
ICD-10 Finland
Corns and callosities
1.9
15.8
248
1351
SAA02
NOMESCO Finland
Basic examination of mouth
1.2
15.8
5316
48657
SPAT1236
SPAT
Informing family of child’s disability
2.1
15.8
182
882
K80.0
ICD-10 Finland
Calculus of gallbladder with acute cholecystitis
1.7
15.8
340
2047
R07.4
ICD-10 Finland
Chest pain, unspecified
1.2
15.8
2363
20049
G59.0*E11.4
ICD-10 Finland
Non-insulin-dependent diabetes mellitus - Diabetic mononeuropathy
33.4
15.7
20
6
J01CA08
ATC
pivmecillinam; oral
1.2
15.6
2345
19895
H36.02
ICD-10 Finland
Preproliferative diabetic retinopathy
9.7
15.6
31
32
T83
ICPC
Overweight
2.6
15.6
113
436
A69.2
ICD-10 Finland
Lyme disease
0.5
15.6
153
2833
G03FA14
ATC
dydrogesterone and estrogen; systemic (progestogens and estrogens, fixed comb.)
0.5
15.6
126
2467
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
1.4
15.6
675
4794
D01AC03
ATC
econazole; topical
1.5
15.5
517
3473
P29
ICPC
Psychological sympt/compl other
1.7
15.3
292
1696
CK2S4
NOMESCO Finland
Plain photography of ocular fundus
1.5
15.3
498
3330
M01AB05
ATC
diclofenac; systemic, rectal
1.2
15.3
6188
57467
AA1AD
NOMESCO Finland
CT of head and brain
1.2
15.2
2067
17347
SPAT1059
SPAT
Spirometry at the office
1.6
15.1
421
2715
ECB00
NOMESCO Finland
Suture of gingiva
1.7
15.1
283
1638
B82
ICPC
Anaemia other/unspecified
2.0
15.1
183
907
F31.9
ICD-10 Finland
Bipolar affective disorder, unspecified
2.1
15.0
162
765
E28.2
ICD-10 Finland
Polycystic ovarian syndrome
6.6
15.0
38
58
SPAT1212
SPAT
Extensive examination of musculoskeletal system
1.5
14.8
582
4055
FN2AB
NOMESCO Finland
Percutaneous transluminal coronary angioplasty (PTCA), drug-eluting balloon
2.3
14.8
137
604
F25.00
ICD-10 Finland
Schizoaffective syndrome, manic type with only simultaneous bipolar and schizophrenic symptoms
3.8
14.7
62
165
5742A
ICD-9 Finland
Cholelithiasis, Calculus of gallbladder without mention of cholecystitis[CHOLECYSTOLITHIASIS SINE CHOLECYSTITIDE,SINE OBSTR]
2.1
14.7
162
773
Z71.9
ICD-10 Finland
Counselling, unspecified
1.6
14.7
396
2536
E000003
ATC
NA
1.7
14.7
310
1857
N20.1
ICD-10 Finland
Calculus of ureter
1.7
14.6
335
2053
P03
ICPC
Feeling depressed
1.5
14.6
446
2938
SFA20
NOMESCO Finland
Filling on two surfaces of tooth
1.2
14.5
4832
44062
C02DE04
ATC
NA
2.1
14.5
160
762
G99.0*E11.4
ICD-10 Finland
Non-insulin-dependent diabetes mellitus - Diabetic autonomic neuropathy
150.1
14.5
15
*
M14.6*A52.1
ICD-10 Finland
Charcot's or tabetic arthropathy
10.0
14.4
28
28
XCW99
NOMESCO Finland
Other investigative procedure of eye
1.4
14.4
862
6483
J01DA09
ATC
[U] cefadroxil; inhalant, oral
1.2
14.4
2107
17809
JDF01
NOMESCO Finland
Laparoscopic gastroplasty
5.7
14.3
40
70
F33.2
ICD-10 Finland
Recurrent depressive disorder, current episode severe without psychotic symptoms
1.7
14.3
268
1553
Z03.89
ICD-10 Finland
Observation for other suspected diseases and conditions
1.3
14.3
895
6779
R02
ICPC
Shortness of breath/dyspnoea
1.4
14.3
882
6665
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
1.3
14.2
1344
10791
SPAT1107
SPAT
Extensive external surface anaesthesia of skin with cream or gel
8.2
14.2
31
38
S76
ICPC
Skin infection other
1.6
14.2
381
2439
E13
ICD-10 Finland
Other specified diabetes mellitus
7.4
14.1
33
45
K59.1
ICD-10 Finland
Functional diarrhoea
1.6
14.1
350
2192
-69
ICPC
Other reason for encounter NEC
1.7
14.1
293
1748
SPAT1051
SPAT
Guidance regarding sleep disorders
2.3
14.0
126
547
R06.5
ICD-10 Finland
Mouth breathing
1.4
14.0
722
5291
T36
ICD-10 Finland
Poisoning by systemic antibiotics
1.7
14.0
264
1530
AN2
HP
Balloon angioplasty, including several vessels
1.8
14.0
253
1449
QDG20
NOMESCO Finland
Operation for chronic ulcer or fistula of skin of lower limb
2.9
14.0
84
292
N06AA09
ATC
amitriptyline; systemic
1.4
14.0
749
5525
F25.9
ICD-10 Finland
Schizoaffective disorder, unspecified
2.9
13.9
82
282
O10.0
ICD-10 Finland
Pre-existing essential hypertension complicating pregnancy, childbirth and the puerperium
3.6
13.9
62
174
R73
ICD-10 Finland
Elevated blood glucose level
0.4
13.9
56
1393
T41
ICPC
Metabolic, Diagnostic radiology/imaging
30.0
13.9
18
6
SPF00
NOMESCO Finland
Repatation of teeth prosthesis
1.8
13.8
231
1290
Z96.1
ICD-10 Finland
Presence of intraocular lens
1.3
13.8
976
7523
I21.99
ICD-10 Finland
Myocardial infarction (acute) UNS unspecified coronary artery status
1.9
13.7
188
976
201
Kela drug reimbursment
Chronic cardiac insufficiency
1.6
13.7
321
1978
K40.2
ICD-10 Finland
Bilateral inguinal hernia, without obstruction or gangrene
0.4
13.7
68
1562
H28.0*E11.3
ICD-10 Finland
Non-insulin-dependent diabetes mellitus - Diabetic cataract
13.6
13.7
23
17
F20.30
ICD-10 Finland
Undifferentiated schizophrenia continuous
2.7
13.7
90
331
203
Kela drug reimbursment
Chronic asthma and similar chronic obstructive pulmonary diseases
1.3
13.6
1432
11647
K04.1
ICD-10 Finland
Necrosis of pulp
1.4
13.6
773
5758
I35.1
ICD-10 Finland
Aortic (valve) insufficiency
0.6
13.5
194
3250
QBJ30
NOMESCO Finland
Correction of abdominal apron
4.2
13.5
50
119
N30.0
ICD-10 Finland
Acute cystitis
1.3
13.4
856
6499
R03BB04
ATC
tiotropium bromide; inhalant
1.4
13.4
792
5939
SPAT1146
SPAT
Puncture of abscess or incision of skin
2.0
13.4
159
784
R11
ICD-10 Finland
Nausea and vomiting
1.5
13.3
493
3392
O36.6
ICD-10 Finland
Maternal care for excessive fetal growth
2.9
13.3
79
273
P01AB01
ATC
metronidazole; oral, rectal
1.2
13.3
3066
27042
Z76.0
ICD-10 Finland
Issue of repeat prescription
1.3
13.3
1052
8246
SPE90
NOMESCO Finland
Other fitting and preparation of partial tooth prosthesis
1.9
13.2
193
1030
N20.0
ICD-10 Finland
Calculus of kidney
1.9
13.2
190
1006
K40
ICD-10 Finland
Inguinal hernia
0.4
13.2
57
1377
M81.9
ICD-10 Finland
Osteoporosis, unspecified
0.5
13.2
91
1866
F49
ICPC
Eye, Other preventive procedure
40.1
13.1
16
*
S02CA02
ATC
flumetasone and antiinfectives; otic
1.5
13.1
409
2713
J01EA01
ATC
trimethoprim; systemic
1.2
13.1
1658
13781
O80.0
ICD-10 Finland
Spontaneous vertex delivery
0.6
13.0
287
4371
F31.7
ICD-10 Finland
Bipolar affective disorder, currently in remission
2.3
13.0
122
542
N05AN01
ATC
lithium; oral
2.0
13.0
165
834
Z34.8
ICD-10 Finland
Supervision of other normal pregnancy
0.5
13.0
80
1702
M54.5
ICD-10 Finland
Low back pain
1.2
12.9
2526
21933
H3601, E119
ICD-10 Finland
NA
28.4
12.9
17
6
A49.9
ICD-10 Finland
Bacterial infection, unspecified
1.3
12.9
831
6315
SPAT1172
SPAT
Guidance concerning hydration
2.0
12.8
160
806
M01AH05
ATC
etoricoxib; oral
1.2
12.8
5277
48749
K43.9
ICD-10 Finland
Other and unspecified ventral hernia without obstruction or gangrene
1.6
12.7
348
2237
SPAT1336
SPAT
Request for examination
1.7
12.7
259
1538
ACC59
NOMESCO Finland
Decompression and freeing of adhesions of peripheral nerve: other or unspecified
1.6
12.7
348
2238
RD210
NOMESCO Finland
NA
2.3
12.7
117
516
R03BA05
ATC
fluticasone; inhalant
1.3
12.7
1280
10354
FL1AC
NOMESCO Finland
Left cardioangiography
2.1
12.7
135
636
M48.0
ICD-10 Finland
Spinal stenosis
1.3
12.7
990
7744
289
Kela drug reimbursment
Combination product containing sacubitril and valsartan
2.6
12.7
88
335
A08AA01
ATC
phentermine; oral
4.5
12.6
44
99
SFC92
NOMESCO Finland
Other demanding adjuvant procedure of filling therapy
1.4
12.6
521
3668
WX240
NOMESCO Finland
Penis blockade
4.5
12.6
43
95
K86
ICPC
Hypertension uncomplicated
1.3
12.6
957
7458
L08
ICPC
Shoulder symptom/complaint
1.2
12.6
1537
12721
P20
ICPC
Memory disturbance
1.3
12.5
929
7210
WYA30
NOMESCO Finland
Preparations for expected poor cooperation
1.5
12.5
497
3468
I83.0
ICD-10 Finland
Varicose veins of lower extremities with ulcer
2.0
12.5
161
820
PAF14
NOMESCO Finland
Thrombendarterectomy of internal carotid artery
2.2
12.5
123
559
FN1CB
NOMESCO Finland
Coronary flow reserve measurement with pressure wire
1.9
12.4
190
1031
KMAK
NOMESCO Finland
NA
1.2
12.4
4187
38047
A08AA04
ATC
dexfenfluramine; oral
7.3
12.4
29
40
M01AX17
ATC
nimesulide; oral
1.2
12.4
2095
17929
P76
ICPC
Depressive disorder
1.6
12.4
322
2045
SPAT1104
SPAT
Monitoring of emergency patient
1.4
12.4
522
3687
X69
ICD-10 Finland
Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances
1.8
12.4
199
1097
J01CE08
ATC
benzathine benzylpenicillin; parenteral
2.6
12.4
87
334
N07BA03
ATC
varenicline; oral
1.6
12.4
356
2316
KEC01
NOMESCO Finland
Percutaneous endoscopic radical prostatectomy
0.5
12.4
91
1829
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
1.3
12.3
847
6500
SPAT1226
SPAT
Implementation of occupational therapy rehabilitation plan
1.8
12.3
195
1071
L02.9
ICD-10 Finland
Cutaneous abscess, furuncle and carbuncle, unspecified
1.9
12.3
173
912
FNC30
NOMESCO Finland
Aorto-coronary venous bypass with three distal anastomoses
2.0
12.3
149
743
QXB99
NOMESCO Finland
Other procedure to treat skin wound, unspecified location
2.2
12.3
125
579
C09BB05
ATC
ramipril and felodipine; oral
3.4
12.2
58
172
N02AA05
ATC
oxycodone; systemic
1.3
12.1
1174
9444
C09AA06
ATC
quinapril; systemic
3.0
12.1
70
237
TPH05
NOMESCO Finland
Open cannulation of peripheral vein
2.9
12.1
72
250
T43
ICPC
Metabolic, Other diagnostic procedure
12.4
12.1
21
17
JAB11
NOMESCO Finland
Laparoscopic repair of inguinal hernia
0.4
12.1
59
1361
F25.10
ICD-10 Finland
Schizoaffective syndrome, depressive type with only concomitant bipolar and schizophrenic symptoms
3.8
12.0
49
128
D07XC01
ATC
betamethasone, combinations; topical
1.3
12.0
950
7440
G03FB05
ATC
norethisterone and estrogen; systemic (progestogens and estrogens, sequential prep.)
0.7
12.0
376
5355
E66.1
ICD-10 Finland
Drug-induced obesity
6.5
12.0
30
46
RK320
NOMESCO Finland
NA
2.7
12.0
79
291
SPAT1138
SPAT
Guidance concerning bowel function
2.3
12.0
109
478
R04.0
ICD-10 Finland
Epistaxis
1.4
12.0
562
4055
S17
ICPC
Abrasion/scratch/blister
2.0
11.9
139
683
WZA90
NOMESCO Finland
Other doctors statement
1.2
11.9
1737
14650
A10AD01
ATC
insulin (human); parenteral (insulins and analog. for injection, intermediate- or long-acting comb. with fast-acting)
2.6
11.8
83
318
C08CA05
ATC
nifedipine; systemic
1.5
11.8
455
3157
C02DE12
ATC
NA
3.4
11.8
56
166
2989X
ICD-9 Finland
Other nonorganic psychoses, Unspecified psychosis
2.9
11.8
71
249
E14.1
ICD-10 Finland
Unspecified diabetes mellitus, with ketoacidosis
7.9
11.8
26
33
M54.4
ICD-10 Finland
Lumbago with sciatica
1.3
11.8
1190
9625
QBB05
NOMESCO Finland
Revision of wound of skin of trunk
2.5
11.8
89
354
J01DA06
ATC
[U] cefuroxime; systemic
1.3
11.7
1059
8445
JCA22
NOMESCO Finland
Endoscopic ligature of oesophageal varices
4.5
11.7
40
89
SPAT1231
SPAT
Assessment of adjustments needed in living environment
2.0
11.6
144
724
D07AD01
ATC
clobetasol; topical
1.3
11.6
1192
9657
L98.4
ICD-10 Finland
Chronic ulcer of skin, not elsewhere classified
2.0
11.6
139
687
S94
ICPC
Ingrowing nail
2.3
11.6
108
481
6663
FHL
Cholecystectomy and cholangiography
2.2
11.6
110
495
S21
ICPC
Skin texture symptom/complaint
1.3
11.6
938
7375
L40.0
ICD-10 Finland
Psoriasis vulgaris
1.6
11.5
320
2066
A10BK04
ATC
ertugliflozin; oral
+∞
11.5
11
*
SPAT1248
SPAT
OTHER EXAMINATIONS, PROCEDURES, TREATMENT ETC.
3.8
11.4
47
125
25009
ICD-8 Finland
Diabetes mellitus, Unspecified
4.2
11.4
42
101
-44
ICPC
Preventive immunization/medic
1.4
11.3
639
4755
D05AX02
ATC
calcipotriol; topical
1.6
11.3
312
2009
PD4CC
NOMESCO Finland
Very extensive arterigography of lower extremity with X-ray
3.0
11.3
62
205
A69
ICPC
General and Unspecified, Other reason for encounter NEC
1.9
11.3
168
903
PF1BT
NOMESCO Finland
Extensive PTA of arteries of knee, lower leg and ankle
3.6
11.3
50
141
B01AF02
ATC
apixaban; oral
1.3
11.2
774
5946
R4160
NOMESCO Finland
Other therapy enhancing rehabilitation
2.2
11.2
109
494
D35.0
ICD-10 Finland
Benign neoplasm: Adrenal gland
2.1
11.2
122
584
SAA03
NOMESCO Finland
Extended examination of mouth
1.2
11.2
2946
26201
J40
ICD-10 Finland
Bronchitis, not specified as acute or chronic
1.8
11.1
192
1085
T92
ICPC
Gout
1.9
11.1
155
815
K10.3
ICD-10 Finland
Alveolitis of jaws
1.6
11.1
255
1568
C02EA01
ATC
NA
2.5
11.1
82
324
C09DX04
ATC
valsartan and sacubitril; oral
2.6
11.1
78
300
381
Kela drug reimbursment
Combination product containing sacubitril and valsartan
2.7
11.1
72
266
N05AE04
ATC
ziprasidone; systemic
4.2
11.1
41
99
SPAT1202
SPAT
Intra-articular injection
1.7
11.0
247
1509
G03FA12
ATC
medroxyprogesterone and estrogen; systemic (progestogens and estrogens, fixed comb.)
0.6
11.0
139
2394
F29
ICD-10 Finland
Unspecified nonorganic psychosis
1.8
11.0
183
1024
K57.3
ICD-10 Finland
Diverticular disease of large intestine without perforation or abscess
1.2
11.0
1425
11862
G04BD12
ATC
mirabegron; oral
1.3
10.9
800
6201
XCD20
NOMESCO Finland
Photoangiography of eye
2.0
10.9
130
646
R60.9
ICD-10 Finland
Oedema, unspecified
1.5
10.9
326
2145
A02BC03
ATC
lansoprazole; oral
1.2
10.9
2414
21149
R03AC03
ATC
terbutaline; inhalant
1.3
10.9
942
7468
F60.30
ICD-10 Finland
Emotionally unstable personality disorder, impulsive
2.6
10.9
77
297
E86
ICD-10 Finland
Volume depletion
1.9
10.9
155
822
X72
ICPC
Genital candidiasis female
3.8
10.9
44
115
SPAT1283
SPAT
Restricted health certificate
1.3
10.9
802
6222
SPAT1221
SPAT
Guidance concerning rehabilitation services and livelihood
2.1
10.9
124
602
F31.6
ICD-10 Finland
Bipolar affective disorder, current episode mixed
2.5
10.9
81
323
UJF92
NOMESCO Finland
Capsular endoscopy
2.0
10.9
136
689
C02EA05
ATC
NA
3.2
10.8
54
167
Z25.8
ICD-10 Finland
Need for immunization against other specified single viral diseases
1.3
10.8
874
6866
Z01.8
ICD-10 Finland
Other specified special examinations
1.2
10.8
1685
14284
F31.30
ICD-10 Finland
Bipolar disorder Depressive episode without somatic syndrome
2.2
10.8
104
469
SPAT1276
SPAT
Outlining of treatment with patient or their family members
1.8
10.8
174
962
EBA10
NOMESCO Finland
Surgical removal of tooth
1.3
10.8
674
5099
A10AD04
ATC
insulin lispro; parenteral (insulins and analog. for injection, intermediate- or long-acting comb. with fast-acting)
4.7
10.8
35
74
JAD30
NOMESCO Finland
Repair of incisional hernia using prosthetic material
2.0
10.8
139
710
C09BB04
ATC
perindopril and amlodipine; systemic
2.1
10.8
121
585
K29
ICPC
Cardiovascular sympt/complt other
1.5
10.7
321
2112
SPAT1094
SPAT
Continuous Positive Airway Pressure
2.3
10.7
99
440
8170/3-C22.0
ICD-O-3
Hepatocellular carcinoma, NOS, of liver
3.8
10.7
43
112
A29
ICPC
General symptom/complaint other
1.3
10.7
811
6318
D12.3
ICD-10 Finland
Benign neoplasm: Transverse colon
1.8
10.7
181
1021
PD3YT
NOMESCO Finland
Pelvic artery PTA with stent
2.3
10.7
98
434
L68.0
ICD-10 Finland
Hirsutism
6.7
10.6
26
39
NHQ30
NOMESCO Finland
Amputation of foot, transmetatarsal
3.3
10.6
52
159
WX105
NOMESCO Finland
Surface analgesia on skin or mucosa
1.3
10.6
650
4905
L95
ICPC
Osteoporosis
0.5
10.6
62
1339
SCA02
NOMESCO Finland
Analysis and advice of nutrition with regard to dentistry
1.4
10.6
557
4099
WZB00
SPAT
NA
1.8
10.6
180
1017
G03BA03
ATC
testosterone; systemic, rectal, sublingual, transdermal
1.4
10.6
516
3749
RK323
NOMESCO Finland
NA
4.1
10.5
40
99
K92.1
ICD-10 Finland
Melaena
1.5
10.5
378
2590
F61.0
ICD-10 Finland
Mixed personality disorders
2.2
10.5
105
484
SPE01
NOMESCO Finland
Mucosa-supported partial denture
2.0
10.4
126
629
A41.9
ICD-10 Finland
Sepsis, unspecified
1.6
10.4
246
1528
SPAT1279
SPAT
Preparation of immediate hospitalisation
2.5
10.4
77
304
S01
ICPC
Pain/tenderness of skin
1.6
10.4
286
1846
WX872
NOMESCO Finland
Intensive care
1.4
10.4
425
2989
S91.1
ICD-10 Finland
Open wound of toe(s) without damage to nail
2.2
10.3
98
441
E000001
ATC
NA
1.2
10.3
1438
12054
QBB10
NOMESCO Finland
Major dressing of wound of skin of trunk
1.6
10.3
237
1463
WX100
NOMESCO Finland
Conjunctival surface anesthesia
1.3
10.3
869
6868
Z03
ICD-10 Finland
Medical observation and evaluation for suspected diseases and conditions, ruled out
0.7
10.3
281
4103
J01FA09
ATC
clarithromycin; systemic
1.2
10.2
2439
21481
PEN23
NOMESCO Finland
Plastic repair of femoral artery
2.6
10.2
74
291
PA6DE
NOMESCO Finland
Neck artery ultrasound examination with Doppler method
1.5
10.2
390
2703
SPAT1359
SPAT
Use of symptom diary
1.8
10.2
171
960
B37.3
ICD-10 Finland
Candidiasis of vulva and vagina
3.1
10.2
54
175
SPAT1016
SPAT
Examination of vision
1.5
10.2
325
2169
F34.1
ICD-10 Finland
Dysthymia
1.7
10.2
198
1165
PEP25
NOMESCO Finland
Percutaneous plastic repair of superficial femoral artery
4.4
10.2
35
79
111
HP
Conventional CABG
2.7
10.2
66
244
TQW80
NOMESCO Finland
Local dermatologic skincare
1.7
10.2
189
1098
WX213
NOMESCO Finland
Lower leg blockade
2.8
10.2
64
231
N30.9
ICD-10 Finland
Cystitis, unspecified
1.5
10.2
320
2131
C02DE10
ATC
NA
2.3
10.1
88
378
S11
ICPC
Skin infection post-traumatic
2.1
10.1
110
528
G03CA03
ATC
estradiol; nasal, systemic, rectal, transdermal, vaginal
0.9
10.1
2261
25568
Z51.88
ICD-10 Finland
Other specified medical care
1.9
10.1
142
750
C10BX11
ATC
atorvastatin, amlodipine and perindopril; systemic
6.9
10.0
24
35
S80.0
ICD-10 Finland
Contusion of knee
1.5
10.0
382
2651
C09CA02
ATC
eprosartan; oral
2.2
10.0
94
422
A09AA02
ATC
multienzymes (lipase, protease etc.)
1.9
10.0
144
769
SPAT1153
SPAT
Removal of sutures
1.2
10.0
2855
25504
XFP20
NOMESCO Finland
Check up of cardiac pacemaker
1.4
10.0
493
3589
K04.7
ICD-10 Finland
Periapical abscess without sinus
1.4
10.0
407
2858
M02AA07
ATC
piroxicam; topical
1.2
10.0
3118
28043
D06AX01
ATC
fusidic acid; topical (antibiotics for topical use)
1.3
10.0
633
4801
C10BA06
ATC
rosuvastatin and ezetimibe; oral
2.7
10.0
64
235
G03CX01
ATC
tibolone; oral
0.4
9.9
48
1107
D64.8
ICD-10 Finland
Other specified anaemias
2.1
9.9
112
545
J01FA15
ATC
telithromycin; oral
1.3
9.8
723
5604
KBV02
NOMESCO Finland
Cystoscopic insertion of stent into ureter
1.8
9.8
171
974
B01AC07
ATC
dipyridamole; systemic
1.6
9.8
270
1745
QDB99
NOMESCO Finland
Other procedure for wound of skin of lower limb
3.1
9.8
51
164
S52.5
ICD-10 Finland
Fracture of lower end of radius
0.7
9.8
386
5295
M81.0
ICD-10 Finland
Postmenopausal osteoporosis
0.4
9.7
34
889
O24.9
ICD-10 Finland
Diabetes mellitus in pregnancy, unspecified
3.7
9.7
41
112
SPAT1294
SPAT
Other function in accordance with health social work nomenclature
1.8
9.7
170
971
I63.5
ICD-10 Finland
Cerebral infarction due to unspecified occlusion or stenosis of cerebral arteries
2.0
9.7
111
545
FNC10
NOMESCO Finland
Aorto-coronary venous bypass with single distal anastomosis
2.0
9.7
111
545
X16
ICPC
Vulval symptom/complaint
2.9
9.7
57
199
SPAT1127
SPAT
Enema
2.8
9.7
61
221
XA420
NOMESCO Finland
Extensive sleep examination
2.1
9.6
99
464
PE1BT
NOMESCO Finland
Femoral artery extensive PTA
2.9
9.6
56
193
A02BA02
ATC
ranitidine; systemic
1.2
9.6
1571
13373
SFA00
NOMESCO Finland
Small filling
1.3
9.6
939
7560
B01AC06
ATC
acetylsalicylic acid; oral (platelet aggregation inhibitors excl. heparin)
1.7
9.6
187
1102
L03
ICPC
Low back symptom/complaint
1.2
9.6
1747
15024
R03BA01
ATC
beclometasone; inhalant
1.3
9.6
983
7962
N18
ICD-10 Finland
Chronic kidney disease
2.6
9.6
67
260
I69.3
ICD-10 Finland
Sequelae of cerebral infarction
1.4
9.6
508
3747
I63.3
ICD-10 Finland
Cerebral infarction due to thrombosis of cerebral arteries
1.5
9.5
281
1846
SPAT1388
SPAT
Extensive health check-up based on individual need
5.0
9.5
29
58
Y6099
ICD-8 Finland
Prenatal care and observation
1.6
9.5
262
1695
SPAT1167
SPAT
Insertion of urinary catheter
1.6
9.5
235
1481
E14
ICD-10 Finland
Unspecified diabetes mellitus
6.0
9.5
25
42
I21.40
ICD-10 Finland
Acute subendocardial infarction no detected stenosis of the coronary artery
1.7
9.5
179
1047
SPAT1244
SPAT
Occupational therapy
2.4
9.5
75
310
N04AA02
ATC
biperiden; systemic
1.9
9.4
137
736
D01BA02
ATC
terbinafine; oral; topical
1.2
9.4
2264
19941
188
Kela drug reimbursment
Psychosis requiring demanding treatment
2.5
9.4
72
294
C09CA08
ATC
olmesartan medoxomil; oral
1.9
9.4
136
728
BEF00
NOMESCO Finland
Continuous subcutaneous glucose monitoring
3.6
9.3
40
111
Z50.0
ICD-10 Finland
Cardiac rehabilitation
2.1
9.3
104
506
P06
ICPC
Sleep disturbance
1.3
9.3
624
4779
N91.1
ICD-10 Finland
Secondary amenorrhoea
3.5
9.3
41
117
8090/3-C44.5
ICD-O-3
Basal cell carcinoma, NOS, of skin of trunk
0.4
9.2
34
874
SPAT1098
SPAT
Exercise ECG
1.8
9.2
164
940
WX723
NOMESCO Finland
CPAP therapy
1.5
9.2
262
1705
I44.1
ICD-10 Finland
Atrioventricular block, second degree
1.8
9.2
149
829
QBA10
NOMESCO Finland
Incision of skin of trunk
2.2
9.2
91
420
KAE12
NOMESCO Finland
Retrograde ureteronephroscopic lithotripsy in pelvis of kidney
2.9
9.2
54
188
J45.0
ICD-10 Finland
Predominantly allergic asthma
1.4
9.2
492
3636
SPAT1300
SPAT
Other function in accordance with FinLOINC classification
5.2
9.2
27
52
K86.00
ICD-10 Finland
Acute pancreatitis caused by alcohol
2.1
9.2
100
480
L02.8
ICD-10 Finland
Cutaneous abscess, furuncle and carbuncle of other sites
2.3
9.1
83
369
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
1.2
9.1
2333
20639
63702
ICD-8 Finland
Pre-eclampsia, eclampsia and toxaemia, unspecified, Oedema
2.8
9.1
55
196
N17.8
ICD-10 Finland
Other acute renal failure
2.3
9.1
79
343
H49.2
ICD-10 Finland
Sixth [abducent] nerve palsy
2.5
9.1
69
278
F25.21
ICD-10 Finland
Schizoaffective syndrome, mixed type with prolonged schizophrenic than bipolar symptoms
4.9
9.1
28
57
D05BB02
ATC
acitretin; oral
1.7
9.1
177
1046
S01CA01
ATC
dexamethasone and antiinfectives; ophthalmic (ophth., corticosteroids and antiinfectives in comb.)
1.2
9.1
2788
25010
JJ2AT
NOMESCO Finland
Biopsy of liver with ultrasound guidance
1.8
9.1
153
863
XCK20
NOMESCO Finland
NA
4.6
9.0
30
66
D07CC01
ATC
betamethasone and antibiotics; topical
1.3
9.0
932
7551
M20.1
ICD-10 Finland
Hallux valgus (acquired)
0.7
9.0
307
4309
K87
ICPC
Hypertension complicated
1.7
9.0
162
932
M05BA07
ATC
risedronic acid; oral
0.5
9.0
73
1416
H02AB02
ATC
dexamethasone; systemic
0.8
9.0
502
6542
K04.09
ICD-10 Finland
Pulpit UNS
1.6
9.0
231
1472
F31.0
ICD-10 Finland
Bipolar affective disorder, current episode hypomanic
2.2
9.0
84
379
J44.8
ICD-10 Finland
Other specified chronic obstructive pulmonary disease
1.3
8.9
732
5762
R2130
SPAT
NA
4.2
8.9
32
76
M14.6
ICD-10 Finland
Neuropathic arthropathy
7.4
8.9
20
27
F50.8
ICD-10 Finland
Other eating disorders
7.4
8.9
20
27
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
1.2
8.9
1267
10639
I25.5
ICD-10 Finland
Ischaemic cardiomyopathy
1.9
8.9
116
599
D89
ICPC
Inguinal hernia
0.4
8.9
42
977
F31
ICPC
Eye, Medical examin/health eval partial
5.2
8.9
26
50
N05CD07
ATC
temazepam; oral
1.3
8.8
887
7165
XF600
NOMESCO Finland
Bloodpressure measurement
1.4
8.8
446
3262
F20
ICD-10 Finland
Schizophrenia
3.0
8.8
49
166
P01BA02
ATC
hydroxychloroquine; oral
0.7
8.8
322
4467
F03
ICD-10 Finland
Unspecified dementia
1.6
8.8
229
1461
L30.4
ICD-10 Finland
Erythema intertrigo
2.2
8.8
83
376
PHD99
NOMESCO Finland
Resection of other vein
0.7
8.8
237
3464
SPAT1241
SPAT
Extensive assessment of psychosocial situation
2.6
8.8
60
229
-63
ICPC
Follow-up encounter unspecified
4.3
8.8
31
73
-1
NOMESCO Finland
NA
1.2
8.7
2409
21423
K85
ICD-10 Finland
Acute pancreatitis
1.9
8.7
123
653
133
Kela drug reimbursment
Severe chronic pancreatic insufficiency
2.0
8.7
102
506
SPAT1165
SPAT
Peritoneal dialysis
7.1
8.7
20
28
G45.9
ICD-10 Finland
Transient cerebral ischaemic attack, unspecified
1.3
8.7
586
4489
Z03.8
ICD-10 Finland
Observation for other suspected diseases and conditions
0.6
8.7
127
2107
D02AE01
ATC
carbamide; topical
1.4
8.7
444
3255
ANC
HP
Coronary artery pressure measurement (FFR, fractional flow reserve)
2.3
8.7
76
331
D37.6
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Liver, gallbladder and bile ducts
2.0
8.7
101
499
J01EE02
ATC
sulfadiazine and trimethoprim; systemic
1.2
8.6
1831
15946
G04CA52
ATC
tamsulosin and dutasteride; systemic
1.2
8.6
922
7504
F70.0
ICD-10 Finland
Mild mental retardation, With the statement of no, or minimal, impairment of behaviour
5.0
8.6
26
52
ZPB96
NOMESCO Finland
Other material in vessel transplant
5.0
8.6
26
52
A04
ICPC
Weakness/tiredness general
1.3
8.6
809
6483
L05.9
ICD-10 Finland
Pilonidal cyst without abscess
2.4
8.6
69
287
C07AA07
ATC
sotalol; systemic
1.5
8.6
273
1828
F20.04
ICD-10 Finland
Paranoid schizophrenia with partial recurrence
3.0
8.6
47
158
F33.9
ICD-10 Finland
Recurrent depressive disorder, unspecified
1.6
8.5
194
1197
SPAT1125
SPAT
Stoma care and guidance
1.9
8.5
113
587
A08
ICPC
Swelling
1.5
8.5
263
1747
K77
ICPC
Heart failure
1.9
8.5
125
673
PEH56
NOMESCO Finland
Bypass from femoral to popliteal artery above knee
2.6
8.5
58
220
Z46.1
ICD-10 Finland
Fitting and adjustment of hearing aid
1.4
8.5
493
3694
L15
ICPC
Knee symptom/complaint
1.2
8.5
1544
13265
S19
ICPC
Skin injury other
1.5
8.5
270
1806
N06AB10
ATC
escitalopram; oral
1.2
8.5
1222
10273
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
1.4
8.5
491
3678
D12.4
ICD-10 Finland
Benign neoplasm: Descending colon
1.9
8.4
121
649
D07BB04
ATC
hydrocortisone butyrate and antiseptics; topical
1.3
8.4
886
7197
BC1AD
NOMESCO Finland
CT of adrenal glands
2.4
8.4
68
285
I71.2
ICD-10 Finland
Thoracic aortic aneurysm, without mention of rupture
0.6
8.4
103
1784
SGA03
NOMESCO Finland
Demanding opening and dilatation of root canal of tooth
1.3
8.3
632
4925
C09BA06
ATC
quinapril and diuretics; systemic
3.4
8.3
38
112
202
Kela drug reimbursment
Connective tissue diseases, rheumatoid arthritis and comparable disease
0.8
8.3
522
6702
N05AA01
ATC
chlorpromazine; systemic, rectal
2.0
8.3
99
496
ZXA10
NOMESCO Finland
Bilateral
1.2
8.3
1412
12055
C02EA06
ATC
NA
3.6
8.3
35
97
E53.9
ICD-10 Finland
Vitamin B deficiency, unspecified
5.8
8.3
22
38
-34
ICPC
Blood test
1.6
8.2
194
1210
F20.09
ICD-10 Finland
Paranoid schizophrenia UNS
2.5
8.2
60
237
K78
ICPC
Atrial fibrillation/flutter
1.3
8.2
598
4636
D12.2
ICD-10 Finland
Benign neoplasm: Ascending colon
1.6
8.2
216
1383
F20.5
ICD-10 Finland
Residual schizophrenia
2.9
8.2
48
168
63701
ICD-8 Finland
Pre-eclampsia, eclampsia and toxaemia, unspecified, Hypertonia
2.0
8.2
100
506
S29
ICPC
Skin symptom/complaint other
1.2
8.2
1236
10437
B02AA02
ATC
tranexamic acid; systemic
1.3
8.2
813
6560
WX892
NOMESCO Finland
Monitored bed care
1.3
8.2
582
4496
SPAT1062
SPAT
Lung clearance therapy
4.9
8.2
25
51
I20.91
ICD-10 Finland
Angina pectoris, unspecified
2.0
8.1
97
485
FN1BB
NOMESCO Finland
Contrast angiography of heart and/or coronary arteries after bypass surgery
2.3
8.1
72
316
Z95.0
ICD-10 Finland
Presence of electronic cardiac devices
1.4
8.1
356
2542
L85.3
ICD-10 Finland
Xerosis cutis
2.3
8.1
70
306
N06AA12
ATC
doxepin; systemic
1.4
8.1
353
2523
JDF21
NOMESCO Finland
Laparoscopic gastric banding
11.7
8.1
14
12
K42.0
ICD-10 Finland
Umbilical hernia with obstruction, without gangrene
2.1
8.1
90
440
SPAT1147
SPAT
Destruction of skin lesion with external methods
1.8
8.0
123
673
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
1.4
8.0
427
3155
S12
ICPC
Insect bite/sting
0.7
8.0
338
4581
FKB10
NOMESCO Finland
Annuloplasty of mitral valve for insufficiency using ring
0.3
8.0
12
469
D75.1
ICD-10 Finland
Secondary polycythaemia
2.7
8.0
51
187
N06AX11
ATC
mirtazapine; oral
1.2
8.0
2396
21423
Z45.0
ICD-10 Finland
Adjustment and management of cardiac devices
1.5
8.0
292
2015
C09BX01
ATC
perindopril, amlodipine and indapamide; systemic
2.7
8.0
51
188
WX725
NOMESCO Finland
Noninvasive ventilation
1.4
7.9
323
2276
L02.4
ICD-10 Finland
Cutaneous abscess, furuncle and carbuncle of limb
1.6
7.9
202
1284
KAT00
NOMESCO Finland
Extracorporeal shock wave lithotripsy of pelvis of kidney
2.1
7.9
84
402
I21.19
ICD-10 Finland
Acute transmural myocardial infarction of inferior wall
1.9
7.9
114
611
L89
ICD-10 Finland
Decubitus ulcer and pressure area
1.9
7.9
106
555
Y75
ICPC
Balanitis
4.9
7.9
24
49
F25.11
ICD-10 Finland
Schizoaffective syndrome, depressive type with prolonged schizophrenic than bipolar symptoms
4.9
7.9
24
49
T50
ICPC
Metabolic, Medication/prescr/renewal
4.2
7.9
28
67
R05
ICPC
Cough
1.2
7.8
1586
13753
SPAT1360
SPAT
Extensive global examination
1.3
7.8
525
4024
OAB74
SPAT
NA
6.1
7.8
20
33
J44.0
ICD-10 Finland
Chronic obstructive pulmonary disease with acute lower respiratory infection
1.4
7.8
297
2067
K43.0
ICD-10 Finland
Incisional hernia with obstruction, without gangrene
2.3
7.8
70
310
N03AX09
ATC
lamotrigine; oral
1.5
7.8
241
1605
E78.49
ICD-10 Finland
Other hyperlipidaemia
2.3
7.8
67
291
FN2CA
NOMESCO Finland
Percutaneous transluminal coronary angioplasty (PTCA), treating more than one main trunk during a single procedure
1.9
7.7
99
511
SPAT1101
SPAT
Orthostatic test
1.4
7.7
309
2168
K76.9
ICD-10 Finland
Liver disease, unspecified
2.0
7.7
94
474
L02
ICD-10 Finland
Cutaneous abscess, furuncle and carbuncle
1.5
7.7
219
1430
SPD01
NOMESCO Finland
Mucosa-supported complete denture
2.4
7.7
64
273
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
1.3
7.7
450
3375
XF655
NOMESCO Finland
Measurement of heart muscle perfusion with exercise
1.5
7.7
223
1464
C09BB02
ATC
enalapril and lercanidipine; systemic
2.6
7.7
54
212
R05DA01
ATC
ethylmorphine; oral
1.3
7.6
574
4470
M03BA52
ATC
carisoprodol, combinations excl. psycholeptics; oral
1.5
7.6
236
1575
IFA01
NOMESCO Finland
Psychiatric pharmacotherapy plan, not specified
2.7
7.6
47
172
H93.1
ICD-10 Finland
Tinnitus
0.7
7.6
285
3934
M05BX04
ATC
denosumab; parenteral
0.7
7.6
178
2666
MAX99
NOMESCO Finland
Assistance to normal delivery
0.4
7.6
26
680
N85.0
ICD-10 Finland
Endometrial glandular hyperplasia
2.0
7.6
88
436
J45.8
ICD-10 Finland
Mixed asthma
1.6
7.5
180
1126
D07BA04
ATC
hydrocortisone and antiseptics; topical
1.3
7.5
592
4641
E78.1
ICD-10 Finland
Pure hyperglyceridaemia
3.7
7.5
31
85
H36.09
ICD-10 Finland
Diabetic retinopathy (E10-E14+ with common fourth character .3)
3.8
7.5
30
80
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.1
7.5
2565
23131
-31
ICPC
Medical examin/health eval partial
1.3
7.5
482
3670
Z36.3
ICD-10 Finland
Antenatal screening for malformations using ultrasound and other physical methods
0.7
7.5
186
2758
NHK30
NOMESCO Finland
Osteotomy or rotation osteotomy of first metatarsal or tarsal bone
0.6
7.5
94
1614
M03BX02
ATC
tizanidine; oral
1.1
7.5
5359
50567
I44.2
ICD-10 Finland
Atrioventricular block, complete
1.6
7.5
170
1053
D09AB01
ATC
zinc bandage without supplements; topical
1.8
7.5
128
730
Z34.0
ICD-10 Finland
Supervision of normal first pregnancy
0.5
7.5
54
1082
SPAT1058
SPAT
PEF monitoring instruction
1.3
7.5
590
4628
A10AA01
ATC
NA
0.5
7.5
54
1082
A99
ICPC
Disease/condition unspecnature/site
1.3
7.5
547
4246
H35.0
ICD-10 Finland
Background retinopathy and retinal vascular changes
2.8
7.5
45
162
C02CA01
ATC
prazosin; oral
1.9
7.4
106
568
N03AG01
ATC
valproic acid; systemic, rectal
1.4
7.4
375
2753
FME20
NOMESCO Finland
Transvenous aortic valve replacement via femoral artery
2.1
7.4
80
386
G43.1
ICD-10 Finland
Migraine with aura [classical migraine]
0.6
7.4
128
2042
T91
ICPC
Vitamin/nutritional deficiency
2.4
7.4
56
230
R74.8
ICD-10 Finland
Abnormal levels of other serum enzymes
0.7
7.4
309
4194
N02CC01
ATC
sumatriptan; nasal, systemic, rectal
0.8
7.4
382
5026
G03FB08
ATC
dydrogesterone and estrogen; systemic (progestogens and estrogens, sequential prep.)
0.6
7.3
155
2373
SPAT1057
SPAT
Peak expiratory flow measurement
1.7
7.3
148
886
C07FB03
ATC
atenolol and nifedipine; systemic
3.7
7.3
30
82
SPAT1232
SPAT
Communication with help of interpreter or assistant
4.3
7.3
25
58
SPAT1266
SPAT
Separate instruction to prepare for procedure
1.6
7.3
195
1256
N20.9
ICD-10 Finland
Urinary calculus, unspecified
1.6
7.3
195
1256
NFQ20
NOMESCO Finland
Amputation of femur
2.7
7.3
45
165
XX_20
NOMESCO Finland
Bioimpedance measurement
6.8
7.3
17
25
OAB72
NOMESCO Finland
Weight control and weight loss guidance
3.4
7.3
33
98
KBE12
NOMESCO Finland
Transluminal endoscopic extraction of calculus of ureter
2.0
7.3
88
444
J05AH02
ATC
oseltamivir; oral
2.7
7.2
47
176
I70
ICD-10 Finland
Atherosclerosis
3.1
7.2
37
120
I21.90
ICD-10 Finland
Myocardial infarction (acute) UNS no detected stenosis of the coronary artery
1.8
7.2
111
613
57309
ICD-8 Finland
Other diseases of liver, Unspecified
3.8
7.2
28
73
F20.34
ICD-10 Finland
Undifferentiated schizophrenia with partial recurrence
3.6
7.2
30
83
QBG99
NOMESCO Finland
Other operation for chronic ulcer or fistula of skin
6.2
7.2
18
29
N95.1
ICD-10 Finland
Menopausal and female climacteric states
0.7
7.2
242
3396
K03
ICPC
Cardiovascular pain NOS
3.2
7.2
35
110
T28
ICPC
Limited function/disability (T)
2.2
7.2
68
309
P28
ICPC
Limited function/disability (P)
2.6
7.1
50
195
FXA00
NOMESCO Finland
Total cardiopulmonary bypass in normothermia or moderate hypothermia at concurrent surgical procedure
1.4
7.1
315
2258
Z72.0
ICD-10 Finland
Tobacco use
1.6
7.1
156
954
B37.4
ICD-10 Finland
Candidiasis of other urogenital sites
3.3
7.1
33
100
R53
ICD-10 Finland
Malaise and fatigue
1.2
7.1
1363
11763
M01AC06
ATC
meloxicam; systemic, rectal
1.1
7.1
3031
27728
F31.8
ICD-10 Finland
Other bipolar affective disorders
2.0
7.1
85
431
D10
ICPC
Vomiting
1.5
7.0
217
1446
L16
ICPC
Ankle symptom/complaint
1.3
7.0
619
4924
Z11.3
ICD-10 Finland
Special screening examination for infections with a predominantly sexual mode of transmission
0.6
7.0
109
1780
J45.1
ICD-10 Finland
Nonallergic asthma
1.3
7.0
443
3367
NK6QA
NOMESCO Finland
Measurement of bone density from tow or more locations with X-ray
0.7
7.0
237
3325
PAN14
NOMESCO Finland
Plastic repair of arteries internal carotid artery
2.4
7.0
57
243
6662
FHL
Cholecystectomy
1.9
7.0
97
517
H60.9
ICD-10 Finland
Otitis externa, unspecified
1.3
7.0
406
3045
JAF30
NOMESCO Finland
Repair of umbilical hernia using prosthetic material
1.6
7.0
176
1119
K86.3
ICD-10 Finland
Pseudocyst of pancreas
2.8
7.0
41
145
R03BA02
ATC
budesonide; inhalant
1.2
7.0
1170
9972
F21
ICPC
NA
2.4
7.0
54
225
FN2CB
NOMESCO Finland
Percutaneous transluminal coronary angioplasty (PTCA) of coronary chronic total occlusion
2.4
7.0
54
225
C09DA08
ATC
olmesartan medoxomil and diuretics; oral
2.4
7.0
54
225
S06
ICPC
Rash localized
1.4
7.0
363
2677
E53.8
ICD-10 Finland
Deficiency of other specified B group vitamins
2.7
7.0
43
158
I73.0
ICD-10 Finland
Raynaud syndrome
0.4
7.0
22
596
SPA47
NOMESCO Finland
Precision impression for denture
1.7
7.0
129
757
SPD00
NOMESCO Finland
Fitting and preparation of total teeth prosthesis
1.9
6.9
88
454
FPE00
NOMESCO Finland
Implantation of transvenous cardiac pacemaker with ventricular electrode
1.7
6.9
132
780
F60.9
ICD-10 Finland
Personality disorder, unspecified
2.2
6.9
69
321
57408
ICD-8 Finland
Cholelithiasis, Alia definita
2.1
6.9
70
331
NHJ10
NOMESCO Finland
Internal fixation of fracture of ankle using wire, rod, cerclage or pin
1.4
6.9
306
2194
IGY01
NOMESCO Finland
Accelerated psychiatric treatment contact
2.1
6.9
69
322
A50
ICPC
General and Unspecified, Medication/prescr/renewal
1.5
6.9
214
1431
F31.4
ICD-10 Finland
Bipolar affective disorder, current episode severe depression without psychotic symptoms
2.0
6.9
77
379
A03DA02
ATC
pitofenone and analgesics; systemic
1.7
6.9
128
750
2957A
ICD-9 Finland
Schizophrenic psychoses, Schizo-affective type
3.4
6.9
31
92
N05CF01
ATC
zopiclone; oral
1.1
6.9
2525
22865
K86.1
ICD-10 Finland
Other chronic pancreatitis
2.2
6.9
62
279
Z46.9
ICD-10 Finland
Fitting and adjustment of unspecified device
2.0
6.8
83
421
Z31.5
ICD-10 Finland
Genetic counselling
0.6
6.8
95
1590
M48.1
ICD-10 Finland
Ankylosing hyperostosis [Forestier]
2.9
6.8
38
131
S82
ICPC
Naevus/mole
0.8
6.8
578
7163
JAH01
NOMESCO Finland
Laparoscopy
1.5
6.8
240
1648
ZPB22
NOMESCO Finland
Autograft of vein
2.7
6.8
44
163
M01AH01
ATC
celecoxib; oral (coxibs)
1.2
6.8
1395
12096
F20.3
ICD-10 Finland
Undifferentiated schizophrenia
3.0
6.8
36
120
Z04.9
ICD-10 Finland
Examination and observation for unspecified reason
1.4
6.8
274
1929
N04BC05
ATC
pramipexole; oral
1.3
6.8
520
4060
JKA20
NOMESCO Finland
Cholecystectomy
1.6
6.8
182
1175
K55.8
ICD-10 Finland
Other vascular disorders of intestine
2.9
6.8
37
126
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
1.2
6.8
962
8070
SPAT1261
SPAT
Real-time image transmission consultation
5.0
6.8
20
40
ZXD05
NOMESCO Finland
Urgent procedure
1.1
6.8
2356
21257
AN3
HP
Balloon angioplasty and metallic stent
1.5
6.7
215
1445
N02CC06
ATC
eletriptan; oral
0.5
6.7
47
954
M03BC51
ATC
orphenadrine, combinations; systemic
1.1
6.7
2120
18992
Z5132
NOMESCO Finland
Nursing associate professional
2.9
6.7
39
136
SPAT1273
SPAT
Structured assessment of psychoactive substance / tobacco use
1.6
6.7
157
979
C08CA03
ATC
isradipine; systemic
1.9
6.7
88
458
C09DA02
ATC
eprosartan and diuretics; oral
2.4
6.7
52
217
M01AX05
ATC
glucosamine; oral
1.2
6.7
1586
13914
F00.20*G30.8
ICD-10 Finland
Dementia in Alzheimer's disease, atypical or mixed type without additional symptoms
1.8
6.7
100
545
N05AF01
ATC
flupentixol; systemic
1.8
6.7
104
576
8140/3-C61.9
ICD-O-3
Adenocarcinoma, NOS, of prostate gland
0.8
6.7
614
7540
D07CA01
ATC
hydrocortisone and antibiotics; topical
1.2
6.7
876
7292
I20.88
ICD-10 Finland
Other angina pectoris other occlusion in coronary artery
3.5
6.7
29
84
F60.31
ICD-10 Finland
Emotionally unstable personality disorder, borderline condition
2.3
6.7
58
257
K25.0
ICD-10 Finland
Gastric ulcer, Acute with haemorrhage
2.0
6.7
79
397
D44.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Adrenal gland
2.0
6.6
75
371
280
Kela drug reimbursment
Clopidogrel
1.8
6.6
102
565
R32
ICD-10 Finland
Unspecified urinary incontinence
1.6
6.6
153
954
XPX08
NOMESCO Finland
Intraoperative flow measurement
2.2
6.6
62
283
I42.0
ICD-10 Finland
Dilated cardiomyopathy
1.5
6.6
201
1337
N06AB05
ATC
paroxetine; oral
1.3
6.6
385
2894
N08.30
ICD-10 Finland
Glomerular disorders in diabetes mellitus microalbuminuria
5.9
6.6
17
29
N51.2*B37.4
ICD-10 Finland
Candidal balanitis
5.9
6.6
17
29
N05BA04
ATC
oxazepam; oral
1.2
6.6
1727
15271
J96.0
ICD-10 Finland
Acute respiratory failure
2.0
6.6
79
401
KBV12
NOMESCO Finland
Transluminal endoscopic removal of stent from ureter
1.8
6.6
99
542
M03BC01
ATC
orphenadrine (citrate); systemic
1.2
6.6
1654
14582
ZXC96
NOMESCO Finland
Robot assisted procedure
0.6
6.6
111
1776
K81.0
ICD-10 Finland
Acute cholecystitis
1.7
6.6
130
776
I21.97
ICD-10 Finland
Suspected acute myocardial infarction
2.0
6.5
74
366
S02
ICPC
Pruritus
1.5
6.5
193
1276
P98
ICPC
Psychosis NOS/other
2.9
6.5
36
124
7140A
ICD-9 Finland
Rheumatoid arthritis and other inflammatory polyarthropathies, Rheumatoid arthritis[ARTHRITIS RHEUMATOIDES SEROPOSITIVA]
0.3
6.5
15
471
N05BA01
ATC
diazepam; systemic, rectal
1.2
6.5
932
7828
R44
ICPC
Respiratory, Preventive immunization/medic
1.7
6.5
114
659
R03AK07
ATC
formoterol and budesonide; inhalant
1.2
6.5
1334
11573
N20.2
ICD-10 Finland
Calculus of kidney with calculus of ureter
2.6
6.5
43
165
IGY02
NOMESCO Finland
Psychiatric monitoring contact
1.9
6.5
84
436
49300
ICD-8 Finland
Asthma, bronchiale
1.6
6.5
151
943
K85.0
ICD-10 Finland
Idiopathic acute pancreatitis
2.4
6.4
50
209
F20.08
ICD-10 Finland
Paranoid schizophrenia other definite
3.8
6.4
25
66
S75
ICPC
Moniliasis/candidiasis skin
2.6
6.4
43
166
PG1XE
NOMESCO Finland
Other ultrasound examination of blood vessel not elsewhere classified
2.6
6.4
43
166
N02CC04
ATC
rizatriptan; oral
0.6
6.4
129
1990
QXA20
NOMESCO Finland
Skin abrasion, unspecified location
3.3
6.4
30
92
S74
ICPC
Dermatophytosis
1.7
6.4
120
704
ZY010
NOMESCO Finland
Hospital outpatient
1.4
6.4
239
1661
TFP46
NOMESCO Finland
Ablation treatment of atrial fibrillation
0.5
6.4
43
881
E61.1
ICD-10 Finland
Iron deficiency
2.4
6.4
52
220
K90.0
ICD-10 Finland
Coeliac disease
0.6
6.4
74
1295
D11
ICPC
Diarrhoea
1.3
6.4
582
4653
CM2S4
NOMESCO Finland
Follow-up photography of age-related macular degeneration lesions
2.7
6.4
39
143
N18.3
ICD-10 Finland
Chronic kidney disease, stage 3
4.7
6.4
20
43
64199
ICD-8 Finland
Abortion induced for other legal indications, Without mention of sepsis or toxaemia
1.4
6.4
331
2442
L03AA13
ATC
pegfilgrastim; parenteral
0.6
6.4
119
1861
H66.0
ICD-10 Finland
Acute suppurative otitis media
1.4
6.4
286
2058
N06AX18
ATC
reboxetine; oral
2.0
6.4
75
378
T29
ICPC
Endocr/metab/nutr sympt/compl other
1.7
6.3
121
714
R96
ICPC
Asthma
1.3
6.3
560
4460
QDB10
SPAT
NA
2.4
6.3
49
204
S82.6
ICD-10 Finland
Fracture of lateral malleolus
1.3
6.3
399
3035
PD4HE
NOMESCO Finland
Postoperative lower extremity artery ultrasound examination with Doppler method
4.4
6.3
21
48
3478X
ICD-9 Finland
Cataplexy and narcolepsy[MUUT ORGANISET UNIHÄIRIÖT]
4.4
6.3
21
48
M75.3
ICD-10 Finland
Calcific tendinitis of shoulder
1.7
6.3
119
700
30188
ICD-8 Finland
Personality disorders, Alia definita
2.8
6.3
38
138
E14.0
ICD-10 Finland
Unspecified diabetes mellitus, with coma
6.5
6.3
15
23
LCC10
NOMESCO Finland
Supravaginal hysterectomy
3.3
6.3
29
88
SPAT1377
SPAT
Polysomnography
1.5
6.3
228
1577
QBB99
NOMESCO Finland
Other procedure for wound of skin of trunk
3.6
6.3
26
73
M51.1
ICD-10 Finland
Lumbar and other intervertebral disc disorders with radiculopathy
1.2
6.2
1073
9165
ICB02
NOMESCO Finland
Psychiatric treatment plan, extended/prolonged
2.8
6.2
37
133
JN3AD
NOMESCO Finland
Abdominal CT examination
1.3
6.2
559
4460
K61.0
ICD-10 Finland
Anal abscess
1.8
6.2
100
561
SPAT1343
SPAT
Referral to private examination or care
26.7
6.2
8
*
JAB12
NOMESCO Finland
Laparoscopic repair of inguinal hernia, TEP
0.3
6.2
12
409
A01
ICPC
Pain general/multiple sites
1.3
6.2
484
3793
C10AA06
ATC
cerivastatin; oral
2.9
6.2
34
117
A41.8
ICD-10 Finland
Other specified sepsis
1.7
6.2
109
628
N17.0
ICD-10 Finland
Acute renal failure with tubular necrosis
2.7
6.1
37
135
KH1AD
NOMESCO Finland
CT of urinary organs
1.4
6.1
235
1643
G01AA10
ATC
clindamycin; vaginal
0.8
6.1
474
5927
NHQ60
NOMESCO Finland
Revision of ampution or exarticulation of ankle or foot
7.7
6.1
13
17
J46
ICD-10 Finland
Status asthmaticus
1.6
6.1
144
903
C02DE02
ATC
NA
1.9
6.1
79
411
E000006
ATC
NA
1.3
6.1
430
3326
S06.0
ICD-10 Finland
Concussion
1.2
6.1
650
5292
H34.2
ICD-10 Finland
Other retinal artery occlusions
2.4
6.1
45
185
B01AB04
ATC
dalteparin; parenteral
1.3
6.1
337
2516
SPAT1203
SPAT
Injection therapy, other than intramuscular or subcutaneous
1.4
6.1
283
2051
4471
FHL
Pharyngoplasty
2.6
6.1
40
153
F25.2
ICD-10 Finland
Schizoaffective disorder, mixed type
3.6
6.1
25
70
M05BA06
ATC
ibandronic acid; systemic
0.5
6.1
33
722
M02AA10
ATC
ketoprofen; topical
1.2
6.0
1187
10259
E78.2
ICD-10 Finland
Mixed hyperlipidaemia
3.3
6.0
28
86
WXQ27
NOMESCO Finland
UVB narrow spectrum light therapy
1.9
6.0
85
458
R06AE07
ATC
cetirizine; oral
1.1
6.0
3176
29352
7890A
ICD-9 Finland
Other symptoms involving abdomen and pelvis, Abdominal pain
1.4
6.0
299
2194
K85.9
ICD-10 Finland
Acute pancreatitis, unspecified
1.7
6.0
125
760
A77
ICPC
Viral disease other/NOS
1.6
6.0
159
1027
F99
ICD-10 Finland
Mental disorder, not otherwise specified
1.8
6.0
96
537
M05BB03
ATC
alendronic acid and colecalciferol; oral
0.5
6.0
54
1010
JAF11
NOMESCO Finland
Laparoscopic repair of umbilical hernia
2.2
6.0
53
237
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(44806420)
256
96
27.21
307.65
2.6
1.9
—
—
—
0
0
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
1611
940
19.56
307.65
2.3
2.7
ug/min
90.9
154.8
2.62
1001
555
(3027923) C peptide [Moles/volume] in Serum or Plasma
419
173
25.04
307.65
1.3
1.6
nmol/l
1.2
1.3
0.25
340
137
(3020682) Albumin/Creatinine [Ratio] in Urine
10681
22073
29.50
307.65
5.4
2.9
mg/mmol
6.8
10.5
11.18
8020
12521
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
11898
95297
7.88
307.65
14.6
4.3
mmol/mol
53.8
37.6
307.65
11343
87130
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
953
460
22.37
307.65
1.1
1.1
iu/ml
474.1
18320.9
0.48
188
121
(3004775) Volume in Urine collected for unspecified duration
540
383
14.70
307.65
2.3
2.5
ml
650.7
772.3
5.01
361
283
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
7392
39894
3.13
307.65
2.3
1.9
pmol/l
91.8
95.5
8.75
4323
20797
(3009508) Creatinine [Moles/volume] in Urine
9964
22251
19.04
307.65
4.3
2.4
mmol/l
7.2
8.0
67.30
8442
18841
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
1384
652
23.78
307.65
1.4
2.6
nmol/l
0.8
0.8
0.04
1177
561
(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal
741
210
37.48
307.65
1.3
1.5
nmol/l
1.4
1.2
1.48
679
184
(4146454)
514
321
16.66
307.65
2.8
2.5
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
10074
21030
21.61
307.65
4.3
2.5
mg/l
120.8
765.3
33.14
7540
12098
(3013826) Glucose [Moles/volume] in Serum or Plasma
8435
61747
2.16
307.65
6.3
4.7
mmol/l
9.0
6.3
307.65
7877
58423
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
4885
19444
3.50
307.65
2.1
1.6
pmol/l
2805256.5
41213362.9
11.92
4100
15978
(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration
287
157
18.69
307.65
2.2
1.9
ug/min
161.7
112.5
0.19
55
42
(3016750) Collection duration of Urine
334
337
10.16
293.88
2.0
2.5
min
499.7
496.1
0.22
256
259
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
4998
31963
1.95
263.52
3.3
3.3
u/l
35.0
35.5
0.17
4692
30306
(3026493) Urate [Moles/volume] in Serum or Plasma
4427
28122
1.90
230.26
2.8
2.7
umol/l
6193.9
4160.0
1.90
3812
24371
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
3945
24338
1.91
222.91
2.7
2.1
mg/l
3.4
2.9
23.69
3520
20678
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
11739
104719
3.47
211.74
7.5
4.8
mmol/l
2.2
2.8
307.65
10996
95921
(3023103) Potassium [Moles/volume] in Serum or Plasma
11971
108399
4.45
204.70
23.7
16.9
mmol/l
4.1
4.0
171.85
11764
105712
(3008037) Lactate [Moles/volume] in Venous blood
675
1909
3.68
201.88
3.3
3.1
mmol/l
2.0
1.4
26.68
664
1860
(3019550) Sodium [Moles/volume] in Serum or Plasma
11934
108107
4.13
198.25
23.5
16.8
mmol/l
139.4
139.7
45.36
11739
105573
(3038515) Glucose [Moles/volume] in Venous blood
646
1801
3.73
197.27
3.4
3.2
mmol/l
9.6
6.6
73.33
637
1759
(1761482) Bacteria [#/volume] in Urine by Culture
754
2329
3.38
196.87
4.5
3.8
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
10616
91328
2.16
189.45
5.1
4.4
mu/l
2.0
2.2
1.78
9777
82688
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
11385
101150
2.62
183.17
7.7
4.2
mmol/l
7.8
5.7
307.65
10477
91909
(3022948) Iron [Moles/volume] in Serum or Plasma
2752
15948
1.93
181.72
2.6
2.5
umol/l
11.0
13.4
64.47
2566
14825
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
11168
98473
2.41
180.83
5.9
3.9
mmol/l
1.8
1.2
307.65
10309
89534
(3004789) Transferrin [Mass/volume] in Serum or Plasma
2593
14789
1.95
179.20
2.6
2.5
g/l
2.5
2.2
69.41
2412
13727
(3027273) Bicarbonate [Moles/volume] in Venous blood
1145
4698
2.58
178.31
3.5
3.4
mmol/l
24.8
25.2
3.92
1128
4548
(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood
1078
4324
2.64
175.74
4.2
3.8
%
47.6
48.8
0.81
1068
4277
(3021447) Carbon dioxide [Partial pressure] in Venous blood
1815
9258
2.13
170.16
3.7
3.8
kpa
5.7
5.8
3.07
1769
9039
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
11460
102722
2.61
170.04
6.5
4.3
mmol/l
4.0
4.7
307.65
10760
94610
(3000034) Microalbumin [Mass/volume] in Urine
338
650
5.32
165.88
4.2
2.0
mg/l
42.7
51.1
0.22
272
423
(3002032) Base excess in Venous blood by calculation
1804
9264
2.11
165.85
3.7
3.8
mmol/l
1.7
1.9
1.27
1416
7694
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
11372
101898
2.47
162.97
6.4
4.3
mmol/l
1.2
1.5
307.65
10578
93349
(3026008) Bacteria identified in Urine by Culture
4197
28419
1.72
162.31
3.7
3.0
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
2409
13909
1.91
158.13
2.6
2.6
%
18.4
24.0
76.67
2008
11846
(3000330) Specific gravity of Urine by Test strip
1103
4805
2.42
150.16
4.1
3.3
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
11925
110287
3.39
144.14
13.3
10.5
u/l
31.3
26.5
25.26
11597
106199
(3033705) Calcium.ionized [Moles/volume] in Venous blood
416
1069
3.99
142.26
2.5
2.3
—
—
—
0
0
(3024354) Oxygen [Partial pressure] in Venous blood
1482
7514
2.10
139.28
3.3
3.1
kpa
4.5
4.6
0.37
1432
7311
(3001122) Ferritin [Mass/volume] in Serum or Plasma
5227
38575
1.62
138.64
3.4
2.7
ug/l
116.0
173.4
43.42
4835
35456
(3004119) Hemoglobin [Mass/volume] in Venous blood
1282
6155
2.21
138.49
3.4
3.3
g/l
128.9
129.8
0.75
1265
5999
(3019309) Folate [Moles/volume] in Red Blood Cells
2997
19256
1.73
135.32
1.9
1.7
nmol/l
1181.5
1150.4
1.00
2395
14457
(3035350) Ketones [Presence] in Urine by Test strip
6332
49165
1.59
133.98
4.2
3.5
estimate
0.0
0.0
1.08
1067
9016
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
5102
37721
1.60
132.38
4.5
3.7
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
6313
49162
1.58
130.51
5.8
4.7
estimate
0.0
0.0
0.22
1088
9255
(3009261) Glucose [Presence] in Urine by Test strip
6348
49739
1.57
125.93
4.2
3.6
estimate
0.1
0.0
4.44
744
9285
(3044889) 12 lead EKG panel
8830
75227
1.61
117.26
4.7
3.9
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
8360
70317
1.59
117.15
4.8
4.2
—
—
—
0
0
(3015736) pH of Urine
5028
37887
1.55
114.98
3.9
3.3
—
5.7
—
0
51
(1761868) Lipid panel - Serum or Plasma
4640
34382
1.56
114.14
4.8
2.7
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
3642
25615
1.60
111.79
3.9
3.2
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
8678
73961
1.58
111.68
4.0
3.7
pmol/l
15.3
14.8
51.04
7912
66626
(3032080) INR in Blood by Coagulation assay
5840
45701
1.53
110.87
11.0
9.3
inr
1.3
1.3
0.44
1589
12790
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
4348
32018
1.55
108.49
3.3
2.9
ng/l
1476.7
1315.2
1.67
3742
27806
(40761511) CBC panel - Blood by Automated count
11515
106483
2.21
106.84
19.0
13.8
—
—
—
0
0
(3024561) Albumin [Mass/volume] in Serum or Plasma
5813
45881
1.50
103.11
5.1
5.0
g/l
35.1
35.2
0.31
5483
42591
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
366
10379
0.33
100.34
1.5
1.5
—
—
—
0
0
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
909
4333
2.19
98.70
4.7
5.4
%
1.6
1.7
1.84
880
4032
(3007853) Bacteria identified in Skin by Aerobe culture
1897
11638
1.74
97.07
2.0
1.7
—
—
—
0
0
(3007930) Methemoglobin/Hemoglobin.total in Blood
895
4269
2.18
96.98
4.8
5.5
%
0.8
0.9
6.05
865
3974
(3023368) Bacteria identified in Blood by Culture
4035
29777
1.53
96.92
4.6
4.4
—
—
—
0
0
(3013512) EKG study
4252
31736
1.52
96.80
5.1
3.9
—
—
—
0
0
(3007461) Platelets [#/volume] in Blood
12020
113869
3.12
96.13
28.5
21.6
e9/l
247.5
242.4
13.70
11794
110772
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
10816
98554
1.79
95.49
17.8
13.8
ml/min/173m2
78.6
78.5
0.21
9207
81891
(3024731) MCV [Entitic volume]
12020
113933
3.10
94.77
28.4
21.5
fl
90.3
91.6
162.89
11883
112267
(3026361) Erythrocytes [#/volume] in Blood
12020
113940
3.09
94.63
28.5
21.6
e12/l
4.6
4.5
36.19
11745
110480
(3035941) MCH [Entitic mass]
12018
113914
3.08
94.56
28.4
21.5
pg
29.9
30.6
258.90
11882
112257
(3000963) Hemoglobin [Mass/volume] in Blood
12021
113964
3.09
94.43
28.7
21.7
g/l
135.8
136.8
8.51
11895
112309
(3010813) Leukocytes [#/volume] in Blood
12019
113949
3.08
94.13
28.6
21.6
e9/l
7.6
6.6
294.31
11746
110478
(3024889) Methemoglobin/Hemoglobin.total in Venous blood
936
4689
2.08
89.06
2.7
2.7
%
0.7
0.6
3.22
910
4502
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
6701
55386
1.46
88.39
6.2
6.7
umol/l
11.1
12.1
7.57
6384
52719
(3020779) Urea [Moles/volume] in Serum or Plasma
1576
9583
1.74
82.14
6.4
7.4
mmol/l
11.2
9.6
14.16
1504
9144
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
7719
66069
1.45
81.02
3.9
3.0
u/l
69.4
51.0
39.55
7191
61140
(3014576) Chloride [Moles/volume] in Serum or Plasma
2104
13849
1.63
81.02
7.8
7.3
mmol/l
104.1
104.6
5.40
2040
13563
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
4290
33159
1.45
77.26
2.7
2.6
u/l
54.8
60.1
3.29
3991
30602
(3008116) Ketones [Moles/volume] in Urine by Test strip
102
125
8.22
77.18
1.3
1.4
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
11081
102877
1.75
75.87
18.1
14.9
mg/l
26.6
25.7
1.83
9430
81826
(3021960) Folate [Moles/volume] in Serum or Plasma
3314
24524
1.48
74.11
1.6
1.5
nmol/l
19.9
20.1
0.29
2885
20897
(3027945) Reticulocytes/100 erythrocytes in Blood
1869
12194
1.63
73.92
2.3
2.5
%
1.9
1.7
9.29
1648
10866
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
9192
81928
1.48
73.61
7.8
7.9
u/l
83.0
78.3
10.19
8708
77179
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
5177
41754
1.41
72.21
4.3
3.6
ng/l
73.7
72.4
0.02
4013
30197
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
6373
53300
1.40
71.90
7.6
6.9
mmol/l
1.2
1.2
8.56
5415
45052
(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal
214
557
3.89
71.84
1.2
1.2
mmol/l
12.7
11.6
0.68
165
77
(3003458) Phosphate [Moles/volume] in Serum or Plasma
2034
13639
1.59
71.57
5.2
6.0
mmol/l
1.1
1.0
17.40
1932
12752
(3051101) Glucose [Moles/volume] in Cord blood
66
48
13.82
71.48
5.9
3.4
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
3624
27533
1.45
69.83
1.9
1.6
mmol/l
1.9
1.3
102.92
2900
23045
(3002385) Erythrocyte distribution width [Ratio]
9314
83721
1.46
67.03
22.4
18.1
%
14.1
13.7
97.40
9120
81996
(3021589) Normoblasts [#/volume] in Blood
5474
45139
1.38
64.31
10.9
10.0
e9/l
0.0
0.0
2.10
4581
36977
(3040151) Glucose [Moles/volume] in Capillary blood
302
1047
2.93
64.27
15.6
10.1
mmol/l
9.6
6.5
22.80
230
877
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
1118
6598
1.76
63.82
3.3
3.6
kpa
5.1
5.1
1.09
1036
6092
(3009343) pH of Capillary blood
1102
6504
1.76
62.86
3.3
3.6
ph
7.4
7.4
1.74
160
805
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
4916
39934
1.38
62.79
2.3
2.2
nmol/l
75.6
78.8
12.84
4397
35587
(3016502) Oxygen saturation in Arterial blood
1744
11615
1.58
62.38
8.9
7.7
%
95.3
95.8
3.07
1699
11190
(3022689) Creatine [Moles/volume] in Urine
109
182
6.03
62.23
1.6
1.5
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
1064
6280
1.76
60.59
3.3
3.5
mmol/l
1.6
1.8
0.60
746
4719
(3003396) Base excess in Arterial blood by calculation
1880
12870
1.54
59.28
8.6
7.3
mmol/l
1.0
1.1
0.13
1414
10274
(3042936) Bacteria identified in Isolate by Culture
2134
15047
1.51
58.51
2.4
2.0
—
—
—
0
0
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
4159
33164
1.38
58.20
2.1
2.2
u/l
208.2
222.6
0.41
3872
31194
(3002173) Hemoglobin [Mass/volume] in Arterial blood
1612
10727
1.58
57.49
9.4
8.1
g/l
122.1
122.2
0.05
1565
10348
(3013707) Erythrocyte sedimentation rate by Westergren method
8556
76588
1.38
56.28
4.3
4.1
mm/h
15.8
11.9
78.64
7989
70632
(3027801) Oxygen [Partial pressure] in Arterial blood
1865
12893
1.53
55.91
8.7
7.3
kpa
11.5
12.5
15.96
1799
12312
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
1866
12902
1.53
55.89
8.7
7.3
kpa
5.1
5.1
0.10
1800
12337
(3023520) Reticulocytes [#/volume] in Blood
1423
9265
1.61
55.54
2.4
2.6
e9/l
75.2
67.3
13.03
1129
7054
(3008152) Bicarbonate [Moles/volume] in Arterial blood
1131
6966
1.69
54.98
7.5
7.1
mmol/l
24.0
24.7
6.31
1071
6504
(3026782) Osmolality of Urine
2745
20773
1.41
50.98
3.0
2.8
mosm/kgh2o
579.8
558.7
4.12
2370
17734
(3009542) Hematocrit [Volume Fraction] of Blood
9901
91466
1.42
49.30
20.3
15.9
%
39.0
40.1
13.62
6032
63760
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
781
4478
1.79
48.80
2.0
2.0
ug/l
2.2
2.3
0.06
728
3967
(3007566) Smooth muscle Ab [Titer] in Serum
499
2480
2.05
48.01
1.2
1.2
titre
97.2
150.8
0.80
54
223
(3031040) Bacteria [#/volume] in Urine by Automated count
7595
67479
1.33
47.63
5.1
4.3
e6/l
1462.9
1151.7
0.29
174
968
(3019150) Specific gravity of Urine by Refractometry
2823
21704
1.39
47.20
4.7
4.0
kg/l
1.0
1.0
0.28
547
3118
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
4688
39016
1.32
46.51
3.4
3.4
—
0.6
—
0
8
(3030981) Hyaline casts [#/volume] in Urine by Automated count
932
5700
1.69
46.23
2.9
2.8
e6/l
0.2
0.3
0.68
919
5584
(3034770) Mitochondria Ab [Titer] in Serum
491
2461
2.04
46.15
1.2
1.2
titre
1515.0
888.9
—
6
81
(3018095) Leukocytes [#/volume] in Urine
4511
37411
1.32
45.61
3.9
3.8
e6/l
130.2
90.2
2.78
3337
27078
(3019198) Lymphocytes [#/volume] in Blood
6078
52551
1.31
45.33
5.7
6.0
e9/l
2.0
1.9
2.76
5378
45931
(3015235) Bicarbonate [Moles/volume] in Capillary blood
505
2587
1.99
44.65
2.9
3.1
mmol/l
24.2
24.8
2.50
457
2241
(3028626) Oxygen [Partial pressure] in Capillary blood
443
2169
2.08
44.37
2.6
2.9
kpa
8.0
8.0
0.08
419
2003
(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma
373
1710
2.22
44.21
1.2
1.4
u/l
23.4
40.4
3.25
325
1474
(3021901) Oxygen saturation in Capillary blood
393
1844
2.17
43.97
2.5
2.9
—
—
—
0
0
(3051387) C reactive protein [Mass/volume] in Capillary blood
425
2069
2.09
43.22
4.1
3.2
mg/l
24.8
28.3
1.14
309
1279
(3002582) Erythrocytes [#/volume] in Urine
4001
32828
1.32
42.91
3.5
3.3
e6/l
79.3
99.9
0.62
3125
25286
(3000991) Gas panel - Venous blood
1334
9048
1.53
42.85
9.8
8.4
—
—
—
0
0
(3006315) Basophils [#/volume] in Blood
5935
51564
1.29
40.88
5.5
6.0
e9/l
0.0
0.0
7.60
5131
44363
(3001604) Monocytes [#/volume] in Blood
5903
51313
1.29
40.23
5.5
6.0
e9/l
0.7
0.6
44.76
5104
44126
(3013115) Eosinophils [#/volume] in Blood
6085
53163
1.29
39.59
5.7
6.2
e9/l
0.2
0.2
23.97
5394
46363
(1616796) Gas panel - Central venous blood
437
2230
1.99
39.06
3.5
3.7
—
—
—
0
0
(3019060) Gas panel - Arterial blood
1122
7474
1.55
38.95
5.2
4.9
—
—
—
0
0
(3002030) Lymphocytes/100 leukocytes in Blood
5684
49317
1.28
38.72
5.9
6.4
%
25.2
27.3
46.15
5285
45885
(3003338) MCHC [Mass/volume]
9231
85318
1.32
38.13
24.7
19.0
g/l
330.7
333.1
96.24
9175
84768
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
1411
9928
1.48
37.66
2.3
2.3
g/l
0.2
0.2
1.97
1320
9254
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
266
1137
2.37
37.22
1.1
1.0
—
—
—
0
0
(3019069) Monocytes/100 leukocytes in Blood
5561
48363
1.27
36.23
6.2
6.6
%
8.4
9.0
37.22
5217
45270
(3022313) Gas panel - Capillary blood
773
4803
1.65
35.86
3.5
3.6
—
—
—
0
0
(3018010) Neutrophils/100 leukocytes in Blood
5578
48610
1.27
35.43
5.8
6.1
%
60.1
57.3
65.62
5215
45430
(3023183) Ammonium ion [Moles/volume] in Plasma
432
2271
1.93
35.43
3.0
2.5
umol/l
36.0
33.3
1.24
379
1918
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
1098
7449
1.52
34.90
1.6
1.7
—
—
—
0
0
(3006504) Eosinophils/100 leukocytes in Blood
5519
48100
1.27
34.79
5.8
6.3
%
2.9
2.9
0.66
5157
44848
(40760892) CBC W Ordered Manual Differential panel - Blood
2725
21717
1.33
34.30
4.6
4.7
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
1549
11316
1.42
33.59
1.8
1.8
%
1.5
1.5
3.16
1345
9825
(3014111) Lactate [Moles/volume] in Serum or Plasma
1357
9699
1.45
33.13
8.8
7.0
mmol/l
1.5
1.3
15.60
1315
9372
(3022096) Basophils/100 leukocytes in Blood
5355
46731
1.26
32.58
5.8
6.3
%
0.6
0.7
9.34
5007
43623
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
2400
18900
1.33
32.56
1.2
1.2
u/ml
1.6
1.9
0.51
667
4951
(3030467) Casts [#/volume] in Urine by Automated count
3631
30252
1.28
32.46
3.3
3.2
e6/l
0.5
0.4
0.43
2804
22778
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
863
5644
1.57
32.32
2.6
2.4
—
—
—
0
0
(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer
74
163
4.56
31.15
4.2
1.6
mmol/l
10.3
6.9
4.01
43
107
(3020491) Glucose [Moles/volume] in Blood
165
616
2.70
30.75
2.1
1.5
mmol/l
9.2
6.4
12.22
102
449
(3011985) Renin [Units/volume] in Plasma
274
1290
2.15
30.47
1.3
1.4
mu/l
117.6
59.5
2.26
239
1143
(3006270) Folate [Moles/volume] in Blood
191
774
2.49
30.13
1.1
1.2
nmol/l
351.6
349.4
0.04
130
681
(3018677) aPTT in Platelet poor plasma by Coagulation assay
2201
17316
1.33
29.72
2.2
2.1
s
30.0
30.0
0.07
2128
16804
(3013650) Neutrophils [#/volume] in Blood by Automated count
6629
59669
1.24
29.17
8.7
9.5
e9/l
4.8
4.1
107.01
5839
51964
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
901
6083
1.52
29.13
1.5
1.5
—
—
—
0
0
(3018405) Lactate [Moles/volume] in Arterial blood
624
3874
1.64
28.98
4.4
4.0
mmol/l
1.8
1.3
9.28
609
3814
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
927
6307
1.51
28.89
11.7
9.7
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
3266
27206
1.27
28.43
4.5
4.0
estimate
0.0
0.0
2.96
1010
8776
(3027456) Digoxin [Moles/volume] in Serum or Plasma
358
1913
1.90
27.99
3.2
2.9
nmol/l
0.8
0.8
0.80
281
1451
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
5574
49386
1.23
27.90
4.6
4.0
—
—
—
0
0
(3001788) Aldosterone [Moles/volume] in Serum or Plasma
253
1197
2.14
27.82
1.3
1.3
pmol/l
271.5
297.9
0.36
190
904
(3017181) Myelocytes/100 leukocytes in Blood
1245
9040
1.42
27.62
3.6
4.3
%
0.9
1.0
0.39
342
2769
(3022621) pH of Urine by Test strip
941
6481
1.49
27.60
3.6
2.8
—
—
—
0
0
(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood
1026
7200
1.46
27.36
11.2
8.9
%
1.4
1.4
0.04
1017
7159
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
1047
7383
1.46
27.22
3.7
3.9
ng/l
90.6
92.4
0.25
913
6349
(44816559) Phosphatidylethanol [Mass/volume] in Blood
305
1561
1.98
27.11
1.4
1.4
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
492
2921
1.71
27.08
1.2
1.3
—
—
—
0
0
(3006217) Methemoglobin/Hemoglobin.total in Arterial blood
1023
7195
1.46
26.95
11.3
9.0
%
0.7
0.7
0.55
1012
7157
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
748
4970
1.54
26.00
1.5
1.6
g/l
1.7
1.5
10.92
641
4242
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
1186
8632
1.41
25.89
3.8
4.0
mmol/l
1.2
1.2
1.99
1050
7521
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
2672
21946
1.28
25.63
1.8
1.7
mg/l
1.3
1.3
0.16
2145
16935
(3021440) Promyelocytes/100 leukocytes in Blood
1178
8584
1.41
25.52
3.6
4.3
%
0.1
0.1
0.72
325
2574
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
5508
49031
1.22
25.43
7.1
6.1
mmol/l
1.2
1.2
3.38
5052
44425
(3010421) pH of Blood
458
2721
1.71
25.15
4.2
4.0
ph
7.4
7.4
3.72
388
2328
(3025159) Blasts/100 leukocytes in Blood
1110
8055
1.42
24.59
3.6
4.3
%
0.6
0.3
0.42
271
2180
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
727
4883
1.52
24.01
4.4
4.1
mmol/l
23.7
24.2
3.65
627
4425
(3020876) Protein [Mass/time] in 24 hour Urine
188
840
2.26
23.89
1.7
2.0
g/24h
1.1
0.7
0.39
12
40
(3020630) Protein [Mass/volume] in Serum or Plasma
1265
9443
1.38
23.68
2.0
2.7
g/l
67.0
66.2
2.87
1162
8636
(3012095) Magnesium [Moles/volume] in Serum or Plasma
2205
17855
1.29
23.40
3.4
3.5
mmol/l
0.8
0.8
46.36
2056
16707
(3047181) Lactate [Moles/volume] in Blood
551
3501
1.60
23.28
6.3
6.2
mmol/l
1.7
1.2
8.87
498
3105
(3000570) Elastase.pancreatic [Mass/mass] in Stool
490
3035
1.64
22.97
1.4
1.4
ug/g
266.8
273.4
0.28
295
1796
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
634
4175
1.55
22.93
3.7
3.8
mmol/l
24.5
24.9
3.93
579
3833
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
1680
13167
1.32
22.71
3.5
4.6
u/l
231.8
249.5
4.75
1584
12524
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
924
6586
1.44
22.57
8.8
7.0
mmol/l
24.4
24.9
2.61
915
6545
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
2154
17471
1.28
22.46
1.8
1.9
—
—
—
0
0
(3043409) Potassium [Moles/volume] in Arterial blood
528
3350
1.60
22.45
4.7
4.3
mmol/l
4.0
3.9
3.73
479
3169
(3036481) Cortisol [Moles/volume] in Serum or Plasma
1157
8597
1.38
22.22
2.1
2.5
nmol/l
376.8
372.6
0.27
1070
7962
(3000850) Epithelial cells [#/volume] in Urine
2740
22924
1.25
21.94
2.8
2.6
e6/l
5.2
4.2
4.28
2413
20069
(3027315) Oxygen [Partial pressure] in Blood
400
2383
1.70
21.78
4.4
4.0
kpa
8.4
8.5
0.85
391
2342
(40768797) Stomach Pathology biopsy report
1818
14486
1.30
21.68
1.3
1.3
—
—
—
0
0
(3012501) Base excess in Blood by calculation
397
2367
1.70
21.56
4.4
4.0
mmol/l
2.9
2.5
1.32
261
1646
(3013290) Carbon dioxide [Partial pressure] in Blood
397
2368
1.70
21.52
4.4
4.0
kpa
5.0
5.0
0.11
388
2328
(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma
35
55
6.38
21.32
1.4
2.8
mmol/l
1.2
1.0
0.17
17
33
(3002179) Metamyelocytes/100 leukocytes in Blood
1107
8224
1.38
21.25
3.5
4.1
%
0.5
0.7
1.17
245
2025
(3051014) Leukocytes [#/area] in Urine sediment by Automated count
167
748
2.25
21.15
2.0
1.9
u/field
2.4
1.8
0.46
69
321
(40767503) Oxygen content in Capillary blood by calculation
378
2236
1.71
21.13
2.5
2.5
%
16.7
16.3
1.21
222
1130
(3020891) Body temperature
655
4436
1.50
20.78
5.5
4.6
—
—
—
0
0
(3006184) Hemoglobin [Mass/volume] in Capillary blood
394
2383
1.67
20.29
2.2
2.2
g/l
129.6
130.2
0.16
299
1669
(3004588) Protein electrophoresis panel - Serum or Plasma
1057
7861
1.38
20.12
1.8
2.5
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
2070
16974
1.26
19.42
1.4
1.5
g/l
3.0
2.6
11.08
1328
10168
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
1300
10036
1.33
19.36
2.6
2.3
ug/l
6.0
8.5
6.17
1155
8843
(42870588) Differential panel, method unspecified - Blood
4077
35900
1.20
19.28
5.3
6.1
—
—
—
0
0
(3028026) IgM [Mass/volume] in Serum or Plasma
811
5816
1.42
19.10
1.4
2.0
g/l
1.0
1.4
12.95
732
5273
(3016273) Islet cell 512 Ab [Units/volume] in Serum
25
31
8.08
18.74
1.0
1.0
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
1414
11095
1.31
18.72
4.0
3.4
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
1199
9201
1.34
18.58
1.5
1.6
—
—
—
0
0
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
1229
9473
1.33
18.47
3.3
2.8
ng/l
200.6
203.6
0.09
1130
8688
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
1516
12076
1.29
17.87
1.7
1.8
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
2262
18915
1.24
17.67
2.9
2.8
e6/l
1.5
1.0
6.72
1383
10859
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
604
4164
1.47
17.56
3.2
3.6
u/ml
864.2
1103.6
0.23
530
3572
(3044640) Blood type and Crossmatch panel - Blood
3802
33519
1.19
17.26
2.6
2.5
—
—
—
0
0
(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)
92
346
2.67
17.11
1.6
1.7
nmol/l
28.3
3.6
0.53
84
291
(3034860) Kappa light chains.free [Mass/volume] in Serum
534
3624
1.49
16.80
2.2
3.7
mg/l
70.3
53.2
1.17
434
2931
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
533
3618
1.49
16.75
2.2
3.7
mg/l
43.5
44.6
0.08
431
2935
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
519
3514
1.50
16.52
2.1
3.7
ratio
16.1
3.3
0.62
47
270
(3037121) Protein [Mass/volume] in Urine
528
3590
1.49
16.46
2.6
3.2
g/l
0.4
0.3
0.78
251
1602
(36304419) Bacteria [Presence] in Urine
3350
29305
1.20
16.40
3.2
3.2
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
1502
12085
1.28
16.27
1.7
1.8
—
—
—
0
0
(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma
139
645
2.17
16.26
1.0
1.0
mg/l
286.5
284.3
0.13
124
577
(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma
230
1276
1.82
16.15
1.1
1.1
g/l
1.6
1.5
0.69
216
1148
(40760888) Immunoglobulin light chains.free panel - Serum
417
2712
1.56
16.01
2.3
3.8
—
—
—
0
0
(3018572) Chloride [Moles/volume] in Blood
402
2594
1.57
15.98
7.1
7.0
mmol/l
104.6
105.2
1.65
382
2333
(3039000) Anion gap in Blood
402
2594
1.57
15.98
7.1
7.0
mmol/l
12.3
11.0
9.60
382
2333
(3011397) Hemoglobin [Presence] in Urine by Test strip
2767
23851
1.21
15.78
4.1
3.5
—
—
—
0
0
(3026692) Albumin [Mass/volume] in Peritoneal fluid
71
247
2.89
15.34
1.5
1.5
g/l
12.2
12.9
0.25
57
187
(3005719) IgG [Mass/volume] in Serum or Plasma
984
7561
1.33
15.03
2.0
2.9
g/l
10.9
10.6
0.70
896
6923
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
287
1732
1.67
15.01
3.1
3.3
—
—
—
0
0
(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay
145
707
2.06
14.96
1.5
1.6
u/ml
26.4
24.2
0.16
30
144
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
1223
9710
1.29
14.66
1.5
1.5
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
2075
17556
1.22
14.14
3.1
3.0
e6/l
2.5
1.8
2.85
1208
9578
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
5658
52128
1.16
13.93
4.7
5.1
ug/l
2.5
3.3
2.13
5064
47139
(3000494) Fungus identified in Specimen by Culture
1532
12595
1.25
13.68
1.5
1.5
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
1109
8833
1.28
12.92
2.9
2.7
ml/min/173m2
63.1
64.6
0.51
444
3387
(3025941) Bacteria identified in Stool by Culture
694
5183
1.36
12.82
1.2
1.3
—
—
—
0
0
(3005715) Vancomycin [Mass/volume] in Serum or Plasma
254
1568
1.63
12.25
6.2
6.3
mg/l
12.0
11.5
1.02
237
1445
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
792
6074
1.32
12.25
12.6
9.2
mmol/l
24.0
24.4
2.00
720
5717
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
361
5283
0.67
12.12
1.7
1.5
—
—
—
0
0
(3028271) Lactate [Moles/volume] in Capillary blood
270
1698
1.60
12.08
2.1
1.8
mmol/l
2.0
1.7
5.22
261
1660
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
62
229
2.72
12.07
3.3
1.9
—
—
—
0
0
(40768441) Liver Pathology biopsy report
139
723
1.93
12.05
1.4
1.3
—
—
—
0
0
(3022145) Colonoscopy Study observation
1466
12157
1.23
12.01
1.3
1.3
—
—
—
0
0
(3036603) Volume of Urine
133
683
1.96
11.98
1.7
1.7
ml
1933.5
1966.1
0.09
54
135
(3018418) pH of Serum or Plasma
3543
31804
1.16
11.84
4.2
4.3
ph
7.4
7.4
2.44
736
6002
(3002331) Protein [Mass/volume] in Peritoneal fluid
60
222
2.71
11.66
1.6
1.3
g/l
24.4
25.8
0.25
47
171
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
378
2587
1.48
11.51
1.5
1.6
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
1541
12905
1.22
11.46
1.3
1.3
titre
539.1
523.8
0.10
254
2734
(3044242) Glucose [Moles/volume] in Arterial blood
106
510
2.09
11.45
1.8
1.9
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
76
320
2.38
11.33
2.4
2.4
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
76
320
2.38
11.33
2.4
2.4
—
—
—
0
0
(3009445) Proteinase 3 Ab [Units/volume] in Serum
631
4737
1.35
11.29
1.3
1.6
u/ml
32.3
13.7
—
8
122
(3027035) Albumin [Mass/time] in 24 hour Urine
30
76
3.95
10.72
1.4
1.5
mg/24h
394.5
1033.7
—
9
6
(40761536) Microorganisms panel - Urine sediment
1040
8425
1.26
10.50
4.2
3.9
—
—
—
0
0
(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence
311
2090
1.50
10.40
1.3
1.3
titre
83.3
105.7
—
6
49
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
388
2730
1.43
10.26
2.6
2.9
mg/l
1.8
1.5
4.89
340
2519
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
630
8187
0.76
10.25
2.3
1.8
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
196
1201
1.64
9.83
1.6
2.3
—
—
—
0
0
(3033799) Differential panel - Peritoneal fluid
73
325
2.25
9.64
2.5
1.8
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
2457
21748
1.16
9.57
4.4
3.8
ng/l
380.9
557.7
1.59
1970
17801
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
193
1187
1.64
9.55
1.3
1.3
nmol/l
—
—
—
0
0
(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma
215
1360
1.59
9.49
1.3
1.3
nmol/l
0.2
0.3
1.12
20
103
(3009613) Erythrocytes [#/volume] in Peritoneal fluid
71
315
2.26
9.47
2.3
1.8
e6/l
10941.1
12183.5
0.06
45
176
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
1435
12154
1.20
9.43
3.9
4.3
ug/l
35.8
24.5
0.53
1209
10052
(3023487) Leukocytes [#/volume] in Peritoneal fluid
78
363
2.16
9.27
2.6
2.0
e6/l
1436.2
5088.0
0.80
60
252
(3026179) Normetanephrine [Moles/volume] in Serum or Plasma
214
1363
1.58
9.19
1.3
1.3
nmol/l
0.7
2.3
0.76
205
1305
(3019977) pH of Arterial blood
112
598
1.88
9.10
2.4
2.5
ph
7.4
7.4
0.41
30
208
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
323
2263
1.44
8.80
1.3
1.4
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
1261
10637
1.21
8.63
2.1
2.3
ug/g
152.3
148.9
0.13
1016
8401
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
517
3934
1.33
8.52
2.4
2.4
ug/l
1243.3
460.3
0.80
498
3720
(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose
55
1221
0.45
8.49
1.1
1.2
mmol/l
11.3
7.0
4.23
24
885
(3022217) INR in Platelet poor plasma by Coagulation assay
1741
15137
1.17
8.43
25.4
25.7
inr
1.4
1.4
0.41
216
2109
(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence
114
629
1.82
8.39
1.2
1.3
titre
402.9
368.6
—
7
43
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
195
1244
1.58
8.36
1.3
1.3
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
129
742
1.75
8.26
1.1
1.2
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
433
3234
1.35
8.11
1.9
1.7
—
—
—
0
0
(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence
110
607
1.82
8.11
1.2
1.3
titre
41.7
94.7
—
6
57
(3012565) Volume of 24 hour Urine
91
476
1.92
7.93
1.7
2.4
ml
2135.1
1963.0
0.67
72
433
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
562
4403
1.29
7.52
1.9
1.8
u/l
35.6
39.3
3.75
486
3861
(3000012) Reticulocyte production index
107
602
1.78
7.44
1.5
1.5
—
—
—
0
0
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
477
3670
1.31
7.32
1.6
1.6
titre
261.6
276.9
0.03
16
167
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
532
4161
1.29
7.22
1.6
2.5
g/l
9.8
10.3
2.15
460
3470
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
377
2813
1.35
7.15
1.9
1.9
mg/l
12.9
11.2
0.75
357
2620
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
251
1752
1.44
7.07
1.2
1.5
—
—
—
0
0
(3037556) Urate [Mass/volume] in Serum or Plasma
65
315
2.07
7.06
1.5
1.4
—
—
—
0
0
(3009466) Valproate [Moles/volume] in Serum or Plasma
206
1384
1.50
7.05
5.3
4.6
umol/l
354.8
358.8
0.16
180
1164
(40768800) Prostate Pathology biopsy report
260
3643
0.71
7.00
1.2
1.2
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
149
933
1.60
6.99
1.5
1.6
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
197
1325
1.49
6.73
1.4
1.4
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
559
4456
1.27
6.55
1.7
2.4
g/l
4.0
3.8
3.00
388
3214
(3016244) Insulin [Units/volume] in Serum or Plasma
73
380
1.93
6.53
2.4
3.4
mu/l
29.5
24.7
0.58
64
363
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
560
4467
1.27
6.53
1.7
2.4
g/l
8.0
7.2
17.63
397
3362
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
1380
12014
1.17
6.52
2.9
2.8
umol/l
9.5
9.1
0.24
1177
10631
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
559
4462
1.26
6.48
1.7
2.4
—
—
—
0
0
(3004451) EKG impression Narrative
96
551
1.75
6.31
1.4
1.3
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
330
2465
1.35
6.27
1.3
1.8
—
—
—
0
0
(40757494) Bilirubin.total [Moles/volume] in Blood
100
583
1.72
6.22
2.3
2.2
umol/l
18.1
32.6
—
8
47
(3021387) Prolactin [Units/volume] in Serum or Plasma
270
1961
1.39
6.13
1.5
1.7
mu/l
261.9
286.9
0.74
246
1822
(3004437) Lymphocytes/100 leukocytes in Peritoneal fluid
26
88
2.96
6.09
2.2
2.4
%
70.0
58.6
1.02
17
56
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
779
6504
1.21
5.97
1.6
1.7
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
113
690
1.64
5.94
1.1
1.2
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
112
683
1.65
5.92
1.3
1.4
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
234
1672
1.41
5.87
1.2
1.2
—
—
—
0
0
(3017704) Immunofixation for Urine
101
603
1.68
5.79
1.2
1.8
—
—
—
0
0
(3017569) Oxygen content in Arterial blood
86
491
1.76
5.79
1.8
2.2
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
490
3914
1.26
5.69
2.8
3.0
u/ml
0.3
0.3
0.38
290
2226
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
109
670
1.63
5.61
1.3
1.4
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
167
1134
1.48
5.53
1.3
1.2
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
3800
35525
1.10
5.53
3.0
3.6
mmol/l
2.4
2.3
12.56
3350
30801
(3013139) Helicobacter pylori Ag [Presence] in Stool
758
6362
1.20
5.52
1.3
1.2
—
—
—
0
0
(3044007) Cell count panel - Peritoneal fluid
58
297
1.96
5.51
2.4
1.8
—
—
—
0
0
(3020961) Endomysium IgA Ab [Titer] in Serum
486
3911
1.25
5.32
1.1
1.1
titre
335.5
232.1
0.18
11
110
(3017732) Neutrophils [#/volume] in Blood
834
7090
1.19
5.28
3.7
3.0
e9/l
4.7
4.0
12.35
632
5340
(3024928) Oxygen saturation in Venous blood
300
2272
1.33
5.27
3.3
3.2
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
831
9735
0.84
5.27
1.3
1.4
—
—
—
0
0
(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum
384
3008
1.29
5.26
1.2
1.5
iu/ml
22.1
14.3
—
9
74
(3016650) Hepatitis A virus Ab [Presence] in Serum
217
1563
1.40
5.25
1.1
1.1
—
—
—
0
0
(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum
445
3570
1.26
5.03
1.1
1.1
u/ml
2.2
8.2
—
9
59
(3045414) Leukocytes [Presence] in Urine
562
4626
1.23
5.02
2.0
1.9
—
—
—
0
0
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
50
252
1.99
5.00
1.1
1.1
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
88
531
1.66
4.92
2.3
3.9
—
—
—
0
0
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
49
248
1.98
4.85
1.1
1.1
—
—
—
0
0
(3019298) Eosinophils/100 leukocytes in Peritoneal fluid
10
20
5.00
4.77
1.5
1.4
%
0.6
0.3
—
10
15
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
50
257
1.95
4.75
1.1
1.1
—
—
—
0
0
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
50
258
1.94
4.70
1.1
1.1
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
227
3030
0.74
4.63
1.6
1.7
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
86
525
1.64
4.62
1.1
1.1
—
—
—
0
0
(4198724)
45
227
1.99
4.52
1.3
2.4
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
8
281
0.28
4.48
1.1
1.4
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
8
281
0.28
4.48
1.1
1.4
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
8
282
0.28
4.47
1.1
1.4
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
8
282
0.28
4.47
1.1
1.4
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
9
297
0.30
4.45
1.0
1.4
—
—
—
0
0
(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline
17
460
0.37
4.43
1.2
1.2
mmol/l
7.3
5.9
2.20
17
435
(3043238) Trisomy 21 risk [Likelihood] in Fetus
6
246
0.24
4.43
1.0
1.4
—
—
—
0
0
(40761535) Cells panel - Urine sediment
1039
9129
1.15
4.37
3.7
3.4
—
—
—
0
0
(3048402) Erythrocytes [#/area] in Urine sediment by Automated count
90
565
1.60
4.35
1.8
1.8
u/field
3.3
2.7
0.21
72
386
(3047352) Trisomy 18 risk [Likelihood] in Fetus
6
238
0.25
4.31
1.0
1.4
—
—
—
0
0
(46234826) Other cells/100 leukocytes in Peritoneal fluid by Manual count
20
72
2.78
4.27
2.0
2.4
%
15.8
15.6
—
10
43
(3005033) Fetal Nuchal fold Thickness US
6
237
0.25
4.15
1.0
1.4
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
308
2427
1.28
4.12
1.3
1.3
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
391
4796
0.81
4.09
1.5
1.7
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
421
3442
1.23
4.08
1.7
1.6
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
797
6911
1.16
4.03
1.1
1.2
—
—
—
0
0
(3009214) Lutropin [Units/volume] in Serum or Plasma
276
2156
1.29
3.97
1.4
1.4
u/l
8.0
9.6
2.06
216
1750
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
258
3305
0.78
3.95
2.1
1.7
mg/l
4.6
3.7
0.50
219
2322
(3035637) Corticotropin [Mass/volume] in Plasma
169
1240
1.37
3.78
1.5
1.5
—
—
—
0
0
(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum
38
710
0.53
3.77
1.1
1.0
u/ml
3.3
0.5
—
8
170
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
49
848
0.58
3.73
2.4
2.6
e6/l
542.5
580.3
0.21
22
344
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
86
557
1.55
3.70
1.2
1.1
—
—
—
0
0
(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay
42
225
1.87
3.62
1.2
1.2
mg/l
0.7
71.1
1.26
32
172
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
265
2088
1.28
3.60
2.9
3.8
%
60.3
57.5
3.37
265
2088
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
226
1745
1.30
3.59
1.4
1.4
—
—
—
0
0
(3013727) Leukocytes other/100 leukocytes in Blood
59
353
1.67
3.52
2.2
3.8
%
56.2
52.0
0.88
54
346
(3001893) Eosinophils/100 leukocytes in Pleural fluid
59
354
1.67
3.48
1.3
1.4
%
2.8
2.9
0.06
52
297
(3016879) Cocaine [Presence] in Urine
211
1623
1.31
3.46
1.8
2.0
—
—
—
0
0
(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum
18
421
0.43
3.43
1.7
2.1
ug/l
72.7
53.7
0.71
18
412
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
106
731
1.45
3.41
1.3
1.5
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
254
2009
1.27
3.37
2.7
3.4
e9/l
4.8
4.1
5.05
254
2004
(3020485) Acetaminophen [Moles/volume] in Serum or Plasma
62
381
1.63
3.36
1.5
1.9
umol/l
62.9
116.2
2.29
30
199
(3016330) Potassium [Moles/time] in 24 hour Urine
27
127
2.13
3.34
1.3
1.2
—
90.7
—
0
6
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
33
168
1.97
3.32
1.4
2.9
—
—
—
0
0
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
43
240
1.79
3.29
1.1
1.1
—
—
—
0
0
(3010726) Horse dander IgE Ab [Units/volume] in Serum
63
989
0.64
3.27
1.0
1.0
u/ml
2.5
1.7
0.17
15
221
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
286
2304
1.25
3.26
1.1
1.1
u/ml
4.5
8.8
0.87
17
261
(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture
24
109
2.20
3.24
1.8
2.2
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
219
1710
1.29
3.24
1.8
2.0
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
201
1552
1.30
3.24
1.4
1.4
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
102
707
1.45
3.22
3.3
2.4
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
222
1738
1.28
3.22
1.8
2.0
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
4080
42702
0.93
3.21
2.1
2.1
—
—
—
0
0
(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay
305
2479
1.24
3.21
3.0
3.5
u/ml
1094.3
718.9
0.47
281
2258
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
124
891
1.40
3.21
1.8
2.0
u/l
1404.8
2901.9
0.46
26
295
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
617
7096
0.86
3.19
2.3
2.4
au/ml
29.6
27.9
0.09
19
340
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
22
97
2.27
3.18
1.0
1.0
—
—
—
0
0
(3052592) Norovirus Ag [Presence] in Stool
38
207
1.84
3.15
1.4
1.3
—
—
—
0
0
(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood
40
693
0.58
3.12
2.4
2.9
%
42.4
36.6
0.87
15
223
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
160
2108
0.76
3.12
1.3
1.3
—
—
—
0
0
(3018301) Testosterone Free [Moles/volume] in Serum or Plasma
71
1074
0.66
3.12
1.7
1.3
pmol/l
59.6
71.1
0.41
35
332
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
79
524
1.51
3.11
1.3
1.5
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
79
524
1.51
3.11
1.3
1.5
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
13
333
0.39
3.11
1.5
1.4
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
223
1756
1.27
3.10
1.8
2.0
—
—
—
0
0
(3005532) Lymphocytes/100 leukocytes in Pleural fluid
65
413
1.58
3.10
1.3
1.4
%
66.3
61.5
0.62
57
336
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
21
92
2.28
3.09
1.0
1.0
—
—
—
0
0
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
495
4230
1.18
3.09
1.8
2.5
g/l
3.0
3.1
0.04
398
3286
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
362
4337
0.83
3.08
1.5
1.6
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
210
1646
1.28
3.04
1.5
1.5
—
—
—
0
0
(43055190) Macrophages [#/area] in Urine sediment by Microscopy high power field
13
45
2.89
3.02
1.1
1.3
u/field
0.5
1.0
—
8
23
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
366
3052
1.21
3.02
1.4
1.4
—
—
—
0
0
(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture
24
113
2.13
2.99
1.8
2.2
—
—
—
0
0
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
44
257
1.71
2.92
1.2
1.1
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
432
3669
1.18
2.92
1.6
1.7
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
78
524
1.49
2.92
1.5
1.6
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
151
1140
1.33
2.90
3.3
3.4
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
172
1324
1.30
2.88
1.9
2.1
—
—
—
0
0
(3027570) Oxalate [Moles/time] in 24 hour Urine
16
64
2.50
2.86
1.6
1.2
umol/24h
306.8
379.7
0.66
16
64
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
209
1651
1.27
2.86
1.2
1.3
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
106
758
1.40
2.86
2.3
2.6
—
—
—
0
0
(3036782) Glucose [Moles/volume] in Pleural fluid
145
1091
1.33
2.85
1.3
1.3
mmol/l
8.3
5.7
13.36
133
1001
(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright
40
229
1.75
2.85
1.3
1.2
pmol/l
265.2
302.4
0.42
30
175
(3003434) Protein [Mass/volume] in Pleural fluid
207
1635
1.27
2.84
1.5
1.4
g/l
31.4
33.2
1.16
185
1487
(3014133) Dog dander IgE Ab [Units/volume] in Serum
55
859
0.64
2.84
1.0
1.0
u/ml
5.5
3.1
0.24
20
315
(3027008) Opiates [Presence] in Urine
220
1753
1.26
2.81
1.8
1.9
—
—
—
0
0
(40768793) Breast Pathology biopsy report
130
1734
0.75
2.80
1.3
1.3
—
—
—
0
0
(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood
44
719
0.61
2.77
2.3
2.6
e6/l
580.7
496.6
0.35
39
613
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
249
2016
1.24
2.77
1.4
1.5
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
106
1455
0.73
2.77
1.1
1.1
—
—
—
0
0
(3034092) Cytoplasmic Ig cells/100 cells in Blood
24
117
2.05
2.76
16.0
7.4
—
—
—
0
0
(3035880) pH of Pleural fluid
92
647
1.43
2.74
1.3
1.3
—
—
—
0
0
(3045716) Anion gap in Serum or Plasma
74
499
1.49
2.74
2.0
2.3
mmol/l
10.4
8.8
3.14
55
365
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
563
6438
0.87
2.73
1.2
1.3
au/ml
52.8
52.9
0.00
21
310
(3051593) INR in Capillary blood by Coagulation assay
82
565
1.45
2.73
12.4
9.7
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
2754
26054
1.07
2.72
2.6
2.4
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
34
590
0.58
2.72
2.5
1.5
—
—
—
0
0
(3023430) Cat dander IgE Ab [Units/volume] in Serum
51
800
0.64
2.70
1.0
1.0
u/ml
1.4
3.0
1.79
20
288
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
396
3364
1.18
2.70
1.6
2.4
g/l
0.0
0.0
1.99
361
3085
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
61
397
1.54
2.67
1.0
1.0
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
220
1770
1.25
2.61
1.5
1.5
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
187
1476
1.27
2.61
1.4
1.2
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
68
457
1.49
2.58
1.2
1.1
—
—
—
0
0
(21494815) CD4 cells/100 lymphocytes in Specimen
65
958
0.68
2.57
2.3
2.2
%
39.1
39.4
—
9
118
(4024509)
130
980
1.33
2.56
1.5
1.6
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
321
3815
0.84
2.56
1.5
1.5
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
1352
12477
1.09
2.49
1.4
1.3
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
283
2353
1.21
2.47
2.5
2.2
—
—
—
0
0
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
40
240
1.67
2.46
1.2
1.1
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
176
1391
1.27
2.46
1.3
1.5
—
—
—
0
0
(40761539) Cells [Type] in Urine sediment by Light microscopy
47
295
1.60
2.43
1.0
1.2
—
—
—
0
0
(3001186) Copper [Moles/volume] in Serum or Plasma
36
211
1.71
2.41
1.3
1.1
umol/l
16.8
16.0
0.55
31
185
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
406
3495
1.17
2.39
1.6
2.3
g/l
37.1
37.7
1.33
358
3004
(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection
6
176
0.34
2.39
1.3
2.3
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
474
4131
1.15
2.37
1.8
1.8
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
1501
13955
1.09
2.34
9.9
6.8
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
513
4504
1.15
2.32
1.9
2.0
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
171
1358
1.26
2.32
1.3
1.5
—
—
—
0
0
(1002224) Polysomnography panel
455
3963
1.15
2.31
1.1
1.1
—
—
—
0
0
(4306422)
109
1444
0.75
2.31
1.2
1.2
—
—
—
0
0
(3041008) Bicarbonate [Moles/volume] standard in Arterial cord blood
12
47
2.55
2.26
1.6
1.4
mmol/l
24.5
23.6
—
7
28
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
93
681
1.37
2.26
1.6
1.8
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
53
349
1.52
2.25
1.3
1.3
—
—
—
0
0
(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay
106
1401
0.75
2.22
1.1
1.1
%
125.4
115.0
2.00
100
1259
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
96
711
1.35
2.18
1.3
1.2
—
—
—
0
0
(3040893) Potassium [Moles/volume] in Capillary blood
8
24
3.33
2.18
4.9
1.9
mmol/l
4.5
4.4
—
8
24
(3019473) Protein [Mass/volume] in Cerebral spinal fluid
299
2535
1.18
2.16
1.3
1.3
mg/l
776.8
560.4
1.24
289
2417
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
364
3138
1.16
2.14
1.6
2.5
g/l
0.0
0.0
0.22
332
2866
(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid
26
144
1.81
2.14
1.2
1.2
—
—
—
0
0
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
440
3850
1.15
2.12
1.8
2.6
g/l
0.6
1.0
2.47
386
3292
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
177
1429
1.24
2.11
1.4
1.5
%
65.7
59.5
1.51
120
913
(3048879) Bone marrow aspiration report
53
355
1.50
2.10
1.5
2.0
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
710
7855
0.90
2.09
1.5
1.4
—
—
—
0
0
(3016426) Methylmalonate [Moles/volume] in Serum or Plasma
9
31
2.90
2.07
1.0
1.2
nmol/l
219.3
262.0
—
9
31
(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
0
55
0.00
2.06
0.0
1.0
—
—
—
0
0
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
357
3084
1.16
2.06
1.6
2.5
g/l
0.0
0.0
0.00
330
2856
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
66
464
1.42
2.06
2.3
2.4
—
—
—
0
0
(3010370) Gastrin [Moles/volume] in Serum or Plasma
26
146
1.78
2.05
1.9
1.6
pmol/l
46.5
43.7
0.06
20
120
(3015183) Erythrocyte sedimentation rate
24
417
0.57
2.01
1.3
1.2
—
—
—
0
0
(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid
26
147
1.77
2.01
1.3
1.2
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
378
3287
1.15
2.01
3.5
3.3
—
—
—
0
0
(3032868) Hemoglobin electrophoresis panel in Blood
14
63
2.22
2.00
1.5
1.5
—
—
—
0
0
(40758558) Short blood count panel - Blood
2769
26453
1.06
1.99
6.3
7.3
—
—
—
0
0
(46235168) Fasting glucose [Moles/volume] in Blood
19
97
1.96
1.99
2.1
1.2
mmol/l
8.2
6.5
1.39
11
27
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
604
5419
1.12
1.99
2.8
3.4
pmol/l
4.3
4.4
3.03
538
4831
(3024522) Salmonella sp identified in Specimen by Organism specific culture
169
1369
1.24
1.98
1.3
1.5
—
—
—
0
0
(4281824)
123
962
1.28
1.94
1.2
1.2
—
—
—
0
0
(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum
105
805
1.31
1.93
1.1
1.2
titre
110.0
180.0
—
5
27
(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum
105
805
1.31
1.93
1.1
1.2
titre
158.7
153.4
0.02
16
159
(3047189) Immunofixation for 24 hour Urine
78
572
1.37
1.93
1.1
1.9
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
167
1356
1.23
1.92
1.3
1.5
—
—
—
0
0
(3011412) CD3 cells [#/volume] in Blood
77
1039
0.74
1.91
2.5
2.4
e9/l
1.1
1.1
0.03
52
614
(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma
28
460
0.61
1.91
2.6
2.3
umol/l
54.0
56.7
0.21
23
375
(3016018) Differential panel - Cerebral spinal fluid
136
1080
1.26
1.91
1.3
1.4
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
137
1089
1.26
1.91
2.9
2.8
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
167
1358
1.23
1.90
1.3
1.5
—
—
—
0
0
(3020044) Glucose [Moles/volume] in Cerebral spinal fluid
262
2225
1.18
1.90
1.2
1.2
mmol/l
5.1
3.6
40.71
252
2097
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
194
1603
1.21
1.89
1.1
1.1
—
—
—
0
0
(3023383) Lactate [Moles/volume] in Pleural fluid
55
381
1.45
1.88
1.4
1.3
mmol/l
3.5
3.5
0.01
50
354
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
61
432
1.41
1.86
2.1
2.6
—
—
—
0
0
(3045519) Venlafaxine [Moles/volume] in Serum or Plasma
8
28
2.86
1.86
1.3
1.3
nmol/l
777.2
568.6
—
8
28
(3025468) Yersinia sp identified in Specimen by Organism specific culture
166
1353
1.23
1.86
1.3
1.5
—
—
—
0
0
(3023199) Leukocytes [#/volume] in Pleural fluid
181
1489
1.22
1.85
1.4
1.5
e6/l
1474.0
3147.6
1.84
127
1098
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
30
478
0.63
1.81
1.3
1.4
—
—
—
0
0
(3022493) Free Hemoglobin [Mass/volume] in Plasma
67
485
1.38
1.81
6.2
4.8
mg/l
65.9
1525.8
1.10
43
351
(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
22
123
1.79
1.79
1.1
1.1
—
—
—
0
0
(3020191) Ethanol [Moles/volume] in Serum or Plasma
105
815
1.29
1.79
1.4
1.4
promille
1.2
1.4
0.69
84
623
(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction
138
1108
1.25
1.78
1.4
1.3
u/l
259.0
557.0
3.23
130
1056
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
310
2686
1.16
1.77
1.3
1.6
—
—
—
0
0
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
119
1496
0.79
1.76
1.2
1.2
u/ml
2.3
4.1
0.97
32
522
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
1056
9805
1.08
1.75
2.6
2.5
u/l
51.2
54.6
0.10
870
8494
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
328
2857
1.15
1.75
1.2
1.6
g/l
0.3
0.2
9.47
312
2706
(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation
306
2652
1.16
1.75
1.8
1.9
pmol/l
176.6
204.6
5.77
280
2508
(3002067) Lambda light chains [Mass/time] in 24 hour Urine
30
185
1.62
1.74
1.9
3.3
—
—
—
0
0
(3004809) Band form neutrophils/100 leukocytes in Blood
226
1912
1.19
1.74
3.0
3.6
%
1.2
1.6
0.86
176
1501
(3017937) Magnesium [Moles/time] in 24 hour Urine
8
30
2.67
1.72
1.4
1.3
—
—
—
0
0
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
260
2231
1.17
1.70
1.5
1.4
e6/l
1461.7
1657.9
0.13
212
1810
(4035726)
928
10021
0.92
1.69
1.4
1.4
—
—
—
0
0
(37021550) Renin [Units/volume] in Plasma --upright
33
211
1.57
1.67
1.3
1.3
mu/l
87.8
65.1
0.28
23
155
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
44
300
1.47
1.66
1.1
1.1
—
—
—
0
0
(3008898) HLA-B27 [Presence]
223
2617
0.85
1.65
1.1
1.1
—
—
—
0
0
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
259
2229
1.17
1.64
1.4
1.3
e6/l
33.7
32.6
0.03
199
1716
(3021879) Hepatitis B virus core Ab [Presence] in Serum
675
6166
1.10
1.63
1.3
1.4
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
192
1612
1.19
1.63
1.3
1.5
—
—
—
0
0
(3000285) Sodium [Moles/volume] in Blood
23
135
1.71
1.62
1.3
1.1
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
13
251
0.52
1.61
1.2
1.4
—
—
—
0
0
(3028029) Mesothelial cells/100 leukocytes in Pleural fluid
27
166
1.63
1.60
1.3
1.4
%
4.9
12.5
2.13
15
80
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
337
2962
1.14
1.60
1.3
1.6
g/l
1.3
1.2
11.25
321
2815
(3000093) Morphology [Interpretation] in Blood Narrative
128
1035
1.24
1.59
1.1
1.1
—
—
—
0
0
(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma
43
295
1.46
1.59
1.2
1.2
g/l
0.3
0.3
0.80
32
238
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
22
363
0.61
1.58
3.3
3.2
—
—
—
0
0
(3016724) Homocysteine [Moles/volume] in Serum or Plasma
87
673
1.29
1.56
1.3
1.5
umol/l
15.0
13.2
1.32
78
646
(3003329) Lymphocytes/100 leukocytes in Synovial fluid
128
1038
1.24
1.56
1.4
1.5
%
19.6
29.3
4.12
85
635
(3000492) Spirometry study
912
9815
0.92
1.55
1.5
1.5
—
—
—
0
0
(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay
100
789
1.27
1.54
1.3
1.4
u/l
25.9
31.1
1.02
82
632
(3049717) Cytology report of Urine Cyto stain
554
5032
1.11
1.52
2.9
2.8
—
—
—
0
0
(3020393) Adenovirus Ag [Presence] in Stool
18
100
1.80
1.52
1.0
1.0
—
—
—
0
0
(3037297) Penicillin G IgE Ab [Units/volume] in Serum
0
43
0.00
1.52
0.0
1.1
—
0.1
—
0
22
(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma
11
219
0.50
1.51
1.0
1.8
ug/l
5.7
7.9
—
5
138
(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay
0
44
0.00
1.51
0.0
1.2
—
—
—
0
0
(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)
38
549
0.69
1.49
1.1
1.1
ratio
1.1
1.1
0.04
14
185
(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum
45
630
0.71
1.48
1.1
1.1
nmol/l
3.3
7.5
—
7
143
(3003181) Sodium [Moles/volume] in Urine
220
1890
1.17
1.46
1.3
1.3
mmol/l
60.8
63.6
0.54
169
1522
(3034274) Bile acid [Moles/volume] in Serum --fasting
55
402
1.37
1.46
1.3
1.6
umol/l
10.3
15.1
0.73
36
278
(3034037) Hematocrit [Volume Fraction] of Mixed venous blood
34
229
1.49
1.40
6.6
7.5
—
—
—
0
0
(3014271) Vancomycin [Susceptibility]
73
561
1.30
1.40
3.2
2.9
—
—
—
0
0
(3038071) Oxygen [Partial pressure] in Mixed venous blood
41
287
1.43
1.40
13.8
8.3
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
57
758
0.75
1.37
1.5
1.7
—
—
—
0
0
(3028308) Erythrocytes [#/volume] in Pleural fluid
161
1358
1.19
1.35
1.4
1.4
e6/l
46324.5
69638.8
1.01
94
834
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
2971
30720
0.96
1.34
2.8
3.1
ug/l
0.7
0.8
0.35
1902
20800
(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid
20
120
1.67
1.33
1.1
1.1
u/l
15.6
19.8
0.60
11
87
(3008691) Amylase [Enzymatic activity/volume] in Peritoneal fluid
13
68
1.91
1.33
1.7
1.3
u/l
209.3
2516.9
1.06
13
58
(3010144) Erythrocytes [#/volume] in Synovial fluid
132
1096
1.21
1.32
1.2
1.3
e6/l
136629.0
137997.3
0.01
93
754
(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose
0
40
0.00
1.32
0.0
1.0
—
8.4
—
0
40
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
120
1451
0.83
1.31
1.2
1.2
u/ml
2.5
3.9
2.62
49
653
(3008536) Aspergillus sp Ab [Presence] in Serum
15
258
0.58
1.30
2.7
2.2
—
—
—
0
0
(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma
21
129
1.63
1.29
1.0
1.3
nmol/l
1335725.9
126135.9
0.42
14
111
(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum
106
1294
0.82
1.28
1.1
1.1
au/ml
12.4
12.2
—
6
63
(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma
39
276
1.41
1.28
1.3
1.2
%
112.1
113.6
0.09
30
245
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
2044
19609
1.05
1.28
3.0
3.3
mmol/l
2.5
2.5
11.16
1777
17258
(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid
11
55
2.00
1.27
1.0
1.0
—
—
—
0
0
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
17
99
1.72
1.26
1.1
1.0
—
—
—
0
0
(3033658) Prothrombin time (PT) actual/Normal
2888
27937
1.04
1.26
4.6
4.0
%
88.3
87.6
0.71
2810
27365
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
1447
13761
1.06
1.26
6.1
4.3
%
31.7
32.2
1.05
1077
9248
(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine
6
25
2.40
1.24
1.8
1.2
—
—
—
0
0
(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma
48
643
0.75
1.24
1.2
1.3
g/l
1.4
1.5
—
6
41
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
75
590
1.27
1.24
1.5
1.8
—
—
—
0
0
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
136
1142
1.19
1.23
1.2
1.2
u/l
55.3
64.5
1.32
103
753
(3003327) Ova and parasites identified in Stool by Light microscopy
333
2986
1.12
1.22
1.6
1.7
—
—
—
0
0
(3003888) Timothy IgE Ab [Units/volume] in Serum
91
1119
0.81
1.20
1.0
1.1
u/ml
4.7
3.8
0.18
36
529
(3025886) Oxalate [Mass/time] in 24 hour Urine
6
26
2.31
1.18
1.0
1.1
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
66
515
1.28
1.18
1.1
1.1
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
233
2050
1.14
1.17
1.4
1.4
—
—
—
0
0
(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
342
3080
1.11
1.17
2.4
2.4
g/l
3.8
3.5
2.37
328
2946
(3012215) Mononuclear cells/100 leukocytes in Synovial fluid
41
298
1.38
1.17
1.2
1.3
%
38.8
36.8
0.11
27
211
(3012494) Peanut IgE Ab [Units/volume] in Serum
25
165
1.52
1.17
1.1
1.0
u/ml
1.7
1.0
—
10
81
(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid
10
50
2.00
1.16
1.0
1.0
—
—
—
0
0
(40762482) Peach recombinant (rPru p) 3 IgE Ab [Units/volume] in Serum
5
20
2.50
1.15
1.0
1.0
u/ml
0.1
0.6
—
5
14
(3042517) Benzodiazepines panel - Urine
8
39
2.05
1.15
6.8
1.7
—
—
—
0
0
(3036670) Protein [Mass/volume] in Synovial fluid
50
377
1.33
1.14
1.3
1.2
g/l
42.2
39.4
0.51
29
184
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
19
118
1.61
1.14
1.2
1.1
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
1712
16406
1.05
1.13
1.2
1.3
iu/ml
40.4
37.2
0.28
506
5232
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
1604
15348
1.05
1.13
1.2
1.3
u/ml
9.2
14.6
2.97
613
5735
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
129
1090
1.19
1.11
3.0
2.9
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
59
458
1.29
1.11
1.2
1.2
—
—
—
0
0
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
40
293
1.37
1.11
1.5
1.6
ug/l
10.6
9.2
0.99
40
293
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
206
2344
0.88
1.11
4.2
5.9
iu/ml
1347.7
1789.7
0.15
27
364
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
630
5857
1.08
1.11
1.3
1.3
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
68
853
0.80
1.10
1.3
1.2
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
255
2269
1.13
1.10
1.7
1.6
—
—
—
0
0
(3005322) IgE [Units/volume] in Serum or Plasma
594
5513
1.08
1.09
1.3
1.3
u/ml
342.0
248.5
1.04
548
5093
(3014765) Yersinia sp identified in Stool by Organism specific culture
313
2821
1.11
1.08
1.2
1.2
—
—
—
0
0
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
44
329
1.34
1.08
13.1
8.3
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
310
2794
1.11
1.07
1.2
1.2
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
149
1280
1.17
1.07
1.4
1.5
—
—
—
0
0
(3042010) Triglyceride [Moles/volume] in Pleural fluid
25
169
1.48
1.06
1.4
1.3
mmol/l
0.5
1.3
0.99
16
107
(3045788) Cell count panel - Pleural fluid
134
1142
1.18
1.06
1.4
1.5
—
—
—
0
0
(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid
17
105
1.62
1.05
1.2
1.1
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
313
2827
1.11
1.05
1.2
1.2
—
—
—
0
0
(3032700) Glomerular basement membrane Ab [Units/volume] in Serum
20
129
1.55
1.05
1.1
1.6
—
10.5
—
0
5
(3010015) Selenium [Moles/volume] in Serum or Plasma
12
67
1.79
1.04
2.0
1.7
umol/l
1.3
1.5
0.69
12
59
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
48
366
1.31
1.04
1.0
1.1
miu/ml
1695.0
1480.1
0.68
48
366
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
99
823
1.20
1.04
1.1
1.1
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
82
1000
0.82
1.04
1.4
1.8
—
—
—
0
0
(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid
23
154
1.49
1.03
1.3
1.3
u/l
87.1
310.5
0.45
15
110
(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method
9
47
1.92
1.02
7.0
9.7
—
—
—
0
0
(3029634) Reagin Ab [Titer] in Serum by VDRL
108
1280
0.84
1.01
1.7
2.3
—
5.4
—
0
37
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
19
123
1.55
0.99
2.3
2.0
umol/l
15.9
18.2
0.54
19
123
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
81
664
1.22
0.99
1.4
1.6
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
34
248
1.37
0.99
1.1
1.1
—
—
—
0
0
(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method
5
23
2.17
0.98
1.0
1.0
—
—
—
0
0
(3012989) Citrate [Moles/time] in 24 hour Urine
5
23
2.17
0.98
2.0
1.3
mmol/24h
1.6
2.2
—
5
23
(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification
47
606
0.77
0.98
4.7
5.9
u/ml
42.4
5508.2
—
7
120
(3002621) Streptococcal DNAse B [Units/volume] in Serum
15
92
1.63
0.97
1.1
1.0
—
—
—
0
0
(4211845)
66
531
1.24
0.96
3.3
3.1
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
14
222
0.63
0.94
1.1
1.1
—
—
—
0
0
(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
157
1794
0.87
0.94
1.8
2.8
u/ml
793.9
6235.7
—
9
129
(3035999) Lactate [Moles/volume] in Cerebral spinal fluid
92
769
1.20
0.94
1.3
1.3
mmol/l
2.5
2.1
2.16
85
726
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
4316
42286
1.03
0.93
4.2
4.4
%
24.0
21.4
18.12
1930
21314
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
244
2192
1.12
0.93
1.3
1.3
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
244
2192
1.12
0.93
1.3
1.3
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
125
1451
0.86
0.93
1.2
1.4
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
98
1159
0.84
0.92
3.2
3.8
—
—
—
0
0
(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
13
78
1.67
0.91
1.2
1.1
—
—
—
0
0
(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)
10
171
0.58
0.91
1.0
1.2
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
5707
56176
1.03
0.90
2.4
2.5
—
—
—
0
0
(3009677) Dengue virus Ab [Presence] in Serum
6
29
2.07
0.89
1.0
1.2
—
—
—
0
0
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
19
278
0.68
0.89
1.3
1.3
—
—
—
0
0
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
48
376
1.28
0.89
1.1
1.2
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
106
903
1.18
0.89
1.4
1.5
—
—
—
0
0
(3034426) Prothrombin time (PT)
24
336
0.71
0.88
1.3
1.2
—
—
—
0
0
(3017115) Methotrexate [Moles/volume] in Serum or Plasma
9
152
0.59
0.88
9.9
8.4
umol/l
0.5
0.3
—
9
140
(3041918) Cholesterol [Moles/volume] in Pleural fluid
31
228
1.36
0.88
1.3
1.2
mmol/l
1.2
1.7
2.34
20
135
(44806071)
7
131
0.53
0.87
1.1
1.1
—
—
—
0
0
(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid
44
342
1.29
0.87
1.3
1.2
ug/l
146.7
454.0
0.97
27
173
(3032057) Clostridioides difficile [Presence] in Stool
31
229
1.35
0.86
1.6
1.8
—
—
—
0
0
(40760435) Tropomyosin IgE Ab [Units/volume] in Serum
11
64
1.72
0.86
1.0
1.0
—
—
—
0
0
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
11
180
0.61
0.85
1.1
1.1
—
—
—
0
0
(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
13
204
0.64
0.85
1.1
1.3
—
—
—
0
0
(3008401) Mugwort IgE Ab [Units/volume] in Serum
92
1084
0.85
0.85
1.0
1.1
u/ml
1.2
1.3
0.04
30
440
(4268621)
83
986
0.84
0.84
2.2
2.3
—
—
—
0
0
(3009876) Amylase isoenzyme 3 panel - Serum or Plasma
13
80
1.63
0.84
1.1
1.3
—
—
—
0
0
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
126
1094
1.15
0.84
1.1
1.1
u/ml
2.1
3.9
2.17
53
460
(3018980) carBAMazepine [Moles/volume] in Serum or Plasma
30
401
0.75
0.84
2.8
3.0
umol/l
25.7
29.3
0.77
19
311
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
301
2753
1.10
0.84
1.5
1.7
—
—
—
0
0
(3028371) Actinomyces sp identified in Specimen by Organism specific culture
20
137
1.46
0.83
1.0
1.1
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
120
1039
1.16
0.83
1.2
1.2
—
—
—
0
0
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
64
777
0.82
0.82
2.0
2.0
%
15.1
16.2
0.21
19
307
(3027974) Hepatitis B virus e Ag [Presence] in Serum
8
46
1.74
0.82
1.8
1.4
—
—
—
0
0
(3013945) Hepatitis B virus e Ab [Presence] in Serum
8
46
1.74
0.82
1.8
1.4
—
—
—
0
0
(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma
67
553
1.21
0.81
1.0
1.1
u/l
23.7
28.8
0.45
47
410
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
33
432
0.76
0.81
1.1
1.1
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
79
664
1.19
0.79
1.4
1.6
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
39
498
0.78
0.79
1.0
1.1
—
—
—
0
0
(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid
40
312
1.28
0.79
1.6
1.4
%
16.0
23.0
1.38
35
261
(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma
67
555
1.21
0.79
1.0
1.1
u/l
83.9
91.7
0.43
48
424
(3034891) Synovial lining cells/100 cells in Synovial fluid
64
528
1.21
0.78
1.5
1.5
%
3.3
3.5
0.05
12
117
(3002619) Bacteria identified in Specimen by Culture
29
216
1.34
0.78
1.5
1.2
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
60
728
0.82
0.78
2.1
2.0
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
191
1716
1.11
0.77
2.1
2.8
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
147
1657
0.89
0.76
1.1
1.1
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
426
3976
1.07
0.75
1.3
1.3
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
77
650
1.19
0.75
3.5
3.8
—
—
—
0
0
(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
10
161
0.62
0.75
1.1
1.5
—
—
—
0
0
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
12
185
0.65
0.75
1.1
1.7
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
187
1684
1.11
0.74
1.3
1.2
miu/ml
129.3
210.3
2.69
44
655
(3033923) Metanephrine [Moles/time] in 24 hour Urine
26
193
1.35
0.72
1.0
1.1
umol/24h
0.9
0.7
1.24
13
101
(3000475) Leukocytes [#/volume] in Synovial fluid
303
2797
1.09
0.72
1.5
1.6
e6/l
16484.6
14188.1
0.38
218
2029
(46235355) HIV 1 and 2 tests - Meaningful Use set
1217
11718
1.04
0.72
1.5
1.6
—
—
—
0
0
(40768446) Kidney Pathology biopsy report
33
423
0.78
0.71
1.5
1.6
—
—
—
0
0
(3043410) Blood group antigens tested for on Red Blood Cells
36
282
1.28
0.70
2.9
1.7
—
—
—
0
0
(3001964) Herpes simplex virus Ag [Presence] in Specimen
24
321
0.75
0.70
1.1
1.6
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
252
2311
1.09
0.70
1.2
1.2
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
138
1226
1.13
0.70
1.4
1.8
—
—
—
0
0
(3040661) Urea [Moles/volume] in Peritoneal dialysis fluid
7
42
1.67
0.68
6.0
5.2
mmol/l
18.1
17.9
—
7
37
(4212803)
7
117
0.60
0.67
1.0
1.1
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
117
1324
0.88
0.67
1.1
1.1
—
—
—
0
0
(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine
14
94
1.49
0.66
1.1
3.3
—
—
—
0
0
(40771922) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood
13
86
1.51
0.66
1.0
1.3
ml/s/173m2
1.0
1.0
—
7
56
(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay
20
145
1.38
0.65
1.1
1.0
—
—
—
0
0
(3019897) Erythrocyte distribution width [Ratio] by Automated count
87
1002
0.87
0.65
7.0
2.7
%
13.6
13.2
2.52
87
984
(3016038) Potassium [Moles/volume] in Urine
82
707
1.16
0.65
1.1
1.1
mmol/l
33.6
34.9
0.22
74
610
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
35
277
1.26
0.65
1.3
1.2
—
—
—
0
0
(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma
387
3629
1.07
0.63
1.8
1.7
nmol/l
32.6
44.6
29.66
371
3505
(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid
103
906
1.14
0.63
1.3
1.3
u/l
10.0
14.8
4.05
96
838
(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma
12
79
1.52
0.62
1.0
1.1
u/l
11.3
11.9
0.05
12
79
(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
17
121
1.41
0.62
1.1
1.2
—
—
—
0
0
(3029075) Extractable nuclear Ab panel - Serum
34
270
1.26
0.62
1.1
1.0
—
—
—
0
0
(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid
11
71
1.55
0.62
1.1
1.0
—
—
—
0
0
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
36
288
1.25
0.62
1.1
1.1
—
—
—
0
0
(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood
6
103
0.58
0.62
1.0
1.2
—
—
—
0
0
(4133840)
23
302
0.76
0.61
1.6
1.2
—
—
—
0
0
(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture
6
104
0.58
0.61
1.7
1.9
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
31
391
0.79
0.61
1.1
1.1
—
—
—
0
0
(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma
54
642
0.84
0.61
1.4
1.5
u/l
8.9
6.0
0.50
45
542
(4015189)
29
368
0.79
0.60
2.1
2.4
—
—
—
0
0
(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay
9
139
0.65
0.60
1.0
1.2
u/ml
66.1
68.6
—
9
132
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
70
601
1.17
0.60
2.7
3.9
—
—
—
0
0
(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma
64
748
0.85
0.60
1.2
1.4
nmol/l
0.1
0.2
3.49
48
539
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
287
2672
1.08
0.59
1.5
1.7
—
—
—
0
0
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
15
209
0.72
0.59
1.5
1.2
—
—
—
0
0
(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]
36
290
1.24
0.59
3.9
6.6
%
60.5
72.5
1.40
26
236
(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum
11
72
1.53
0.59
1.1
1.0
u/ml
0.2
1.3
—
6
55
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
21
277
0.76
0.59
1.0
1.1
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
21
277
0.76
0.59
1.0
1.1
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
21
277
0.76
0.59
1.0
1.1
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
21
277
0.76
0.59
1.0
1.1
—
—
—
0
0
(3046861) Legionella sp Ag [Presence] in Urine
10
64
1.56
0.58
1.0
1.1
—
—
—
0
0
(3036071) Salmonella sp Ab [Titer] in Serum
23
299
0.77
0.58
1.1
1.1
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
63
735
0.86
0.58
2.2
1.6
—
—
—
0
0
(3045683) HLA typing for celiac disease panel - Blood or Tissue
54
455
1.19
0.58
1.1
1.0
—
—
—
0
0
(3037692) Legionella sp identified in Specimen by Organism specific culture
39
474
0.82
0.57
1.1
1.5
—
—
—
0
0
(3004905) Lipase [Enzymatic activity/volume] in Serum or Plasma
27
211
1.28
0.56
2.9
5.3
u/l
61.5
54.8
0.17
14
77
(3044941) Cell count panel - Synovial fluid
190
1743
1.09
0.56
1.3
1.4
—
—
—
0
0
(21494434) Karyotype in Bone marrow
121
1085
1.12
0.56
1.0
1.2
—
—
—
0
0
(4010399)
835
8030
1.04
0.56
1.5
1.4
—
—
—
0
0
(40765089) Chromosome analysis panel - Blood by G-banded
5
88
0.57
0.56
1.0
1.0
—
—
—
0
0
(3036525) Urea [Moles/time] in 24 hour Urine
10
65
1.54
0.55
2.5
3.5
—
—
—
0
0
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
43
357
1.21
0.54
1.2
1.2
—
—
—
0
0
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
113
1260
0.90
0.54
1.1
1.1
u/ml
0.8
1.3
0.88
40
494
(3005011) Chlamydia sp Ab [Titer] in Serum
8
123
0.65
0.54
2.3
1.7
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
43
514
0.84
0.53
1.6
1.6
—
—
—
0
0
(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid
20
151
1.33
0.53
1.2
1.3
%
58.3
54.2
—
10
70
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
173
1885
0.92
0.53
1.2
1.2
u/ml
39.1
44.5
0.21
14
200
(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma
21
160
1.31
0.53
1.1
1.2
ng/l
107.8
603.2
0.51
16
111
(3028717) Thiamine [Mass/volume] in Blood
15
108
1.39
0.53
1.3
1.1
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
2828
27776
1.02
0.51
1.3
1.3
—
—
—
0
0
(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma
187
1724
1.09
0.51
2.1
2.0
ug/l
24.9
22.2
0.35
181
1692
(3011335) Digoxin [Mass/volume] in Serum or Plasma
12
83
1.45
0.51
2.8
2.1
—
—
—
0
0
(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine
9
134
0.67
0.51
1.6
1.5
—
—
—
0
0
(1617658) Protocol used for examination of sentinel lymph nodes
52
607
0.86
0.50
1.0
1.0
—
—
—
0
0
(3006462) Nitrate [Presence] in Urine
56
481
1.16
0.50
3.5
3.3
—
—
—
0
0
(3030136) 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma
82
725
1.13
0.50
3.0
3.5
nmol/l
201.8
141.0
0.52
82
718
(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma
72
631
1.14
0.50
1.2
1.3
u/l
37.5
20.7
1.13
63
526
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
302
3210
0.94
0.50
2.1
2.1
%
88.0
89.0
0.30
287
2995
(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method
14
101
1.39
0.49
1.1
1.1
—
—
—
0
0
(3025443) Phadiatop IgE Ab [Units/volume] in Serum
35
422
0.83
0.49
1.1
1.1
u/ml
4.5
6.3
—
9
61
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
314
2960
1.06
0.48
1.5
1.8
—
—
—
0
0
(3042847) Granulocytes/100 leukocytes in Cerebral spinal fluid
12
85
1.41
0.46
1.2
1.2
%
24.0
18.8
—
5
26
(3029396) Erythrocyte agglutination [Presence] in Blood
7
48
1.46
0.46
1.1
2.2
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
142
1302
1.09
0.46
1.6
1.5
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
108
977
1.11
0.46
1.6
1.5
—
—
—
0
0
(3020874) Milk IgE Ab [Units/volume] in Serum
31
375
0.83
0.46
1.0
1.0
u/ml
0.7
0.8
0.13
13
103
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
53
458
1.16
0.45
2.7
2.4
—
—
—
0
0
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
227
2125
1.07
0.45
1.6
1.7
iu/l
42.3
4.6
0.49
81
693
(3036489) Thrombin time
373
3920
0.95
0.44
2.0
2.0
s
22.3
21.8
0.55
343
3453
(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum
73
648
1.13
0.44
1.2
1.4
u/ml
1.1
1.1
0.03
38
335
(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay
9
131
0.69
0.43
1.0
1.1
—
—
—
0
0
(3017446) Testosterone [Moles/volume] in Serum or Plasma
1036
10654
0.97
0.42
2.5
2.1
nmol/l
10.0
13.5
48.33
903
9492
(3015076) Soybean IgE Ab [Units/volume] in Serum
27
328
0.82
0.42
1.0
1.0
u/ml
1.3
2.0
—
7
44
(3001729) Color of Synovial fluid
13
96
1.35
0.41
1.2
1.4
—
—
—
0
0
(3001556) Androgen free Index in Serum or Plasma
5
33
1.52
0.41
1.2
1.3
—
—
—
0
0
(3004268) Protein electrophoresis panel - Cerebral spinal fluid
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
(3046682) IgA [Presence] in Skin by Immunofluorescence
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
(3007463) Buprenorphine [Presence] in Urine
0
16
0.00
0.41
0.0
8.7
—
—
—
0
0
(3007919) Fasciola sp Ab [Titer] in Serum
0
16
0.00
0.41
0.0
1.1
—
—
—
0
0
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
19
239
0.79
0.41
1.3
1.2
—
—
—
0
0
(36303858) Crystals [Presence] in Urine
0
17
0.00
0.40
0.0
1.1
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
222
2087
1.06
0.40
1.4
1.6
—
—
—
0
0
(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
10
138
0.72
0.40
1.0
1.0
—
—
—
0
0
(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay
8
60
1.33
0.40
1.1
1.0
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
169
1574
1.07
0.40
1.3
1.6
—
—
—
0
0
(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma
73
653
1.12
0.40
1.2
1.3
u/l
107.0
84.0
0.83
65
558
(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection
0
18
0.00
0.40
0.0
1.3
—
—
—
0
0
(3041184) Isoniazid [Presence] in Urine
0
18
0.00
0.40
0.0
3.1
—
—
—
0
0
(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis
20
159
1.26
0.40
14.8
10.2
mmol/l
4.8
5.3
0.58
20
159
(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma
76
682
1.12
0.39
1.6
1.6
u/l
11.9
5.6
0.89
41
326
(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum
252
2666
0.94
0.39
1.2
1.3
u/ml
26.6
40.1
—
8
166
(3050794) Legionella sp Ab [Presence] in Serum
7
103
0.68
0.39
1.0
1.1
—
—
—
0
0
(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination
5
35
1.43
0.39
1.0
1.0
—
—
—
0
0
(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method
10
71
1.41
0.39
1.0
1.0
—
—
—
0
0
(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection
0
19
0.00
0.39
0.0
1.5
—
—
—
0
0
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
22
270
0.81
0.39
1.6
1.6
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
125
1153
1.08
0.38
1.5
1.8
—
—
—
0
0
(40757373) Influenza virus identified in Isolate
27
224
1.21
0.38
1.3
1.8
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
69
619
1.12
0.37
1.2
1.2
—
—
—
0
0
(3031659) Enterovirus NOS Ab [Titer] in Cerebral spinal fluid
5
37
1.35
0.37
1.0
1.1
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
47
412
1.14
0.36
1.5
1.5
—
—
—
0
0
(40768443) Skin Pathology biopsy report
500
4820
1.04
0.36
1.2
1.2
—
—
—
0
0
(3009015) Lactate [Moles/volume] in Synovial fluid
11
146
0.75
0.36
1.5
1.3
mmol/l
12.5
6.5
—
5
68
(3047007) Chlamydophila sp Ab [Presence] in Serum
119
1286
0.92
0.35
1.3
1.2
—
—
—
0
0
(3025315) Body weight
12
90
1.33
0.35
4.6
4.9
—
—
—
0
0
(3019174) dRVVT (LA screen)
5
76
0.66
0.35
1.2
1.2
—
—
—
0
0
(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay
5
76
0.66
0.35
1.2
1.6
—
—
—
0
0
(40761995) Spermatozoa Progressive [#/volume] in Semen
5
76
0.66
0.35
3.0
3.0
—
—
—
0
0
(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum
5
77
0.65
0.35
1.0
1.0
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
63
564
1.12
0.35
1.3
1.5
—
—
—
0
0
(3039744) RNA polymerase III Ab [Units/volume] in Serum
5
78
0.64
0.35
1.0
1.1
—
6.9
—
0
8
(36305075) Vedolizumab [Mass/volume] in Serum or Plasma by Immunoassay
5
80
0.62
0.35
2.2
2.1
mg/l
22.0
20.2
—
5
73
(3024980) IgG subclass 4 [Mass/volume] in Serum
176
1653
1.07
0.35
1.6
1.6
g/l
0.7
0.9
1.38
132
1233
(3003721) Smooth muscle Ab [Units/volume] in Serum
6
43
1.40
0.35
1.0
1.2
—
1.5
—
0
5
(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid
50
442
1.13
0.34
1.1
1.1
ng/l
129.7
783.9
1.97
12
105
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
54
606
0.89
0.34
5.6
6.5
—
—
—
0
0
(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma
90
982
0.92
0.34
1.6
1.9
mg/l
4.6
3.8
0.96
81
935
(3008757) Leukocyte morphology finding [Identifier] in Blood
137
1277
1.07
0.34
3.2
4.2
—
—
—
0
0
(3008295) Osmolality of Serum or Plasma
116
1075
1.08
0.33
1.3
1.4
mosm/kgh2o
284.4
277.0
1.96
87
841
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
236
2483
0.95
0.33
1.2
1.3
u/ml
9.7
6.6
0.23
31
415
(3009871) Measles virus Ab [Titer] in Serum
28
328
0.85
0.32
1.5
1.7
—
—
—
0
0
(3015479) Mycobacterium sp identified in Blood by Organism specific culture
24
201
1.19
0.32
1.5
1.6
—
—
—
0
0
(4034850)
326
3399
0.96
0.32
14.4
9.6
—
—
—
0
0
(44790049)
136
1272
1.07
0.31
1.4
1.6
—
—
—
0
0
(44790048)
136
1272
1.07
0.31
1.4
1.6
—
—
—
0
0
(44790047)
136
1272
1.07
0.31
1.4
1.6
—
—
—
0
0
(44806118)
136
1272
1.07
0.31
1.4
1.6
—
—
—
0
0
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
234
2458
0.95
0.31
1.2
1.3
u/ml
5.3
6.2
0.12
21
280
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
69
627
1.10
0.31
1.2
1.2
—
—
—
0
0
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
18
219
0.82
0.31
1.2
1.2
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
115
1071
1.07
0.30
1.1
1.1
—
—
—
0
0
(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose
7
100
0.70
0.30
1.0
1.1
—
—
—
0
0
(44813793)
66
600
1.10
0.30
1.1
1.1
—
—
—
0
0
(3025577) Chromium [Mass/volume] in Blood
80
870
0.92
0.30
2.0
2.0
ug/l
2.5
2.4
0.08
60
724
(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method
12
93
1.29
0.30
1.2
1.2
nmol/l
0.1
0.2
—
6
63
(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay
17
139
1.22
0.29
1.1
1.0
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
62
564
1.10
0.28
1.3
1.5
—
—
—
0
0
(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid
92
853
1.08
0.28
1.1
1.0
ng/l
287.7
336.1
0.62
67
607
(3043870) Heparin induced platelet Ab [Units/volume] in Serum
14
112
1.25
0.28
1.1
1.1
—
—
—
0
0
(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma
22
259
0.85
0.28
1.5
1.5
ug/l
0.4
0.4
0.35
15
167
(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma
8
64
1.25
0.27
1.1
1.0
—
—
—
0
0
(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
9
118
0.76
0.27
1.1
1.0
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
110
1029
1.07
0.27
1.5
1.8
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
110
1029
1.07
0.27
1.5
1.8
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
110
1029
1.07
0.27
1.5
1.8
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
118
1108
1.07
0.26
1.2
1.2
—
—
—
0
0
(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid
92
856
1.08
0.26
1.1
1.0
ng/l
721.3
728.6
0.07
67
584
(40758292) HTLV I+II Ab panel - Serum
15
182
0.82
0.26
1.4
1.5
—
—
—
0
0
(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma
5
74
0.68
0.26
2.2
2.1
—
—
—
0
0
(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen
5
75
0.67
0.25
6.0
6.1
—
—
—
0
0
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
29
330
0.88
0.25
1.1
1.1
—
—
—
0
0
(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
279
2897
0.96
0.25
2.4
2.4
%
219.6
197.4
3.35
265
2738
(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum
71
768
0.92
0.25
1.1
1.1
—
45.0
—
0
5
(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay
92
859
1.07
0.25
1.1
1.0
ng/l
32.6
43.4
2.48
64
601
(3004616) Nuclear Ab [Presence] in Serum
120
1271
0.94
0.24
1.2
1.3
—
—
—
0
0
(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
197
2058
0.96
0.24
1.2
1.2
u/ml
1.5
5.5
1.89
12
173
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
176
1843
0.95
0.23
1.6
1.8
—
—
—
0
0
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
27
307
0.88
0.23
1.1
1.1
—
—
—
0
0
(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method
5
38
1.32
0.23
1.0
1.1
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
43
474
0.91
0.23
1.3
1.2
—
—
—
0
0
(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum
49
536
0.91
0.23
1.1
1.1
iu/ml
8.2
11.4
0.54
11
124
(3030862) Granulocytes [#/volume] in Cerebral spinal fluid
36
323
1.11
0.22
1.3
1.2
%
1.0
25.1
—
6
54
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
163
1557
1.05
0.22
1.7
1.6
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
163
1704
0.96
0.21
1.1
1.2
u/ml
314.1
286.5
0.52
95
1104
(3015694) Chlamydophila pneumoniae IgG Ab [Titer] in Cerebral spinal fluid
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3009992) Blasts/100 cells in Bone marrow
0
11
0.00
0.21
0.0
1.6
—
19.0
—
0
11
(3039114) Acanthocytes/1000 erythrocytes in Blood by Light microscopy
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(3017074) Chlamydophila pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3023693) von Willebrand factor (vWf) multimers in Platelet poor plasma by Immunoblot
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
(3013336) Amino acids [Identifier] in Serum or Plasma
0
10
0.00
0.21
0.0
4.4
—
—
—
0
0
(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3017986) Aspergillus versicolor IgE Ab [Units/volume] in Serum
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(3021374) Sirolimus [Mass/volume] in Blood
0
10
0.00
0.21
0.0
10.6
—
7.1
—
0
10
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
13
156
0.83
0.21
1.2
1.2
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
74
691
1.07
0.21
1.0
1.1
—
—
—
0
0
(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing
8
102
0.78
0.21
1.1
1.2
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
75
701
1.07
0.21
1.2
1.2
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
176
1835
0.96
0.21
1.1
1.2
—
—
—
0
0
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
15
177
0.85
0.21
1.0
1.0
—
—
—
0
0
(3021691) Plasmodium malariae Ab [Titer] in Serum
0
13
0.00
0.21
0.0
2.2
—
—
—
0
0
(3042585) Pyridoxine [Moles/volume] in Serum or Plasma
28
314
0.89
0.20
1.1
1.3
nmol/l
168.3
129.7
0.34
18
226
(3042733) HLA Ab [Presence] in Serum
39
354
1.10
0.20
4.4
5.1
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
75
702
1.07
0.20
1.2
1.2
—
—
—
0
0
(3016284) Epstein Barr virus nuclear Ab [Units/volume] in Serum
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(3003531) Amoxicillin IgE Ab [Units/volume] in Serum
0
14
0.00
0.20
0.0
1.0
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
243
2348
1.04
0.20
1.1
1.1
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
75
703
1.07
0.20
1.2
1.2
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
50
541
0.92
0.19
1.2
1.2
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
117
1228
0.95
0.19
1.1
1.1
—
—
—
0
0
(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum
20
228
0.88
0.19
1.2
1.1
—
—
—
0
0
(3024263) Appearance of Synovial fluid
56
602
0.93
0.19
1.1
1.6
—
—
—
0
0
(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method
10
81
1.23
0.18
7.2
4.5
—
—
—
0
0
(3045781) Inhibin B [Mass/volume] in Serum or Plasma
16
137
1.17
0.18
1.4
3.6
ng/l
72.7
180.2
—
8
47
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
84
889
0.94
0.18
1.1
1.1
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
197
1901
1.04
0.18
1.1
1.2
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
75
706
1.06
0.18
1.2
1.2
—
—
—
0
0
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
294
3024
0.97
0.18
1.6
1.6
iu/ml
11.0
5.8
0.19
66
665
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
75
707
1.06
0.17
1.2
1.2
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
75
707
1.06
0.17
1.2
1.2
—
—
—
0
0
(3024932) HLA-DR beta [Type]
39
358
1.09
0.17
1.1
1.1
—
—
—
0
0
(3019779) Phenytoin [Moles/volume] in Serum or Plasma
18
157
1.15
0.17
4.4
3.4
umol/l
48.2
41.9
0.78
18
130
(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy
7
62
1.13
0.17
1.1
1.1
—
—
—
0
0
(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection
5
69
0.72
0.16
2.2
4.4
—
—
—
0
0
(3019768) Coxiella burnetii Ab [Presence] in Serum
8
68
1.18
0.16
1.0
1.2
—
—
—
0
0
(3000213) Normetanephrine [Moles/time] in 24 hour Urine
12
101
1.19
0.16
1.0
1.2
umol/24h
2.9
1.7
1.31
12
101
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
34
371
0.92
0.16
1.1
1.2
—
—
—
0
0
(3047166) Epithelial cells [#/area] in Urine sediment by Automated count
14
120
1.17
0.16
2.6
2.2
u/field
0.6
0.4
0.42
14
120
(3028433) Virus identified in Specimen by Culture
36
391
0.92
0.16
1.1
1.2
—
—
—
0
0
(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum
8
73
1.10
0.15
1.0
1.1
—
—
—
0
0
(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis
8
73
1.10
0.15
1.1
1.2
—
—
—
0
0
(3032743) Legionella sp IgG Ab [Presence] in Serum
6
79
0.76
0.15
1.0
1.1
—
—
—
0
0
(21494567) Legionella sp IgM Ab [Presence] in Serum
6
80
0.75
0.15
1.0
1.1
—
—
—
0
0
(3014599) Egg white IgE Ab [Units/volume] in Serum
33
358
0.92
0.14
1.0
1.0
u/ml
0.8
0.6
0.25
13
72
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
60
635
0.94
0.14
1.0
1.1
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
57
604
0.94
0.14
1.1
1.2
—
—
—
0
0
(3018851) Theophylline [Moles/volume] in Serum or Plasma
12
103
1.17
0.13
2.1
1.7
umol/l
47.1
43.7
0.30
12
103
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
31
336
0.92
0.13
1.2
1.2
—
—
—
0
0
(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis
8
100
0.80
0.13
4.5
5.8
—
—
—
0
0
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
20
222
0.90
0.13
1.3
1.1
—
—
—
0
0
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
175
1802
0.97
0.13
1.2
1.5
u/ml
116.5
116.5
0.00
41
402
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
295
2886
1.02
0.13
1.5
1.7
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
196
2014
0.97
0.13
1.2
1.5
—
—
—
0
0
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
137
1416
0.97
0.13
2.0
2.2
mg/l
33.3
26.4
0.71
46
384
(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
14
159
0.88
0.13
3.4
5.0
—
—
—
0
0
(3026470) Cobalt [Mass/volume] in Blood
85
887
0.96
0.13
1.9
1.9
ug/l
4.2
3.6
0.16
70
790
(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma
16
142
1.13
0.12
1.3
1.4
—
—
—
0
0
(3013247) Albumin in CSF/Albumin in Serum or Plasma
16
142
1.13
0.12
1.0
1.1
mg/g
8.6
8.2
0.12
16
130
(3048929) Epstein Barr virus Ab [Presence] in Serum
233
2385
0.98
0.12
1.2
1.2
—
—
—
0
0
(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid
51
482
1.06
0.12
1.0
1.1
u/l
1.1
1.1
0.03
26
249
(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum
81
844
0.96
0.12
1.1
1.2
u/ml
88.9
42.0
—
7
63
(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid
51
483
1.06
0.11
1.2
1.3
%
82.4
63.5
—
5
59
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
30
322
0.93
0.11
1.0
1.1
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
57
543
1.05
0.11
1.4
1.4
—
—
—
0
0
(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma
371
3771
0.98
0.11
3.2
4.0
u/ml
106.7
69.7
0.48
357
3633
(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma
11
96
1.15
0.10
1.1
1.0
—
—
—
0
0
(3024471) HLA-A [Type]
39
368
1.06
0.10
1.0
1.0
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
95
982
0.97
0.10
1.1
1.1
—
—
—
0
0
(3012984) Norclozapine [Mass/volume] in Serum or Plasma
5
45
1.11
0.09
2.0
8.3
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
54
565
0.96
0.09
1.1
1.1
—
—
—
0
0
(3007302) Hemoglobin [Mass/volume] in Mixed venous blood
5
47
1.06
0.09
66.8
12.6
—
—
—
0
0
(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay
5
48
1.04
0.09
1.0
1.0
—
—
—
0
0
(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay
17
186
0.91
0.09
1.2
1.2
%
81.1
72.0
—
7
66
(3020650) Glucose [Presence] in Urine
28
262
1.07
0.09
1.4
1.4
—
—
—
0
0
(21491866) Provasopressin.C-terminal [Moles/volume] in Serum or Plasma by Immunoassay
11
97
1.13
0.09
1.2
1.3
pmol/l
16.3
19.6
0.17
11
86
(3020123) Porphyrins [Interpretation] in Serum or Plasma
6
54
1.11
0.09
1.0
1.1
—
—
—
0
0
(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay
27
288
0.94
0.08
1.8
1.9
%
222.9
198.4
0.46
27
275
(3021788) Differential panel - Synovial fluid
213
2091
1.02
0.08
1.4
1.5
—
—
—
0
0
(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen
13
144
0.90
0.08
1.5
1.2
—
—
—
0
0
(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen
13
144
0.90
0.08
1.5
1.2
—
—
—
0
0
(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen
13
144
0.90
0.08
1.5
1.2
—
—
—
0
0
(3027401) Testosterone Free/Testosterone.total in Serum or Plasma
5
60
0.83
0.08
1.0
1.2
%
1.3
1.3
—
5
60
(3024869) Neuronal Ab [Presence] in Serum
21
226
0.93
0.08
1.1
1.1
—
—
—
0
0
(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture
5
64
0.78
0.08
3.0
3.5
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
431
4260
1.01
0.08
1.1
1.1
—
—
—
0
0
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
11
123
0.89
0.08
1.0
1.1
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
252
2481
1.02
0.08
1.4
1.3
—
—
—
0
0
(3035457) Cefaclor IgE Ab [Units/volume] in Serum
7
67
1.04
0.08
1.0
1.1
—
—
—
0
0
(3007368) IgG [Mass/volume] in Cerebral spinal fluid
67
693
0.97
0.08
1.1
1.1
mg/l
55.1
43.0
1.15
58
585
(3044009) aPTT.lupus sensitive (LA screen)
6
72
0.83
0.07
1.3
1.2
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
128
1308
0.98
0.07
1.4
1.7
—
—
—
0
0
(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis
16
147
1.09
0.07
4.5
5.6
ug/min
59.6
54.5
0.09
16
125
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
47
489
0.96
0.07
1.8
2.2
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
47
489
0.96
0.07
1.8
2.2
—
—
—
0
0
(3004446) Plasmodium sp identified in Blood by Light microscopy
10
89
1.12
0.06
2.3
2.7
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
208
2052
1.01
0.06
1.5
1.8
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
92
900
1.02
0.05
1.1
1.2
—
—
—
0
0
(40762814) Titanium [Mass/volume] in Blood
23
243
0.95
0.05
2.3
2.2
ug/l
3.1
3.8
—
8
80
(3017354) Segmented neutrophils/100 leukocytes in Blood
123
1208
1.02
0.05
3.5
3.6
%
60.0
59.0
0.22
85
798
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
20
188
1.06
0.05
1.5
2.0
—
—
—
0
0
(3015171) Extractable nuclear Ab [Units/volume] in Serum
373
3697
1.01
0.05
1.2
1.2
u/ml
0.4
1.1
2.53
26
350
(3028679) Herpes simplex virus Ab [Presence] in Serum
42
406
1.03
0.05
1.1
1.2
—
—
—
0
0
(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay
11
120
0.92
0.05
1.2
1.1
—
—
—
0
0
(3023323) Follitropin [Units/volume] in Serum or Plasma
220
2224
0.99
0.04
1.4
1.3
iu/l
25.0
33.8
5.08
193
1901
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
38
367
1.04
0.04
2.5
1.9
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
63
615
1.02
0.04
1.6
2.0
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
63
615
1.02
0.04
1.7
2.0
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
63
615
1.02
0.04
1.7
2.0
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
63
615
1.02
0.04
1.7
2.0
—
—
—
0
0
(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma
79
806
0.98
0.04
4.7
5.3
u/ml
35.1
91.1
2.34
27
244
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
526
5229
1.01
0.04
1.2
1.2
iu/ml
140.0
140.1
0.00
182
1918
(3023419) Bacteria identified in Sputum by Culture
152
1537
0.99
0.03
1.8
2.4
—
—
—
0
0
(4062490)
102
1034
0.99
0.03
1.4
1.4
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
63
642
0.98
0.03
1.0
1.1
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
63
642
0.98
0.03
1.0
1.1
—
—
—
0
0
(3002256) Pathology report gross observation
1434
14307
1.00
0.03
1.3
1.3
—
—
—
0
0
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
21
219
0.96
0.03
1.2
1.1
—
—
—
0
0
(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay
26
269
0.97
0.02
1.2
1.1
%
79.3
84.6
0.29
13
139
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
259
2606
0.99
0.02
1.3
1.3
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
146
1473
0.99
0.02
1.5
1.8
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
117
1182
0.99
0.02
1.2
1.1
—
—
—
0
0
(3019225) pH of Specimen
1103
11054
1.00
0.02
4.5
4.3
—
—
—
0
0
(21494814) CD8 cells/100 lymphocytes in Specimen
44
449
0.98
0.02
2.4
1.9
—
—
—
0
0
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
34
332
1.02
0.01
1.0
1.1
—
—
—
0
0
(3014891) Appearance of Pleural fluid
14
147
0.95
0.01
1.6
1.6
—
—
—
0
0
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
23
223
1.03
0.01
1.3
1.2
—
—
—
0
0
(3039162) Centromere protein B Ab [Units/volume] in Serum
118
1172
1.01
0.01
1.2
1.3
u/ml
41.4
56.6
—
8
88
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
93
923
1.01
0.01
2.2
2.4
—
—
—
0
0
(40765096) Chromosome analysis panel by Banding
37
364
1.02
0.00
1.2
1.1
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
49
496
0.99
0.00
1.8
2.2
—
—
—
0
0
(4094501)
327
3264
1.00
0.00
1.1
1.1
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
429
4296
1.00
0.00
2.5
2.8
—
—
—
0
0
(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay
18
183
0.98
0.00
1.2
1.2
%
95.0
78.5
—
7
66
(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)
24
237
1.01
0.00
1.2
1.4
—
—
—
0
0
(4027681)
50
497
1.01
0.00
1.1
1.2
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
99
987
1.00
0.00
1.2
1.3
—
—
—
0
0
(3017315) Amylase [Enzymatic activity/volume] in Urine
60
596
1.01
0.00
1.2
1.2
u/l
197.5
445.2
2.43
53
551
(3024139) IgG subclass 3 [Mass/volume] in Serum
103
1034
1.00
0.00
1.3
1.4
g/l
0.4
0.4
0.01
65
710
(43055514) Macroprolactin [Presence] in Serum or Plasma
13
125
1.04
0.00
1.2
1.6
—
—
—
0
0
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
16
155
1.03
0.00
1.0
1.1
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
23
235
0.98
0.00
1.4
1.6
—
—
—
0
0
(3028192) IgG subclass 2 [Mass/volume] in Serum
103
1035
1.00
0.00
1.3
1.4
g/l
3.1
3.0
0.17
65
707
(3027135) IgG subclass 1 [Mass/volume] in Serum
103
1035
1.00
0.00
1.3
1.4
g/l
7.3
7.0
0.36
65
708
(3003740) Influenza virus B Ag [Presence] in Specimen
118
1185
1.00
0.00
1.2
1.1
—
—
—
0
0
(3032352) Blasts [#/volume] in Cerebral spinal fluid
13
128
1.02
0.00
1.5
1.8
—
—
—
0
0
(3013293) Extractable nuclear Ab [Presence] in Serum
14
142
0.99
0.00
1.8
1.7
—
—
—
0
0
(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay
26
262
0.99
0.00
1.2
1.2
%
81.6
83.4
0.07
13
140
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
54
539
1.00
0.00
1.2
1.2
—
—
—
0
0
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
24
241
1.00
0.00
1.1
1.1
—
—
—
0
0
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
22
219
1.00
0.00
2.4
2.7
—
—
—
0
0
(21494671) JAK2 gene exon 14 targeted mutation analysis in Bone marrow by Molecular genetics method
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3016976) Cortisol [Moles/volume] in Serum or Plasma --baseline
0
9
0.00
0.00
0.0
1.6
—
287.6
—
0
9
(3020893) t(14;18)(q32;q21.3)(IGH,BCL2) fusion transcript [Presence] in Blood or Tissue by Molecular genetics method
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3045462) Protein/Creatinine [Ratio] in Urine
5
58
0.86
0.00
3.0
3.1
g/mol
130.2
26.4
—
5
49
(3039183) Clostridium tetani toxoid IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay
6
61
0.98
0.00
1.0
1.2
—
—
—
0
0
(3010801) 5-Hydroxyindoleacetate [Moles/volume] in 24 hour Urine
0
7
0.00
0.00
0.0
1.0
—
20.1
—
0
7
(3032995) BK virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(36304079) Mucus [Presence] in Urine sediment
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3003095) Rheumatoid factor [Units/volume] in Synovial fluid
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3000876) Codfish IgE Ab [Units/volume] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3022577) Toxoplasma gondii IgM Ab [Presence] in Cerebral spinal fluid
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3002853) Influenza virus B Ab [Titer] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3028468) Fragments [Presence] in Blood by Light microscopy
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3025566) Toxoplasma gondii IgG Ab [Units/volume] in Cerebral spinal fluid
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(40760087) Plasmodium sp Ab [Presence] in Serum by Immunofluorescence
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3035153) Lemon IgE Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3018910) Alkaline phosphatase.bone [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3017461) Flecainide [Moles/volume] in Serum or Plasma
7
79
0.89
0.00
2.0
1.4
umol/l
0.9
0.7
—
7
53
(40763629) HC gene rearrangements [Presence] in Bone marrow by Molecular genetics method
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3019420) Tryptase [Mass/volume] in Serum or Plasma
48
480
1.00
0.00
2.1
1.7
ug/l
12.4
10.0
0.23
48
437
(3011325) HIV 1+2 Ab [Presence] in Serum
5
49
1.02
0.00
1.0
1.0
—
—
—
0
0
(36031836) Tocilizumab [Mass/volume] in Serum
0
5
0.00
0.00
0.0
1.2
—
18.9
—
0
5
(3000690) Aldosterone [Moles/time] in 24 hour Urine
0
7
0.00
0.00
0.0
1.0
—
35.3
—
0
7
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: COMB_ORAL_GLUCLOW – Combinations of oral blood glucose lowering drugs
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).